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A B S T R A C T
Background
Complex regional pain syndrome (CRPS) is a painful and disabling condition that usually manifests in response to trauma or surgery.
When it occurs, it is associated with significant pain and disability. It is thought to arise and persist as a consequence of a maladaptive
pro-inflammatory response and disturbances in sympathetically-mediated vasomotor control, together with maladaptive peripheral and
central neuronal plasticity. CRPS can be classified into two types: type I (CRPS I) in which a specific nerve lesion has not been identified,
and type II (CRPS II) where there is an identifiable nerve lesion. Guidelines recommend the inclusion of a variety of physiotherapy
interventions as part of the multimodal treatment of people with CRPS, although their effectiveness is not known.
Objectives
To determine the effectiveness of physiotherapy interventions for treating the pain and disability associated with CRPS types I and II.
Search methods
We searched the following databases from inception up to 12 February 2015: CENTRAL (the Cochrane Library), MEDLINE,
EMBASE, CINAHL, PsycINFO, LILACS, PEDro, Web of Science, DARE and Health Technology Assessments, without language
restrictions, for randomised controlled trials (RCTs) of physiotherapy interventions for treating pain and disability in people CRPS.
We also searched additional online sources for unpublished trials and trials in progress.
Selection criteria
We included RCTs of physiotherapy interventions (including manual therapy, therapeutic exercise, electrotherapy, physiotherapist-
administered education and cortically directed sensory-motor rehabilitation strategies) employed in either a stand-alone fashion or
in combination, compared with placebo, no treatment, another intervention or usual care, or of varying physiotherapy interventions
compared with each other in adults with CRPS I and II. Our primary outcomes of interest were patient-centred outcomes of pain
intensity and functional disability.
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Data collection and analysis
Two review authors independently evaluated those studies identified through the electronic searches for eligibility and subsequently
extracted all relevant data from the included RCTs. Two review authors independently performed ’Risk of bias’ assessments and rated
the quality of the body of evidence for the main outcomes using the Grading of Recommendations Assessment, Development and
Evaluation (GRADE) approach.
Main results
We included 18 RCTs (739 participants) that tested the effectiveness of a broad range of physiotherapy-based interventions. Overall,
there was a paucity of high quality evidence concerning physiotherapy treatment for pain and disability in people with CRPS I. Most
included trials were at ’high’ risk of bias (15 trials) and the remainder were at ’unclear’ risk of bias (three trials). The quality of the
evidence was very low or low for all comparisons, according to the GRADE approach.
We found very low quality evidence that graded motor imagery (GMI; two trials, 49 participants) may be useful for improving pain
(0 to 100 VAS) (mean difference (MD) −21.00, 95% CI −31.17 to −10.83) and functional disability (11-point numerical rating
scale) (MD 2.30, 95% CI 1.12 to 3.48), at long-term (six months) follow-up, in people with CRPS I compared to usual care plus
physiotherapy; very low quality evidence that multimodal physiotherapy (one trial, 135 participants) may be useful for improving
’impairment’ at long-term (12 month) follow-up compared to a minimal ’social work’ intervention; and very low quality evidence that
mirror therapy (two trials, 72 participants) provides clinically meaningful improvements in pain (0 to 10 VAS) (MD 3.4, 95% CI
−4.71 to −2.09) and function (0 to 5 functional ability subscale of the Wolf Motor Function Test) (MD −2.3, 95% CI −2.88 to
−1.72) at long-term (six month) follow-up in people with CRPS I post stroke compared to placebo (covered mirror).
There was low to very low quality evidence that tactile discrimination training, stellate ganglion block via ultrasound and pulsed
electromagnetic field therapy compared to placebo, and manual lymphatic drainage combined with and compared to either anti-
inflammatories and physical therapy or exercise are not effective for treating pain in the short-term in people with CRPS I. Laser therapy
may provide small clinically insignificant, short-term, improvements in pain compared to interferential current therapy in people with
CRPS I.
Adverse events were only rarely reported in the included trials. No trials including participants with CRPS II met the inclusion criteria
of this review.
Authors’ conclusions
The best available data show that GMI and mirror therapy may provide clinically meaningful improvements in pain and function
in people with CRPS I although the quality of the supporting evidence is very low. Evidence of the effectiveness of multimodal
physiotherapy, electrotherapy and manual lymphatic drainage for treating people with CRPS types I and II is generally absent or
unclear. Large scale, high quality RCTs are required to test the effectiveness of physiotherapy-based interventions for treating pain and
disability of people with CRPS I and II. Implications for clinical practice and future research are considered.
P L A I N L A N G U A G E S U M M A R Y
Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II
Background
Complex regional pain syndrome (CRPS) is a painful and disabling condition. Most commonly it affects a person’s arm and hand or
leg and foot and may occur after a traumatic injury. There are two types of CRPS: CRPS I in which there is no nerve injury, and CRPS
II in which there is a nerve injury. Guidelines recommend physiotherapy, which could include different kinds of exercise therapy or
electrotherapy for instance, along with other medical treatments for treating the pain and disability associated with CRPS. However,
we do not know how well these treatments work.
Review question
Which types of physiotherapy treatment are effective for reducing the pain and disability associated with CRPS in adults?
Study characteristics
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We searched for clinical trials of physiotherapy up to 12 February 2015. We included 18 trials that had 739 participants with CRPS I.
In most of these trials the participants had CRPS I of the arm and hand. We did not find any clinical trials that included participants
with CRPS II.
Key results
Overall we did not find any good quality clinical trials of physiotherapy aimed at reducing the pain and disability of CRPS I in adults.
Most included trials were not well designed and contained only small numbers of patients. We did find some low quality trials suggesting
that two broadly similar types of rehabilitation training, known as ’graded motor imagery’ (GMI) and ’mirror therapy’, might be useful
for reducing the pain and disability associated with CRPS I after traumatic events or surgery or a stroke. From the limited evidence
available it appears that some types of electrotherapy, such as ultrasound and pulsed electromagnetic field therapy, as well as a type of
massage therapy known as manual lymphatic drainage, are not effective. Most studies did not report on adverse events and so we do
not know if these treatments have any harmful side-effects.
On the whole, because of the limited number and low quality of available trials for the various physiotherapy treatments, we cannot
be sure if any of the physiotherapy treatments we evaluated are effective for treating the pain and disability of CRPS I in adults. It is
possible that some treatments, such as GMI or mirror therapy, might be effective. Further high quality clinical trials of physiotherapy
are needed in order to find out if any of the different types of physiotherapy treatment are effective at improving pain and disability in
people with CRPS.
B A C K G R O U N D
Description of the condition
Complex regional pain syndrome (CRPS) is a persistent, painful
and disabling condition that usually, but not exclusively, manifests
in response to acute trauma or surgery (Goebel 2011; Shipton
2009). The International Association for the Study of Pain (IASP)
introduced the diagnostic label ’CRPS’ in the 1990s in order to
standardise inconsistencies in terminology and diagnostic criteria
(Merskey 1994). Two sub-categories ofCRPShave beendescribed:
CRPS type I (CRPS I) (formerly and variously referred to as reflex
sympathetic dystrophy (RSD), algodystrophy, Sudek’s atrophy) in
which no nerve lesion is present and CRPS type II (CRPS II)
(formerly referred to as causalgia, algoneurodystrophy), in which
a co-existing nerve lesion (as determined by nerve conduction
studies or surgical inspection for example) is present (Coderre
2011; Todorova 2013).
CRPS is characterised by symptoms and signs typically confined
to a body region or limb, but which may becomemore widespread
(van Rijn 2011). The diagnostic criteria for CRPS originally pro-
posed by the IASP (Merskey 1994) have since been revised in
response to their low specificity and potential to over-diagnose
cases of CRPS. The Budapest criteria proposed by Harden 2010
have enhanced diagnostic accuracy and are now widely accepted
(Goebel 2011). The diagnosis of CRPS is clinical (Goebel 2011)
and the cardinal features include:
1. continuing pain disproportionate to any inciting event;
2. the presence of clusters of various symptoms and signs
reflecting sensory (e.g. hyperaesthesia, allodynia), vasomotor
(e.g. asymmetries of temperature or skin colour, or both),
sudomotor (e.g. oedema or altered sweating or both), motor (e.g.
reduced range of motion, tremor) or trophic (e.g. altered hair or
nails, or both) disturbances; and
3. the absence of any other medical diagnosis that might
better account for an individual’s symptoms and signs.
The pathophysiological mechanisms underlying CRPS are not
fully understood (Harden 2010). Current understanding impli-
cates multiple mechanisms including complex contributions from
a maladaptive pro-inflammatory response and a disturbance in
sympathetically mediated vasomotor control, together with mal-
adaptive peripheral and central neuronal plasticity (Bruehl 2010;
Bruehl 2015;Marinus 2011; Parkitny 2013). Furthermore, mech-
anisms, and in consequence symptoms and signs, may vary be-
tween individuals and within individuals over the time course of
the disorder, thus heightening the complexity (Marinus 2011).
The incidence of CRPS is not accurately known but population
estimates indicate an incidence of somewhere between five and 26
cases per 100,000 person-years (Marinus 2011). A likely conserva-
tive 11-year period prevalence rate for CRPS of 20.57 per 100,000
people has been reported (Sandroni 2003). CRPS is three to four
times more likely to occur in women than in men, and although
it may occur at any time throughout the lifespan it tends to oc-
cur more frequently with increasing age (Shipton 2009). Genetic
susceptibility may serve as an aetiological risk factor for the de-
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velopment of CRPS (de Rooij 2009). In individuals who develop
CRPS after a fracture, intra-articular fracture, fracture-dislocation,
pre-existing rheumatoid arthritis, pre-existing musculoskeletal co-
morbidities (e.g. low-back pain, arthrosis) (Beerthuizen 2012) and
limb immobilisation (Marinus 2011) may increase the risk of its
development. Psychological traits, such as depression, anxiety, neu-
roticism and anger, have so far been discounted as risk factors for
the development of CRPS (Beerthuizen 2009: Lohnberg 2013),
although further prospective studies are required to substantiate
this assertion (Harden 2013).
People with CRPS experience significant suffering and disability
(Bruehl 2010; Lohnberg 2013). Preliminary data suggest that in-
terference with activities of daily living, sleep, work and recreation
is common and further contributes to a diminished quality of life
(Galer 2000; Geertzen 1998; Kemler 2000; Sharma 2009).
Studies into the course of CRPS present contradictory findings.
Whilst some studies have reported complete and partial symptom
resolution within one year (Sandroni 2003; Zyluk 1998), other
studies have indicated more protracted symptoms and impair-
ments lasting from three to nine years (de Mos 2009; Geertzen
1998;Vaneker 2006). In addition, emerging evidence suggests that
people with CRPS of an upper limb (which develops less often
in response to a fracture) and whose affected limb is colder than
the contralateral limb, may experience significantly longer disease
duration than people with CRPS of a lower limb (which occurs
more commonly after fracture) and whose affected limb is warmer
than the contralateral limb (de Mos 2009).
Although guidelines for the treatment of CRPS recommend an
interdisciplinary multimodal approach, comprising pharmacolog-
ical and interventional pain management strategies together with
rehabilitation, psychological therapy and educational strategies
(Goebel 2012; Harden 2013; Perez 2010; Stanton-Hicks 2002),
determining the optimal approach to therapy remains clinically
challenging (Cossins 2013; O’Connell 2013).
Description of the intervention
Guidelines recommend the inclusion of a variety of physiother-
apy interventions as part of the multimodal treatment of CRPS
(Goebel 2012; Perez 2010; Stanton-Hicks 2002) but their effec-
tiveness is not known. Physiotherapy has beendefined as “the treat-
ment of disorders with physical agents and methods” (Anderson
2002) and for CRPS could include any of the following inter-
ventions employed either as stand-alone interventions or in com-
bination: manual therapy (e.g. mobilisation, manipulation, mas-
sage, desensitisation); therapeutic exercise and progressive load-
ing regimens (including hydrotherapy); electrotherapy (e.g. tran-
scutaneous electrical nerve stimulation (TENS), therapeutic ul-
trasound, interferential, shortwave diathermy, laser); physiothera-
pist-administered education (e.g. pain neuroscience education); as
well as cortically directed sensory-motor rehabilitation strategies
(e.g. graded motor imagery (GMI), mirror therapy, sensory motor
retuning, tactile discrimination training).
How the intervention might work
The precise mechanisms of action through which various phys-
iotherapy interventions are purported to relieve the pain and dis-
ability associated with CRPS are not fully understood. Theories
underpinning the use of manual therapies to relieve pain include
the induction of peripheral or central nervous system-mediated
analgesia, or both (Bialosky 2009; Goats 1994). Therapeutic ex-
ercise may induce analgesia, via endorphin-mediated inhibition
(Nijs 2012), and improve function, and by extension disability, by
restoring range of movement at affected joints and improving neu-
romuscular function (Kisner 2002). Theories underlying the use
of electrotherapymodalities for pain relief variously include spinal
cord-mediated electro-analgesia, heat- or cold-mediated analgesia
and anti-inflammatory effects (Atamaz 2012; Robertson 2006).
Pain neuroscience education may reduce pain and disability by
helping individuals to better understand the biological processes
underlying their pain in a way that positively changes pain percep-
tions and attitudes (Louw 2011). Other rehabilitation strategies,
such GMI or mirror therapy, may provide pain relief or increase
mobility, or both, by ameliorating maladaptive somatosensory and
motor cortex reorganisation (Moseley 2005; Moseley 2012).
Why it is important to do this review
A number of systematic reviews suggest that physiotherapy inter-
ventions (e.g. exercise, GMI, TENS) employed in combination
with medical management may be beneficial in reducing the pain
and disability associated with CRPS (Daly 2009; Smith 2005).
However, the inclusion of non-randomised clinical trials and case
series designs, together with the exclusion of studies involving peo-
ple with CRPS type II as well as those published in a language
other than English, may have biased these conclusions. Further-
more, the methodologies used for conducting systematic reviews
have been substantially revised in recent years, such as those rec-
ommended within the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach for describing
the strength of the evidence (Balshem 2011), which has not been
utilised in previous reviews. Given the limitations of existing sys-
tematic reviews, together with the availability of potentially nu-
merous physiotherapy treatment strategies for CRPS, an up-to-
date systematic review of the evidence from randomised clinical
trials for the effectiveness of these interventions may assist clini-
cians in their treatment choices and inform future clinical guide-
lines that may be of use to policymakers and those who commis-
sion health care for people with CRPS.
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O B J E C T I V E S
To determine the effectiveness of physiotherapy interventions for
treating pain and disability associated with CRPS types I and II.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) (including those
of parallel, cluster-randomised and cross-over design) published in
any language. Translators identified by theManaging Editor of the
Cochrane Pain, Palliative and Supportive Care Group evaluated
studies published in a language other than English. We excluded
studies in which participants were not randomised to intervention
groups.
Types of participants
We included trials of adults, aged 18 years or older, diagnosed
with CRPS I or II, or with an alternative diagnostic label for these
conditions (e.g. RSD, causalgia). We grouped trials according to
diagnosis (i.e. CRPS types I and II, or mixed). Since the use of
formal diagnostic criteria for CRPS is inconsistent across studies
(Reinders 2002), we included trials that used established or vali-
dated diagnostic criteria, including the Veldman criteria (Veldman
1993), the International Association for the Study of Pain (IASP)
criteria (Merskey 1994), Bruehl criteria (Bruehl 1999), Budapest
criteria (Harden 2010) and Atkins criteria (Atkins 2010), as well
as studies that either predate these criteria or use non-standard
diagnostic criteria.
Types of interventions
We included all randomised controlled comparisons of physio-
therapy interventions, employed in either a stand-alone fashion or
in combination, compared with placebo, no treatment, another
intervention or usual care, or of varying physiotherapy interven-
tions compared with each other, which were aimed at treating pain
or disability, or both, associated with CRPS. We included trials
in which non-physiotherapists (e.g. occupational therapists) deliv-
ered such physiotherapy interventions, as defined in ’Description
of the intervention’, and reported the professional discipline of the
clinician delivering the intervention. After the publication of our
Cochrane protocol, (Smart 2013) we decided to exclude studies
that evaluated non-physiotherapy based interventions (e.g. phar-
macological) in which all arms received the same physiotherapy
intervention (differing only in the application of the non-physio-
therapy component) as they are unlikely to offer any insight into
the value of physiotherapy management (see Differences between
protocol and review).
Types of outcome measures
Primary outcomes
1. Changes in pain severity/intensity as measured using a
visual analogue scale (VAS), numerical rating scale (NRS), verbal
rating scale or Likert scale;
2. changes in disability as measured by validated self-report
questionnaires/scales or functional testing protocols.
We presented and analysed primary outcomes as change on a con-
tinuous scale or in a dichotomised format as the proportion of par-
ticipants in each group who attained a predetermined threshold of
improvement. For example, we judged cut-points from which to
interpret the likely clinical importance of (pooled) effect sizes ac-
cording to provisional criteria proposed in the Initiative on Meth-
ods, Measurement, and Pain Assessment in Clinical Trials (IMM-
PACT) consensus statement (Dworkin 2008). Specifically, reduc-
tions in pain intensity compared with baseline were judged as fol-
lows:
1. less than 15%: ’no important change’;
2. 15% or more: ’minimally important change’;
3. 30% or more: ’moderately important change’;
4. 50% or more: ’substantially important change’.
We planned to use the cut-points for ’minimally’, ’moderately’
and ’substantially’ important changes to generate dichotomous
outcomes, the effect size for which we would have expressed as the
risk ratio (or relative risk (RR)) but a lack of data did not permit
any such analyses.
Secondary outcomes
We planned to analyse the following secondary outcome measures
where such data were available:
1. changes in composite scores for CRPS symptoms;
2. changes in health-related quality of life (HRQoL) using any
validated tool;
3. changes in patient global impression of change (PGIC)
scales;
4. incidence/nature of adverse effects.
We planned to analyse and present secondary outcomes as change
on a continuous scale or in a dichotomised format but a lack of
data did not permit any such analyses. For example, equivalent
measures of treatment effect with respect to PGIC have been de-
fined as: ’much’ or ’very much’ improved (moderate benefit) and
very much’ improved (substantial benefit) (Dworkin 2008). Fu-
ture updates may allow such analyses where relevant data are avail-
able.
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Search methods for identification of studies
Electronic searches
We identified relevant RCTs by electronically searching the fol-
lowing databases:
1. Cochrane Central Register of Controlled Trials
(CENTRAL) in the Cochrane Library, Issue 1 of 12, 2015;
2. Database of Abstracts of Reviews of Effects in the Cochrane
Library, Issue 1 of 4 2015;
3. Health Technology Assessments in the Cochrane Library,
Issue 1 of 4 2015;
4. MEDLINE (OVID) (1966 to 11 February 2015);
5. EMBASE (OVID) (1974 to 11 February 2015);
6. CINAHL (EBSCO) (1982 to 11 February 2015);
7. PsycINFO (OVID) (1806 to 11 February 2015);
8. LILACS; (1982 to 15 February 2015);
9. PEDro; (1929 to 15 February 2015);
10. Web of Science (ISI);(1945 to 15 February 2015).
The Trials Search Co-ordinator of the Cochrane Pain, Palliative
and Supportive Care Group devised the search strategies. She and
the review authors ran these searches. We used a combination of
controlled vocabulary, i.e. medical subject headings (MeSH) and
free-text terms. The search strategies are in Appendix 1.
Searching other resources
Reference lists
Oncompletion of the electronic searches we searched the reference
lists of all eligible studies in order to identify additional relevant
studies. In addition we screened the reference lists of key physio-
therapy textbooks and previous systematic reviews.
External experts
We sent the list of included trials to a content expert to help
identify any additional relevant studies.
Unpublished data
In order tominimise the impact of publication biaswe searched the
following registers and databases to identify unpublished research
as well as research in progress:
1. OpenGrey (System for Information on Grey Literature in
Europe);
2. Dissertation Abstracts (ProQuest);
3. National Research Register Archive;
4. Health Services Research Projects in Progress;
5. Current Controlled Trials Register (incorporating the meta-
register of controlled trials and the International Standard
Randomised Controlled Trial Number);
6. ClinicalTrials.gov;
7. International Clinical Trials Registry Platform;
8. Pan African Clinical Trials Registry;
9. EU Clinical Trials Register.
Data collection and analysis
Selection of studies
Two review authors (KMS and BMW) independently assessed the
titles and abstracts of studies we identified by the search strategy for
eligibility. If the eligibility of a trial was unclear from the title and
abstract, we assessed the full-text article.We excluded trials that did
not match the inclusion criteria (see the ’Criteria for considering
studies for this review’ section). We resolved any disagreements
between review authors regarding a study’s inclusion by discussion.
If we could not resolve disagreements, a third review author (NEO)
assessed relevant studies and we made a majority decision. Trials
were not anonymised prior to assessment.We obtained potentially
relevant studies identified in the first round of screening in full
text and independently assessed these for inclusion using the same
process outlined above.Wedidnot apply any language restrictions.
Data extraction and management
Two review authors (KMS and BMW) independently extracted
data from all included trials. We extracted data using a standard-
ised and piloted form.We resolved any discrepancies and disagree-
ments by consensus. In cases where we could not achieve consen-
sus, a third review author (NEO) assessed the trial and we took
a majority decision. We extracted the following data from each
included trial:
1. country of origin;
2. study design;
3. study population (including diagnosis, diagnostic criteria
used, symptom duration, age range, gender split);
4. type of noxious initiating event: surgery, fracture, crush
injury, projectile, stab injury, other or no event;
5. type of tissue injured: nerve, soft tissue, bone;
6. presence of medicolegal factors (that may influence the
experience of pain and the outcomes of therapeutic
interventions);
7. concomitant treatments that may affect outcome:
medication, procedures etc.;
8. sample size: active and control/comparator groups;
9. intervention (including type, parameters (e.g. frequency,
dose, duration), setting and professional discipline of the
clinician delivering the therapy);
10. type of placebo/comparator intervention;
11. outcomes (primary and secondary) and time points assessed;
12. adverse effects;
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13. author conflict of interest statements;
14. assessment of risk of bias.
Assessment of risk of bias in included studies
We assessed the overall risk of bias for each included trial on the ba-
sis of an evaluation of key domains using a modified version of the
Cochrane ’Risk of bias’ assessment tool.We classified risk of bias as
either ’low’ (low risk of bias for all key domains), ’unclear’ (unclear
risk of bias for one ormore key domains) or ’high’ (high risk of bias
for one or more key domains), as outlined in the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011a). We
also considered experimental design-specific (e.g. cross-over study
designs) ’Risk of bias’ issues where appropriate (Higgins 2011b).
We assessed the following key domains of risks of bias for each
included trial using either ’yes’, ’no’ or ’unclear’ judgements:
1. random sequence generation (checking for possible
selection bias). We assessed the method used to generate the
allocation sequence as either: low risk of bias (any truly random
process, e.g. random number table; computer random number
generator); unclear risk of bias (method used to generate
sequence not clearly stated); or high risk of bias (studies using a
quasi/non-random process (e.g. odd or even date of birth;
hospital or clinic record number);
2. allocation concealment (checking for possible selection
bias). The method used to conceal allocation to group prior to
assignment determines whether intervention allocation could
have been foreseen in advance of, or during recruitment, or
changed after assignment. We assessed the methods used as: low
risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes); unclear risk
of bias (method not clearly stated); or high risk of bias (studies
that do not conceal allocation (e.g. open list));
3. blinding of study participants and personnel (checking for
possible performance bias). We assessed the methods used to
blind participants and care providers as either: low risk of bias
(participants and care providers blinded to allocated intervention
and unlikely that blinding broken; or no/incomplete blinding
but judged that both intervention arms reflect active
interventions of relatively equal credibility delivered with equal
enthusiasm); unclear risk of bias (insufficient information
provided to permit a judgement of low/high risk of bias); or high
risk of bias (participants and care providers not blinded to the
allocated intervention and interventions are clearly identifiable as
control and experimental; or participants and care providers
blinded to the allocated intervention but likely that blinding was
broken);
4. blinding of outcome assessment (self reported outcomes)
(checking for possible detection bias). We assessed the methods
used to blind study participants self-reporting outcomes (e.g.
pain severity) from knowledge of which intervention a
participant received. We assessed the methods as either: low risk
of bias (participants blinded to allocated intervention and
unlikely that blinding broken; or no/incomplete blinding but
judged that both intervention arms reflect active interventions of
relatively equal credibility delivered with equal enthusiasm);
unclear risk of bias (insufficient information provided to permit
a judgement of low/high risk of bias); or high risk of bias
(participants not blinded to the allocated intervention and
interventions are clearly identifiable as control and experimental;
or participants blinded to the allocated intervention but likely
that blinding was broken);
5. blinding of outcome assessment (investigator-administered
outcomes) (checking for possible detection bias). We assessed the
methods used to blind researchers undertaking outcome
assessments (e.g. functional testing protocols) from knowledge of
which intervention a participant received. We assessed the
methods as at either: low risk of bias (researchers blinded to
allocated intervention and unlikely that blinding broken);
unclear risk of bias (insufficient information provided to permit a
judgement of low/high risk of bias); high risk of bias (researchers
not blinded to the allocated intervention; or researcher blinded
to the allocated intervention but likely that blinding was broken);
6. incomplete outcome data (drop out) (checking for possible
attrition bias). We first assessed for risk of attrition bias by
evaluating participant drop out rates according to judgements
based on the following criteria: low risk of bias (less than 20%
drop out and appears not to be systematic, with numbers for
each group and reasons for drop out reported); unclear risk of
bias (less than 20% drop out but appears to be systematic or
numbers per group and reasons for drop out not reported); high
risk of bias (greater than or equal to 20% drop out);
7. incomplete outcome data (method of analysis) (participants
analysed in the group to which they were allocated) (checking for
possible attrition bias). We further assessed for risk of attrition
bias by separately evaluating the appropriateness of the method
of analysis employed, using the following criteria: low risk of bias
(participants analysed in the group to which they were allocated
(intention-to-treat (ITT) or as an available case analysis); unclear
risk of bias (insufficient information provided to determine if
analysis was based on the principle of ITT or per protocol); or
high risk of bias (if per protocol analysis used or where available
data is not analysed or participant’s data were included in group
to which they were not originally assigned to);
8. selective reporting (checking for possible reporting bias).
We assessed studies for selective outcome reporting using the
following judgements: low risk of bias (study protocol available
and all pre-specified primary outcomes of interest adequately
reported or study protocol not available but all expected primary
outcomes of interest adequately reported or all primary
outcomes numerically reported with point estimates and
measures of variance for all time points); unclear risk of bias
(insufficient information provided to permit a judgement of low/
high risk of bias); or high risk of bias (incomplete reporting of
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pre-specified primary outcomes or point estimates and measures
of variance for one or more primary outcome not reported
numerically (e.g. graphically only) or one or more primary
outcomes reported using measurements, analysis methods or
subsets of data that were not pre-specified or one or more
reported primary outcomes were not pre-specified or results for a
primary outcome expected to have been reported were excluded);
9. other bias. We assessed studies for other potential sources of
bias. We determined judgements regarding low/unclear/high risk
of bias according to the potential confounding influence of
identified factors, for example: low risk of bias (appears free of
other potentially serious sources of bias e.g. no serious study
protocol violations identified); unclear risk of bias (other sources
of bias may be present but there is either insufficient information
to assess whether an important risk of bias exists or insufficient
rationale or evidence regarding whether an identified problem
will introduce bias); or high risk of bias (results may have been
confounded by at least one potentially serious risk of bias, e.g. a
significant baseline imbalance between groups; a serious protocol
violation; use of ’last observation carried forward’ when dealing
with missing data).
We also evaluated included trials for the additional sources of bias
associated with:
1. sample size; and
2. duration of follow-up, as recommended by Moore 2010.
Small studies are more prone to bias because of their inherent im-
precision and due to the effects of publication biases (Dechartres
2013; Moore 2012; Nüesch 2010). Inadequate length of follow-
up may produce an overly positive view of the true clinical ef-
fectiveness of interventions, particularly in persistent conditions
(Moore 2010). These additional criteria were not considered ’key
domains’ and therefore did not inform judgements of a trial’s over-
all risk of bias. We assessed these trials according to the following
criteria:
1. sample size (checking for possible biases confounded by
small sample size): we assessed trials as being at low risk of bias
(greater than or equal to 200 participants per treatment arm);
unclear risk of bias (50 to 199 participants per treatment arm);
high risk of bias (less than 50 participants per treatment arm);
2. duration of follow-up (checking for possible biases
confounded by a short duration of follow-up): we assessed trials
as being at low risk of bias (follow-up of greater than or equal to
eight weeks); unclear risk of bias (follow-up of two to seven
weeks); or high risk of bias (follow-up of less than two weeks).
Two review authors (KMS and BMW) independently undertook
the ’Risk of bias’ assessments, and resolved any disagreements by
discussion. If they could not reach an agreement, a third review
author (NEO) undertook a ’Risk of bias’ assessment and we took
a majority decision.
Measures of treatment effect
We presented treatment effect sizes using appropriate metrics. We
calculated the risk ratio (RR) with 95% confidence intervals (CIs)
for dichotomised outcome measures, and the number needed to
treat (NNT) as an absolute measure of treatment effect where
possible.
We expressed the size of treatment effect on pain intensity, as
measured with a VAS or NRS, using the mean difference (MD)
(where all studies utilised the same measurement scale) or the
standardised mean difference (SMD) (where studies used different
scales). In order to aid interpretation of the pooled effect size we
planned to back-transform the SMD value to a 0 to 100 mmVAS
format on the basis of the mean standard deviation (SD) from
trials using a 0 to 100 mm VAS where possible.
We analysed the data using Review Manager (RevMan) (RevMan
2014). We plotted the results of each RCT with available data
as point estimates with corresponding 95% CIs and displayed
them using forest plots. If included trials demonstrated clinical
homogeneity we performed ameta-analysis to quantify the pooled
treatment effect sizes using a random-effects model. We did not
perform a meta-analysis when clinical heterogeneity was present.
Similarly we presented secondary outcomes, though we did not
consider them for meta-analysis.
Unit of analysis issues
All included trials randomised participants at the individual partic-
ipant level.We planned to meta-analyse estimates of treatment ef-
fect (and their standard errors (SE)) from cluster-RCTs employing
appropriate statistical analyses using the generic inverse-variance
method in RevMan (RevMan 2014), as suggested in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011b).
Where we considered such trials to have employed inappropriate
analyses, we planned to utilise methods for ’approximately correct
analysis’ where possible (Higgins 2011b). In addition, we planned
to enter cross-over trials into a meta-analysis when it was clear that
data were free from carry-over effects, and to combine the results
of cross-over trials with those of parallel trials by imputing the
post-treatment between-condition correlation coefficient from an
included trial that presented individual participant data and use
this to calculate the SE of the SMD. These data may be entered
into a meta-analysis using the generic inverse-variance method
(Higgins 2011b). Issues concerning cluster-RCTs and crossover
trials did not arise as we did not identify any cluster-RCTs thatmet
the inclusion criteria of this review and we did not conduct any
quantitative analyses on the one included crossover trial. We may
include such analyses where relevant data are available in future
updates of this Cochrane review.
Dealing with missing data
We attempted to contact the authors of included trials when nu-
merical data were unreported or incomplete. If trial authors only
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presented data in graphical form, we did not attempt to extract
the data from the figures. If SD values were missing from follow-
up assessments but were available at baseline, we used these values
as estimates of variance in the follow-up analyses.
Assessment of heterogeneity
We evaluated the included trials for clinical homogeneity regard-
ing study population, treatment procedure, control intervention,
timing of follow-up and outcome measurement. For trials that
were sufficiently clinically homogenous to pool, we formally ex-
plored heterogeneity using the Chi² test to investigate the statisti-
cal significance of any heterogeneity, and the l² statistic to estimate
the amount of heterogeneity. Where significant heterogeneity (P
value < 0.1) was present, we planned to explore subgroup analyses
(see the ’Differences between protocol and review’ section).
Assessment of reporting biases
Weplanned to test for the possible influence of publication bias on
trials that utilised dichotomised outcomes by estimating the num-
ber of participants in trials with zero effect required to change the
NNT to an unacceptably high level (defined as an NNT of 10), as
outlined by Moore 2008. An absence of relevant data meant that
we did not undertake any analyses. Instead, we considered the pos-
sible influence of small study/publication biases on review findings
as part of our ’Risk of bias’ assessment (see the ’Assessment of risk
of bias in included studies’ section) and as part of our Grading
of Recommendations Assessment, Development and Evaluation
(GRADE) assessments (Guyatt 2011a) of the quality of evidence
(see the ’Data synthesis’ section). We may include such analyses
in future updates of this Cochrane review where relevant data are
available.
Data synthesis
Where possible, we grouped extracted data according to diagno-
sis (CRPS types I or II, or mixed), intervention, outcome (i.e.
pain, disability) and duration of follow-up (short-term: zero to less
than two weeks postintervention; mid-term: two to seven weeks
postintervention; and long-term: eight or more weeks postinter-
vention). Regarding intervention, we planned to pool data from
trials that investigated the same single therapy separately for each
therapy. We planned to pool trials of multimodal physiotherapy
programmes together.
For all analyses, we report the outcome of the ’Risk of bias’ as-
sessments. Where we found inadequate data to support statistical
pooling, we performed a narrative synthesis of the evidence. We
were only able to combine trials through meta-analysis for one
type of intervention (graded motor imagery (GMI)) because of
insufficient data and clinical heterogeneity. We conducted a qual-
itative analysis of all trial findings and used the GRADE approach
to assess the quality of evidence (Guyatt 2011a; Guyatt 2011b).
To ensure consistency of GRADE judgements we applied the fol-
lowing criteria to each domain equally for all key comparisons of
the primary outcome:
1. limitations of studies: we downgraded once if more than
25% of the participants were from trials we classified as being at
high risk of bias;
2. inconsistency: we downgraded once if heterogeneity was
statistically significant and the I² statistic value was greater than
40%. When a meta-analysis was not performed we downgraded
once if the trials did not show effects in the same direction;
3. indirectness: we downgraded once if more than 50% of the
participants were outside the target group;
4. imprecision: we downgraded once if there were fewer than
400 participants for continuous data and fewer than 300 events
for dichotomous data;
5. publication bias: we downgraded once where there was
direct evidence of publication bias or if estimates of effect based
on small scale, industry sponsored studies raised a high index of
suspicion of publication bias.
Two review authors (KS and NO)made the judgement of whether
these factors were present or not. We considered single trials to
be inconsistent and imprecise, unless more than 400 participants
were randomised for continuous outcomes or more than 300 for
dichotomous outcomes. We applied the following definitions of
the quality of the evidence (Balshem 2011):
1. high quality: we are very confident that the true effect lies
close to that of the estimate of the effect;
2. moderate quality: we are moderately confident in the effect
estimate. The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different;
3. low quality: our confidence in the effect estimate is limited.
The true effect may be substantially different from the estimate
of the effect;
4. very low quality: we have very little confidence in the effect
estimate. The true effect is likely to be substantially different
from the estimate of effect.
Subgroup analysis and investigation of heterogeneity
We planned to perform subgroup analyses based on the type of
CRPS (i.e. I, II or mixed) and its temporal characteristics (i.e.
acute (defined as symptoms and signs of CRPS of zero to 12 weeks
duration) and chronic (symptoms and signs of CRPS lasting 13
weeks). However, we did not undertake them due to the insuffi-
cient number of included trials.
Sensitivity analysis
We planned to perform sensitivity analyses on risk of bias (inves-
tigating the influence of excluding studies classified at high risk
of bias) and choice of meta-analysis model (investigating the in-
fluence of using a fixed-effect analysis). We did not perform them
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as insufficient data were available (see the ’Differences between
protocol and review’ section).
R E S U L T S
Description of studies
See the ’Characteristics of included studies’ and ’Characteristics
of excluded studies’ sections.
Results of the search
We conducted the literature search up to 12 February 2015 and
identified 990 papers that comprised original research studies, re-
views and poster abstracts, of which 744 remained after we re-
moved duplicates. After we screened titles and abstracts, we dis-
carded 702 records because they did not meet the inclusion cri-
teria of this Cochrane review. We retrieved 42 records for full-
text screening. We deemed 21 trial reports from 18 original tri-
als for inclusion (Askin 2014; Aydemir 2006; Cacchio 2009a;
Cacchio 2009b; Dimitrijevic 2014; Duman 2009; Durmus 2004;
Hazneci 2005; Jeon 2014; Li 2012;Moseley 2004;Moseley 2005;
Moseley 2006; Moseley 2009; Mucha 1992; Oerlemans 1999;
Schreuders 2014; Severens 1999; Uher 2000). Four published trial
manuscripts reported data pertaining to a single included trial
(Oerlemans 1999).
One additional trial is awaiting submission for publication
(ISRCTN39729827), one trial is available only as a conference
abstract (Mete-Topcuoglu 2010) and we were unable to contact
the authors of one registered trial (NCT00625976). These three
trials are awaiting classification (see the ’Characteristics of studies
awaiting classification’ table).
In addition, we identified five ongoing trials (see the ’
Characteristics of ongoing studies’ section). We have presented a
flow diagram outlining the trial screening and selection process
(Figure 1). Two review authors (KMS and BMW) reported study
details in the ’Characteristics of included studies’ and ’Risk of bias’
tables for two papers published in the Turkish language (Aydemir
2006; Hazneci 2005) based on an English translation of the orig-
inal trial report; and one review author (BMW) reported study
details in the ’Characteristics of included studies’ and ’Risk of bias’
tables for two papers published in the German language (Mucha
1992; Uher 2000).
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Figure 1. Study flow diagram.
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Included studies
We have provided the details of all included trials in the
’Characteristics of included studies’ tables. We extracted rele-
vant data from eight included trials (Askin 2014; Aydemir 2006;
Cacchio 2009a; Dimitrijevic 2014; Duman 2009; Durmus 2004;
Hazneci 2005; Li 2012). We contacted or attempted to contact
the corresponding authors of 10 trials on three occasions in or-
der to obtain missing outcomes data (Cacchio 2009b; Jeon 2014;
Moseley 2004; Moseley 2005; Moseley 2006; Moseley 2009;
Mucha 1992; Oerlemans 1999; Schreuders 2014; Uher 2000).
One trial author responded and supplied data for an outcome
measure of ’impairment’ but we were unable to extract outcome
data linked to ’pain intensity’ from the supplied data (Oerlemans
1999); one trial author responded stating that they were unable
to supply the relevant data (Schreuders 2014); and there was no
response from the other trial authors we had contacted.
Design
All included trials were RCTs, and 17 essentially used a paral-
lel-group design. Whilst the selected participants in three trials
crossed over from comparator to intervention groups (Cacchio
2009b; Moseley 2004; Mucha 1992), none employed a true ran-
domised crossover design and we analysed them up to the point of
crossover as parallel group-designs. One trial employed a within-
subject randomised crossover design (Moseley 2009). Twelve tri-
als included two intervention arms (Cacchio 2009a; Dimitrijevic
2014; Duman 2009; Durmus 2004; Hazneci 2005; Jeon 2014;
Li 2012; Moseley 2004; Moseley 2006; Mucha 1992; Schreuders
2014; Uher 2000), five trials included three arms (Askin 2014;
Aydemir 2006; Cacchio 2009b; Moseley 2005; Oerlemans 1999)
and one study used four arms (Moseley 2009). No cluster-RCTs
met the inclusion criteria of this Cochrane review.
Participants
The 18 trials included a total of 739 participants and the total
number of participants per trial ranged from 10 to 135. All 18 tri-
als included participants with CRPS I using a range of diagnostic
criteria, most commonly using those of Bruehl 1999. There were
no trials that included participants with CRPS II. Fourteen trials
included participants with CRPS I of the upper limb (Askin 2014;
Aydemir 2006; Cacchio 2009a; Cacchio 2009b; Duman 2009;
Durmus 2004; Hazneci 2005; Li 2012; Moseley 2004; Moseley
2005; Moseley 2009; Mucha 1992; Oerlemans 1999; Schreuders
2014), two with either upper or lower limb CRPS I (Dimitrijevic
2014; Moseley 2006), one with CRPS I of the lower limb (Uher
2000) and one trial included participants with either upper, lower,
multi-limb or whole body CRPS I (Jeon 2014). Participants de-
veloped CRPS I linked to a range of aetiologies including on-
set post fracture, soft-tissue injuries, stroke, surgery, carpal tunnel
syndrome as well as of idiopathic onset. Participants had acute
symptoms (less than or equal to three months) of CRPS I in six
trials (Cacchio 2009a; Dimitrijevic 2014; Durmus 2004; Hazneci
2005; Li 2012; Mucha 1992), chronic symptoms (greater than
three months) in seven trials (Duman 2009; Jeon 2014; Moseley
2004; Moseley 2005; Moseley 2006; Moseley 2009; Schreuders
2014), a mix of acute and chronic symptoms in two trials (Askin
2014; Oerlemans 1999), and three trials did not report the dura-
tion of symptoms (Aydemir 2006; Cacchio 2009b; Uher 2000).
Trials were undertaken across a range of geographical locations
including: Turkey (N = 5); Australia (N = 4); Italy, Germany, the
Netherlands (N = 2 each); China, Serbia, and South Korea (N =
1 each).
Interventions
We have provided a detailed description of the interventions de-
livered in each included trial in the ’Characteristics of included
studies’ table. The types of physiotherapy interventions delivered
were heterogenous across the included trials and included various
electrotherapy modalities (ultrasound, TENS, laser, interferential
therapy, pulsed electromagnetic field therapy), cortically-directed
sensory-motor rehabilitation strategies (GMI, mirror therapy, vir-
tual body swapping, tactile sensory discrimination training), exer-
cise (active, active-assisted, passive, stretching, strengthening, mo-
bilising, functional; supervised and unsupervised), manual lym-
phatic drainage (MLD) and pain management advice. Five tri-
als directly compared an active and placebo intervention (Askin
2014; Aydemir 2006; Cacchio 2009a; Cacchio 2009b; Durmus
2004). Six trials evaluated electrotherapy modalities (Askin 2014;
Aydemir 2006; Dimitrijevic 2014; Durmus 2004; Hazneci 2005;
Mucha 1992), eight trials evaluated cortically-directed sensory-
motor rehabilitation strategies (Cacchio 2009a; Cacchio 2009b;
Jeon 2014; Moseley 2004; Moseley 2005;Moseley 2006; Moseley
2009; Schreuders 2014), two trials evaluatedMLD (Duman 2009;
Uher 2000) and two trials evaluated general rehabilitation thera-
pies (Li 2012; Oerlemans 1999).
Excluded studies
We have listed the details regarding the 13 trial reports that we ex-
cluded in the ’Characteristics of excluded studies’ table. The main
reasons for exclusion were that the studies were either not RCTs
(N = 8), investigated clinically irrelevant outcome measures (N =
2), tested interventions that fell outside the scope of physiotherapy
(N = 2) or included participants with mixed aetiologies with only
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one participant with CRPS I in each of the two arms of the trial
(N = 1).
Risk of bias in included studies
We presented a summary of the ’Risk of bias’ assessments for all
included trials in Figure 2 and Figure 3. We judged the overall
risk of bias as being ’high’ for 15 trials (Askin 2014; Cacchio
2009a; Cacchio 2009b; Dimitrijevic 2014; Duman 2009; Jeon
2014; Li 2012; Moseley 2004; Moseley 2005; Moseley 2006;
Moseley 2009; Mucha 1992; Oerlemans 1999; Schreuders 2014;
Uher 2000) and ’unclear’ for three trials (Aydemir 2006; Durmus
2004; Hazneci 2005). We did not judge any of the included trials
as having an overall ’low’ risk of bias.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each ’Risk of bias’ item presented as
percentages across all included trials.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each ’Risk of bias’ item for each
included trial.
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Allocation
Only seven out of the 18 trials reported using, or were judged to
have used, adequate methods to generate a random sequence and
conceal allocation (Aydemir 2006; Dimitrijevic 2014; Li 2012;
Moseley 2004; Moseley 2005; Moseley 2006; Schreuders 2014)
and as such we judged them as being of ’low’ risk of selection bias.
The risk of selection bias was ’unclear’ in 10 trials (Cacchio 2009a;
Cacchio 2009b;Duman 2009;Durmus 2004;Hazneci 2005; Jeon
2014; Moseley 2009; Mucha 1992; Oerlemans 1999; Uher 2000)
where the methods used to generate the allocation sequence or
where the method of allocation concealment were not adequately
reported enough in order to allow a judgement of ’high’ or ’low’
risk of bias. One trial, Askin 2014, used a quasi-randomisation
method and we judged it as having a ’high’ risk of selection bias.
Blinding
We judged six trials to have a ’low’ risk of performance bias (Askin
2014; Aydemir 2006; Dimitrijevic 2014; Durmus 2004; Hazneci
2005;Moseley 2005), where participants were adequately blinded
to their intervention or where we considered a lack of blinding
to have been unlikely to have biased trial outcomes. Eight trials
were at ’high’ risk of performance bias and consequently detection
biases because of inadequate or a lack of blinding (Duman 2009;
Li 2012; Moseley 2004; Moseley 2006; Mucha 1992; Oerlemans
1999; Schreuders 2014; Uher 2000). We judged three trials, all
of which tested the efficacy of electrotherapy-based modalities, as
at ’low’ risk of detection bias because they successfully blinded
participants and outcome assessors (Askin 2014; Aydemir 2006;
Durmus 2004).
Incomplete outcome data
Twelve trials either had no drop-outs or a drop-out rate of less
than 20% and as such we judged them as having a ’low’ risk of at-
trition bias secondary to drop-outs (Askin 2014; Cacchio 2009b;
Duman 2009; Durmus 2004; Jeon 2014; Li 2012; Moseley 2004;
Moseley 2005; Moseley 2006; Moseley 2009; Mucha 1992; Uher
2000). In five trials the risk of attrition bias was ’unclear’ either be-
cause the drop-out rate was not reported (Aydemir 2006; Hazneci
2005) or the drop-out rate between groups was unequal and the
effect of which was uncertain (Cacchio 2009a; Dimitrijevic 2014;
Oerlemans 1999). One trial, with an overall drop-out rate of 44%,
had a ’high’ risk of attrition bias (Schreuders 2014). We judged
11 trials (Cacchio 2009a; Cacchio 2009b; Duman 2009; Durmus
2004; Jeon 2014; Li 2012;Moseley 2004;Moseley 2006;Moseley
2009; Mucha 1992; Oerlemans 1999), two trials (Aydemir 2006;
Hazneci 2005) and five trials (Askin 2014; Dimitrijevic 2014;
Moseley 2005; Schreuders 2014; Uher 2000) respectively as being
at ’low’, ’unclear’ and ’high’ risk of attrition bias as a consequence
of their adopted method of analysis.
Selective reporting
We judged a total of nine trials as being of ’high’ risk of reporting
bias; three trials because of inadequate or incomplete reporting of
primary outcomes, or both (Jeon 2014; Oerlemans 1999; Uher
2000) and six trials because the trial authors presented data in
graphical format only, i.e. point estimates with measures of varia-
tion were not reported (Cacchio 2009b; Moseley 2004; Moseley
2005; Moseley 2009; Mucha 1992; Schreuders 2014). The other
nine trials adequately reported outcome data and we judged them
as being at ’low’ risk of reporting bias (Askin 2014; Aydemir 2006;
Cacchio 2009a; Dimitrijevic 2014; Duman 2009; Durmus 2004;
Hazneci 2005; Li 2012; Moseley 2006).
Other potential sources of bias
We considered three trials to be at ’high’ risk of other potential
sources of bias; one trial because it was published as a ’Letter to
the Editor’ and not as a full trial report (Cacchio 2009b); one trial
because violations of the random sequence generation were per-
mitted (Oerlemans 1999); and one trial because it did not report
the baseline data of three participants excluded from the analysis
and because of a likely highly significant baseline imbalance in
duration of symptoms between groups (Schreuders 2014). The 15
other trials appeared to be free of other potential sources of bias.
Sample size
None of the included trials had intervention arms with 200 or
more participants per treatment arm. One trial randomised 60
participants to each trial arm and we judged it as being at ’unclear’
risk of bias (Li 2012). The remaining 17 trials had less than 50
participants per trial arm and we judged them as being at ’high’
risk of bias based on this criterion.
Duration of follow-up
Nine trials employed a follow-up period of less than two weeks and
we judged them as being at ’high’ risk of bias based on this criterion
(Askin 2014; Cacchio 2009b; Dimitrijevic 2014; Durmus 2004;
Hazneci 2005; Jeon 2014; Moseley 2009; Mucha 1992; Uher
2000). Six trials employed a follow-up period of eight or more
weeks and we judged them as being at ’low’ risk of bias (Cacchio
2009a; Duman 2009; Li 2012; Moseley 2005; Moseley 2006;
Oerlemans 1999). Three trials reported a follow-up period of two
to seven weeks and we judged them as being at ’unclear’ risk of
bias (Aydemir 2006; Moseley 2004; Schreuders 2014).
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Effects of interventions
Multimodal physiotherapy
One three-arm trial, Oerlemans 1999, (135 participants), which
we judged as being at ’high’ risk of bias based on a number of crite-
ria, compared a physiotherapy programme (pain management ad-
vice, relaxation exercises, connective tissuemassage, TENS and ex-
ercise) plus medical treatment according to a fixed pre-established
protocol, to an occupational therapy (OT) programme (splinting,
de-sensitisation, functional rehabilitation) plus medical manage-
ment and to a control intervention, described as ’social work’ (SW),
(attention, advice) plus medical management in participants with
CRPS I of the upper limb secondary to mixed aetiologies. The
trial authors did not adequately report details regarding the nature
of the interventions and did not standardise the number of treat-
ment sessions given with the intensity and frequency of treatment
adjusted to the individual needs of participants. The trial authors
did not report the overall duration of the treatment periods for
each trial group.
According to the trial authors, adjuvant physiotherapy, and to a
lesser extent, OT were superior to SW for reducing pain accord-
ing to all four measures of pain intensity at three months post-
recruitment, and for reducing pain from effort of use of the af-
fected extremity at six months. However, there were no signifi-
cant between-group differences for any measure of pain intensity
at 12 months follow-up. Numerical data (i.e. group means and
standard deviations (SD) for each time-point) for the four self-
reported measures of pain intensity (current pain, pain from effort
of use of the affected extremity, least and worst pain experienced
in the preceding week) were not reported, and the trial authors
have not provided these data. Consequently, no further analyses
of these measures were possible and we could not determine effect
sizes.
Physiotherapy demonstrated a small but statistically significant
between-group improvement in impairment at 12 months com-
pared to SW (impairment level sum score, five to 50 scale; mean
difference (MD) 3.7, 95% (CI) −7.13 to −0.27, P = 0.03; but
not OT.
The trial authors did not report numerical data from other out-
comes of interest, including measures of function (Radboud Skills
Questionnaire, modified Greentest, Radboud Dexterity Test),
HRQoL (Sickness Impact Profile) and adverse events although
Oerlemans 1999 state that there were no between-group differ-
ences in function or well-being at 12 months follow-up.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, down-
graded once for methodological limitations, once for impreci-
sion and once for inconsistency) that physiotherapy plus medical
treatment may be more effective at reducing pain at short- (three
months) but not long-term follow-up (12 months) compared to a
control intervention of SW and that physiotherapy plus medical
treatment may be more effective at reducing impairment com-
pared to SW at long-term follow-up in the treatment of CRPS I
of the upper limb.
Cortically directed sensory-motor rehabilitation
strategies
Graded Motor Imagery
We included four separate trials of GMI, all of which were small
trials (13 to 37 participants) judged to be at ’high’ risk of bias.
Two trials compared the same GMI protocol to control interven-
tions of standard care (Moseley 2004; Moseley 2006); one com-
pared a different GMI protocol plus conventional treatment (oc-
cupational and therapy physiotherapy) to conventional treatment
alone (Schreuders 2014); and one compared three different GMI
protocols to each another (Moseley 2005).
Moseley 2004 (N = 13) compared a six-week GMI programme
(consisting of two weeks of limb laterality recognition followed
by two weeks of imagined movements followed by two weeks of
mirror-box therapy) to 12 weeks of ongoing medical management
(predominantly physiotherapy) in participants with longstanding
CRPS I of the upper limb post wrist fracture. Moseley 2006 com-
pared the same GMI programme to physical therapy and usual
care in a combined cohort of 14 participants with phantom-limb
pain and 37 participants with CRPS I of the upper or lower limb
of mixed aetiologies. Schreuders 2014 (N = 18) compared a six-
week GMI programme (consisting of one week of limb lateral-
ity recognition, followed by one week of imagined movements,
followed by four weeks of mirror-box therapy) plus conventional
care (physiotherapy and OT) to conventional care alone in par-
ticipants with longstanding CRPS I of the upper limb (aetiology
not reported).
Moseley 2004 reported a statistically significant improvement in
pain, asmeasured by theNeuropathic Pain Scale (NPS) at sixweeks
post-treatment, in participants that received GMI compared to
ongoing medical management. Moseley 2004 reported a NNT to
obtain a 50% reduction in the NPS (total score) of three (95% CI
1.4 to 10.1). Moseley 2006 reported statistically significant im-
provements in pain, as measured by a 0 to 100 VAS, and function,
as measured by an 11-point NRS, immediately postintervention
and at six months post-treatment for the combined cohort of par-
ticipants with CRPS I and phantom limb pain. At six weeks post-
treatment Schreuders 2014 found no statistically significant dif-
ferences between groups on any measure of pain intensity or func-
tion. None of these trials reported any data about adverse events
and did not measure other outcomes of interest, such as composite
scoring of symptoms, HRQoL and PGIC.
Moseley 2004,Moseley 2006 and Schreuders 2014 presented data
for changes in pain and function in participants specifically with
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CRPS I graphically only and did not report numerical data (i.e.
group means and SD values at each time-point) for measures of
pain intensity or function, or both. However, 0 to 100 VAS pain
and functiondatawere available fromMoseley 2004 and theCRPS
I participants in Moseley 2006 from a previous overview of sys-
tematic reviews of interventions for CRPS (O’Connell 2013). We
used these data in this Cochrane review with the authors’ permis-
sion. Pooling of these results gave an effect size (weighted mean
difference) of −14.45 (95% CI −23.02 to −5.87, P = 0.001, 49
participants, two trials; Analysis 1.1) with no significant hetero-
geneity. We expressed this data as a percentage of the mean base-
line pain levels in the larger trial (58 out of 100), which equated
to a 25% (95% CI 10 to 40) reduction in pain intensity at the
end of the treatment period. Moseley 2004 presented outcomes at
medium-term follow-up (six weeks post-treatment, N = 13, MD
−20.00, 95% CI −7.97 to −32.13, P = 0.001). This equated
to an improvement of 34% (95% CI 14 to 55) of the baseline
VAS pain level in the Moseley 2006 trial (average baseline data for
pain VAS was not available from the Moseley 2004 trial report).
At long-term follow-up (six months post-treatment (N = 36)) in
Moseley 2006, the MDwas −21.00, 95% CI−10.83 to−31.17,
P < 0.001, which equates to an improvement of 36% (95% CI
19% to 54%). The immediate post-treatment effect was below
the threshold for a moderately clinically important difference but
exceeded the threshold for a minimally clinically important differ-
ence. The medium- and long-term effects met the threshold for a
moderately important benefit. We were unable to obtain numeri-
cal data from Schreuders 2014.
We pooled the data on function from two trials (Moseley 2004 and
Moseley 2006; data on CRPS I participants only), which returned
aMD of: 1.87 (95%CI 1.03 to 2.71, 49 participants, two trials; P
< 0.001; Analysis 1.2) at the end of treatment; 2.26 (95% CI 1.42
to 3.10, P < 0.001) at medium-term follow-up (Moseley 2004,
N = 13); and 2.30 (95% CI 1.12 to 3.48, P < 0.001) at long-
term follow-up (Moseley 2006, N = 36). This represented a large
improvement in function from the baseline function score (0.5)
in the control group of the larger trial (Moseley 2006).
In a three-arm trial, Moseley 2005 (N = 20) compared a six-week
GMI programme with its three components delivered in the ’cor-
rect’ order (i.e. two weeks of laterality recognition followed by two
weeks of imagined movements followed by two weeks of mirror-
box therapy) to two other GMI programmes with selected com-
ponents delivered in different orders at odds with its hypothesised
mechanism of action, in participants with longstanding CRPS I
of the upper limb post wrist fracture. We found statistically signif-
icant improvements in pain and function in the correctly ordered
GMI group compared to both comparison groups, as measured
by the NPS and an 11-point NRS respectively at 12 weeks post-
treatment. Moseley 2005 reported that at 12-week follow-up, the
mean reduction inNPS score for the correctly orderedGMI group
was approximately seven and 18 points greater than the mean re-
ductions in the other two groups respectively. The trial did not
report numerical data for measures of pain intensity and function,
and we have been unable to obtain these data from the trial author.
Consequently we were unable to perform any further analyses of
these measures and we could not determine the effect sizes. The
trial did not report any data concerning adverse events and did not
measure other outcomes of interest, such as composite scoring of
symptoms, HRQoL and PGIC.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, down-
graded once for methodological limitations, once for imprecision
and once for inconsistency) that GMI plus medical management
may be more effective at reducing pain and improving function
than conventional physiotherapy plus medical management in the
treatment of CRPS I of the upper limb. There is very low quality
evidence (RCT evidence: high, downgraded once for methodolog-
ical limitations, once for imprecision and once for inconsistency)
that appropriately ordered GMI was more effective at reducing
pain and improving function than inappropriately ordered GMI.
Mirror therapy
We included two trials of mirror therapy (Cacchio 2009a; Cacchio
2009b). Cacchio 2009a (N = 48) compared four weeks of mirror
therapy plus conventional stroke rehabilitation to placebo mirror
therapy (covered mirror) plus conventional stroke rehabilitation
in participants with CRPS I of the upper limb post-stroke. In a
trial judged to be at ’unclear’ risk of bias, Cacchio 2009a reported
statistically significant improvements in pain and function, at all
post-treatment time-points, in themirror therapy group compared
to the placebo group. Specifically, Cacchio 2009a reported a mean
between-group difference following treatment in pain at rest (0 to
10 VAS) of −2.9 (95% CI −4.23 to −1.57, P < 0.001) and in
pain on movement (shoulder flexion) of −3.10 (95% CI −4.28
to−1.92, P < 0.001). At six-month follow-up the differences were
still present, −3.4 (95% CI −4.71 to −2.09, P < 0.001) for pain
at rest, and−3.8 (95%CI−4.96 to−2.64, P < 0.001) for pain on
movement. The post-treatment and six-months follow-up mean
differences for pain at rest equated to a 38% (95% CI 21 to 56%)
and 45% (95% CI 28 to 62%) reduction in the average baseline
pain level respectively, whist the post-treatment and six-months
follow-up mean differences for pain on movement equated to a
36%(95%CI23 to50%) and45%(95%CI31 to58%) reduction
in the average baseline pain level respectively, consistent with a
moderately important benefit.
Regardingdisability,Cacchio 2009a also reported significantmean
between-group differences in functional limitation, as measured
by the functional ability subscale of theWolf Motor Function Test
(WMFT, zero to five score range) of −1.9 (95% CI −2.36 to
−1.44, P < 0.001) at the end of treatment and of −2.3 (95% CI
−2.88 to −1.72, P < 0.001) at six-months follow-up.
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In a separate three-arm trial, judged to be at ’high’ risk of bias,
Cacchio 2009b (N=24) compared four weeks ofmirror therapy to
either placebo mirror therapy (covered mirror) or mental imagery
training in participants with CRPS I of the upper limb post stroke.
Cacchio 2009b reported that seven out of eight participants in the
mirror therapy group reported reduced pain (median change in
zero to 100 VAS of −51 mm, range −70 to −18) compared with
one of eight participants in the covered mirror therapy group and
two of eight participants in the mental imagery group; the median
change was not reported for either the covered mirror or mental
imagery groups. At the end of the treatment period, pain scores
were significantly lower in the mirror therapy group compared to
the other two groups. However, the trial authors did not report
any further between-group data andwe have been unable to obtain
these data from the trial authors. Consequently we were unable
to perform any further analyses of these measures and we could
not determine the effect size. The trial authors did not report data
from other outcomes of interest, including measures of function
and adverse events, while they did not measure outcomes, such as
composite scoring of symptoms, HRQoL and PGIC.
Quality of the evidence
There was very low quality evidence (RCT evidence: high, down-
graded once for methodological limitations, once for imprecision,
once for indirectness) that mirror therapy reduced pain and im-
proved upper limb function in participants with post stroke CRPS
I of the upper limb compared with covered mirror therapy.
Virtual body swapping
We included one trial of virtual body swapping with mental re-
hearsal compared to virtual body swapping alone (Jeon 2014) (N
= 10) in participants with CRPS I of either the upper or lower
limbs, multiple limbs or the whole body, the aetiology of which
was not reported. Participants underwent a single session of their
allocated intervention with follow-up immediately post-treatment
only. Jeon 2014 reported that there was no difference between the
groups regarding pain intensity, as measured by an 11-point Likert
rating scale ranging from zero (no pain) to 10 (severe pain) imme-
diately post-treatment. The trial authors did not report numerical
data for measures of pain intensity, and we have been unable to
obtain these data from the trial authors. As a result, we could not
conduct any further analyses and we could not determine the ef-
fect size. We rated the trial as at ’unclear’ risk of bias for random
sequence generation and allocation concealment, and at ’high’ risk
of bias for selective outcome reporting. The trial authors did not
report any data concerning adverse events and did not measure
other outcomes of interest, such as measures of function, compos-
ite scoring of symptoms, HRQoL and PGIC.
Quality of the evidence
There was very low quality evidence (RCT evidence: high, down-
graded once for methodological limitations, once for imprecision
and once for inconsistency) that virtual body swapping with men-
tal rehearsal does not reduce pain in people with CRPS I in the
short-term.
Tactile discrimination training
We included one trial, Moseley 2009, that compared four tactile
discrimination training (TDT) protocols with one another (N =
10) in participants with CRPS I of the upper limb from mixed
aetiologies. Moseley 2009 reported no significant differences in
self-reported pain intensity (0 to 100 VAS) at two day follow-
up. The trial authors did not report numerical data for measures
of pain intensity, and they have not supplied us with these data.
Thus wewere unable to perform any further analyses and we could
not determine the effect size. We rated the trial at ’high’ risk of
bias for selective outcome reporting, sample size and duration of
follow-up. Regarding adverse events, three participants reported
that the pressure stimuli associated with the TDT occasionally
hurt but that this was not enough to necessitate modification or
cessation of the TDT training. The trial authors did not measure
other outcomes of interest, such as function, composite scoring of
symptoms, HRQoL and PGIC.
Quality of the evidence
There was very low quality evidence (RCT evidence: high, down-
graded once for methodological limitations, once for imprecision
and once for inconsistency) that TDT does not reduce the pain
associated with CRPS I at short-term follow-up.
Electrotherapy interventions
Ultrasound of the stellate ganglion versus placebo
Two trials, Askin 2014 and Aydemir 2006, investigated the effec-
tiveness of applying ultrasound directed to the stellate ganglion
versus placebo. Both trials were small, with fewer than 50 partici-
pants, and were at ’high’ or ’unclear’ risk of bias based on a number
of criteria. Askin 2014 (N = 45) compared two doses (3.0 watts
and 0.5 watts intensity) of high frequency ultrasound to placebo
ultrasound. All trial groups also receivedmultimodal conventional
treatment that included a course of medication (including vitamin
C, gabapentin and prednisolone) and physiotherapy (including
TENS, contrast baths, active and passive range of motion exercises
and stretching, resistance and mirror box exercises). The partici-
pants received treatments daily for 20 days. Aydemir 2006 (N =
25) compared stellate ganglion block with ultrasound to blocks
with lidocaine and placebo conditions for both interventions. All
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trial groups received exercises, TENS, contrast baths, compression
and oral paracetamol. While only one trial, Aydemir 2006, pro-
vided data in an extractable format for meta-analysis, both trials
demonstrated no statistically significant difference of ultrasound
over placebo for pain. Regarding assessment of function, Askin
2014 used the DASH score to measure function. While Askin
2014 did not present data in a format extractable for meta-anal-
ysis, they reported no statistically significant effect of ultrasound.
Aydemir 2006 measured hand function using a Functional Hand
Scale (0 to 19 scale, with lower scores indicating better function)
and reported statistically significant improvements in all three trial
groups post-treatment and at one month follow-up. According to
our analyses there were significantly greater improvements in the
placebo group post-treatment (MD 7.86, 95% CI 1.93 to 13.79,
P = 0.009) and at one month follow-up (MD 6.79, 95% CI 0.85
to 12.73, P = 0.02). The trial authors did not present any data
concerning adverse events and did not measure other outcomes
of interest, such as composite scoring of symptoms, HRQoL and
PGIC.
Quality of the evidence
There is low quality evidence (RCT evidence: downgrade once for
methodological limitations and once for imprecision) that stellate
ganglion block via ultrasound is not effective for the treatment of
pain or loss of hand function in people with CRPS I.
Ultrasound of the stellate ganglion versus TENS.
One trial with 30 participants compared ultrasound of the stellate
ganglion to TENS in military recruits with acute (mean duration
of symptoms: 44 days) CRPS I of the upper limb secondary to
mixed aetiologies (Hazneci 2005). Both groups also received con-
trast baths and physiotherapist prescribed exercises. In this trial
the ultrasound group demonstrated inferior post-treatment pain
scores (0 to 10 VAS; MD 2.13, 95% CI 1.47 to 2.79, P < 0.001)
which equates to a potentially clinically important difference of
27% (95% CI 19 to 36) of the average baseline pain score. The
trial authors measured pain severity at the end of the three-week
intervention period only without longer-term follow-up.We rated
the trial at ’unclear’ risk of bias for random sequence generation
and allocation concealment. They did not report any data con-
cerning adverse events and did not measure other outcomes of in-
terest, such as function, composite scoring of symptoms, HRQoL
and PGIC.
Quality of the evidence
There is low quality evidence (RCT evidence: high, downgraded
once for imprecision and once for inconsistency) that ultrasound
to the stellate ganglion is inferior to TENS for the treatment of
pain in people with CRPS I in the short-term.
Pulsed electromagnetic field therapy
One trial with 40 participants, Durmus 2004, compared pulsed
electromagnetic field (PEMF) treatment (100 Gauss, 50 Hz, five
times weekly for six weeks) plus calcitonin and a stretching exercise
routine to placebo EMF plus calcitonin and stretching in partici-
pants with acute (mean duration of symptoms: 52 days) CRPS I
of the upper limb following Colles fracture. At the end of treat-
ment, Durmus 2004 found no statistically significant between-
group difference in pain at rest (VAS), pain on activity, or range of
motion. We rated the trial at ’high’ risk of bias for study size and
duration of follow-up and at ’unclear’ risk of bias for allocation
concealment. The trial authors did not report any data concerning
adverse events and did not measure other outcomes of interest,
such as function, composite scoring of symptoms, HRQoL and
PGIC.
Quality of the evidence
There is low quality evidence (RCT evidence: high, downgraded
once for imprecision and once for inconsistency) that PEMF is not
superior to placebo for the treatment of pain or range of motion
in people with CRPS I.
Laser therapy versus Interferential therapy
One trial with 50 participants compared 20 sessions of low-
level laser therapy with interferential current therapy in partic-
ipants with post-traumatic CRPS I of the upper or lower limb
(Dimitrijevic 2014). Both trial groups also received kinesitherapy
that consisted of individualised active and active assisted exercises,
strictly dosed up to pain threshold. We rated the trial at ’high’
risk of bias for incomplete outcome data, trial size and duration
of follow-up. Post-therapy the results demonstrated a statistically
significant between-group mean difference for pain at rest (0 to
100 VAS) of−8.6 (95% CI−16.27 to−0.93, P = 0.03) in favour
of laser therapy. This equates to a difference of 14% (95% CI
1.5 to 26) from the mean baseline pain score of the two groups,
which falls below our criteria for a minimal clinically important
difference. There was no statistically significant post-treatment be-
tween-group difference with respect to pain with movement of the
affected wrist or ankle according to our analysis (P = 0.07). The
trial authors reported that there were no negative effects of therapy
recorded. The trial authors did not measure other outcomes of in-
terest, such as function, composite scoring of symptoms, HRQoL
and PGIC.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, down-
graded once for methodological limitations, once for imprecision
and once for inconsistency) that low level laser therapy does not
result in a clinically important reduction in pain when compared
to interferential therapy when added to exercise therapy.
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CO2 Bath therapy
One trial, Mucha 1992, with 40 participants compared carbon
dioxide (CO2) baths in addition to exercise therapy with exercise
therapy alone in participants with post-traumatic CRPS I of the
hand.Neither intervention is clearly described in the paper though
the baths were administered in 12-minute sessions five times a
week for four weeks. Mucha 1992 reported that there was a sta-
tistically significant between-group difference in pain at rest, pain
with movement and night pain in favour of the CO2 bath group.
The trial authors did not report numerical data, and we have been
unable to obtain these data from the trial authors. Consequently,
we were unable to perform any further analyses of these measures
and could not determine an effect size. We rated the study at
’high’ risk of bias on five separate criteria. The trial authors did not
report any data concerning adverse events and did not measure
other outcomes of interest, such as function, composite scoring of
symptoms, HRQoL and PGIC.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, down-
graded once for methodological limitations, once for imprecision
and once for inconsistency) that CO2 baths combined with ex-
ercise therapy are more effective for relieving the pain associated
with CRPS I than exercise alone.
Electro-acupuncture and massage versus rehabilitation
One trial, Li 2012, with 120 participants compared 30 sessions of
electro-acupuncture combined with upper limb massage therapy
to 30 sessions of rehabilitation in participants with post stroke
shoulder-hand syndrome. Rehabilitation consisted of active-as-
sisted scapular movements, Bobath exercises to clench the fist,
functional transfer training and proprioceptive neuromuscular fa-
cilitation (PNF) exercise. It is unclear if the primary aim of the
rehabilitation offered was to manage the shoulder-hand syndrome
explicitly or if it was a general rehabilitation programme aimed at
addressing the motor impairments related to the stroke. This trial
measured pain in the shoulder when it was taken passively to 90°
of elevation but did not include any other measure of upper limb
or hand pain. We rated the trial at ’high’ risk of bias for blinding
of participants and at ’unclear’ risk of bias for sample size. Li 2012
reported greater reductions on the outcome pain (in the shoulder
when taken passively to 90º) in favour of the electro-acupuncture
and massage group at the end of the six-week treatment period
(MD −1.70, 95% CI −2.09 to −1.31, P = 0.01) which were
sustained at 12-weeks follow-up (MD −1.40, 95% CI −1.78 to
−1.02, P < 0.001). The post-treatment and 12-week follow-up
MD values equated to a 21% (95% CI 16 to 26%) and 18%
(95% CI 13 to 22%) reduction in the average baseline pain level
respectively. These were below the threshold for a moderately clin-
ically important difference but exceeded the IMMPACT thresh-
old (15%) for a minimally important benefit. Li 2012 reported
no statistically significant difference in hand function between the
two trial groups, but a statistically significant difference in upper
limb function in favour of the electro-acupuncture and massage
group at the end of treatment (MD 4.5, 95% CI 0.85 to 8.15,
P = 0.05) which was no longer significant at 12-weeks follow-
up. The trial authors reported that there were no adverse reac-
tions to intervention in either trial group. They did not measure
other outcomes of interest, such as composite scoring of symp-
toms, HRQoL and PGIC. Notably, we also have some concerns
regarding the diagnostic equivalence of ’shoulder-hand syndrome’
and CRPS I and whether the control intervention was directed
towards the management of the shoulder-hand syndrome or the
upper limb functional stroke problem, both of which may have
implications for the generalisability of this trial’s findings.
Quality of the evidence
There is very low quality evidence (RCT evidence: high, down-
graded once for methodological limitations, once for imprecision
and once for indirectness) that a course of electro-acupuncture and
massage is superior to rehabilitation therapy for pain on passive
shoulder elevation in participants with post stroke shoulder-hand
syndrome, but not hand-specific function. Also, the magnitude of
effect on pain severity was clinically minimal.
Other interventions
Manual Lymphatic Drainage therapy
Two included trials, Duman 2009 and Uher 2000, investigated
the effectiveness of addingMLD therapy to rehabilitation.Duman
2009 (N = 34) compared the addition of MLD massage to con-
ventional care (nonsteroidal anti-inflammatory drugs and physical
therapy) to conventional care alone in participants with CRPS I of
the upper limb of mixed aetiology. Uher 2000 (N = 40) compared
the addition of MLD in addition to exercise therapy to exercise
therapy alone in participants with CRPS I of the lower limb of
mixed aetiology. We rated both trials as being at ’high’ risk of bias
on multiple criteria. We were only able to extract data on relevant
outcomes from Duman 2009, but both trials demonstrated no
statistically significant effect of the addition of MLD on pain. The
trial authors did not report any data on adverse events and did not
measure other outcomes of interest, such as function, composite
scoring of symptoms, HRQoL and PGIC.
Quality of the evidence
There is low quality evidence (RCT evidence: high, downgraded
once formethodological limitations and once for imprecision) that
the addition of MLD to rehabilitation does not improve pain in
people with CRPS I.
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D I S C U S S I O N
Summary of main results
Given the paucity of high quality of evidence derived from our
analyses of the 18 included randomised controlled trials (RCTs)
(739 participants), we cannot draw any firm conclusions regarding
the effectiveness or harmfulness of a broad range of physiotherapy-
based interventions for treating the pain and disability associated
with complex regional pain syndrome (CRPS) I in adults.
The results of one included trial, Oerlemans 1999, provided very
low quality evidence that a multimodal physiotherapy programme
may provide a small, long-term improvement in impairment, as
measured by a composite scoring method, compared to a minimal
intervention of ‘social work’, but the magnitude of this effect is
of questionable clinical significance. We could not determine its
effect on a range of pain-related outcomes.
Evidence that supports the use of cortically-directed sensory-mo-
tor rehabilitation strategies was mixed. Our findings suggest that
graded motor imagery (GMI) may provide clinically meaningful
medium- and long-term improvements in both pain and disabil-
ity in people with CRPS I, although the results from these trials
were from very low quality studies and were inconsistent. While
our meta-analysis of two trials, Moseley 2004 and Moseley 2006,
provided evidence of such benefits, we were unable to obtain and
include data from one, as yet unpublished, clinical trial with con-
tradictory results (Schreuders 2014); these results should therefore
be treated with caution.
Based on two included trials we found very low quality evidence
that mirror therapy provides long-term clinically meaningful im-
provements in pain and function in people with CRPS I follow-
ing stroke (Cacchio 2009a; Cacchio 2009b). The effectiveness of
mirror therapy in broader participant populations with CRPS I
(e.g. post-trauma) is unknown. We also found very low quality ev-
idence that the more novel interventions of virtual body swapping
± mental rehearsal (Jeon 2014) and tactile discrimination training
(TDT) (Moseley 2009) do not provide any short-term benefits
for pain in people with CRPS I.
Evidence that supported the use of electrotherapy-based interven-
tions was mixed. There was low to very low quality evidence that:
1. stellate ganglion block via ultrasound combined with a
conventional treatment programme was not superior to placebo
ultrasound for pain and hand function at medium-term follow-
up (Askin 2014; Aydemir 2006);
2. stellate ganglion block via ultrasound combined with
contrast baths and exercise was inferior to TENS combined with
contrast baths and exercise for pain and short-term follow-up
(Hazneci 2005);
3. PEMF therapy was not superior to placebo PEMF for pain
at short-term follow-up (Durmus 2004);
4. laser therapy combined with exercise may provide a small,
probably clinically insignificant, benefit in pain compared to
interferential current therapy and exercise at short-term follow-
up (Dimitrijevic 2014); and
5. CO2 bath therapy combined with exercise may improve
pain compared to exercise therapy alone although the effect size
could not be determined (Mucha 1992) and the interventions
were inadequately described.
Two RCTs provided low quality evidence that manual lymphatic
drainage (MLD) combined with and compared to either non-
steroidal anti-inflammatories and physical therapy (Duman 2009)
or exercise therapy (Uher 2000) is not beneficial for pain in people
with CRPS I.
We found very low quality evidence from one trial, Li 2012, that
electro-acupuncture and massage were superior to a stroke reha-
bilitation programme for pain on passive shoulder movement in
shoulder-hand syndrome post stroke at longer-term follow-up.
However, the magnitude of this effect was unlikely to be clinically
important and both the reliability and validity of the outcome
measure used are questionable.
Only two trial reports, one related to laser and interferential ther-
apies, Dimitrijevic 2014, and one to TDT, Moseley 2009, com-
mented on the presence or absence of adverse events and reported
no serious events.
We did not find any clinical trials that included participants with
CRPS II that met the inclusion criteria of this Cochrane review.
Overall, we identified a lack of high or moderate quality evidence
with which to inform or guide rehabilitation practice in people
with CRPS I or II. Based on the current body of evidence, we
cannot draw any accurate or firm conclusions regarding the effec-
tiveness or safety of any of the specific physiotherapy-based inter-
ventions we identified in this Cochrane review.
Overall completeness and applicability of
evidence
The evidence base for the use of physiotherapy interventions in
CRPS is incomplete, although this reflects a broader problem for
all intervention research in CRPS (O’Connell 2013). Most in-
cluded trials (16/18) used established diagnostic criteria to identify
participants with CRPS I. However, as might be expected given
the development history of such criteria in CRPS, there was some
variation in the criteria used between included trials. Beyond var-
ious issues relating to risk of bias and study size (see Quality of
the evidence) there are very few instances where more than one
included trial tested a specific intervention. Two trials, Duman
2009 and Hazneci 2005, specifically recruited participants from
military populations. As such, it is possible that contextual fac-
tors specific to that participant group and environment may limit
the applicability of those results to civilian clinical practice. Eight
trials only measured outcomes immediately at the end of treat-
ment with no longer-term follow-up. Such trials offer limited in-
formation about the genuine clinical utility of interventions for a
condition that is commonly persistent. The broad heterogeneity
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of interventions assessed in the included trials afforded us limited
opportunities to pool data. However, it is possible that advances
in meta-analytical statistics may permit such analyses in the future
(Melendez-Torres 2015).
The aim of this Cochrane review was to investIgate the effective-
ness of physiotherapy interventions for people with CRPS I or II.
We used a deliberately inclusive definition to attempt to include
evidence on any intervention that might reasonably be delivered
within a physiotherapy context for people with CRPS. As a result
the included trials varied considerably but most were designed to
test the specific effectiveness of individual modalities either alone,
when added to other treatments or compared to other treatments.
While these trials offered information about the specific or ad-
ditional clinical benefits of those modalities, they are less infor-
mative about the effectiveness of physiotherapy programmes that
incorporate multiple treatment modalities, but are more likely to
reflect physiotherapy as it is delivered in clinical practice. Only one
included trial, Oerlemans 1999, took the pragmatic approach of
testing amultimodal physiotherapy programme against a minimal
treatment control group. Notably, this trial pre-dates substantial
developments in the pathophysiological models of CRPS and it
is possible that a modern multimodal physiotherapy programme
might differ substantially. In addition, the included trials rarely
reported on adverse events (two out of 18 trials) and it is unclear
whether or not this represents an absence of adverse events or a
failure to report them.
While we categorised these interventions under the label “physio-
therapy” in this Cochrane review, we recognise that rehabilitation
therapies may be delivered by a range of different professionals,
including occupational therapists and nurses.
Quality of the evidence
As reflected by theGrading of Recommendations Assessment, De-
velopment and Evaluation (GRADE) ratings, the overall quality
of the evidence in this Cochrane review was low or very low. This
reflects the fact that most included trials were at unclear or high
risk of bias for criteria included under the standard domains of
the Cochrane ’Risk of bias’ tool, and under the additional ’Risk
of bias’ criteria of study size and duration included in this review.
The included trials studied a broad heterogeneity of interventions,
which afforded us limited opportunity to pool data and that, cou-
pled with study size, led to issues of imprecision and inconsistency.
It is likely that small study effects, wherein there is a propensity
for negative studies to not be published, might lead to an overly
positive picture for some interventions, particularly in a field with
such a limited evidence base. Evidence from the wider literature
indicates that this might lead to an overly positive picture for some
interventions (Dechartres 2013; Moore 2012; Nüesch 2010). In a
review of meta-analyses, Dechartres 2013 demonstrated that trials
with fewer than 50 participants, which reflects most trials (17/18)
included in this Cochrane review, returned effect estimates that
were on average 48% larger than the largest trials and 23% larger
than estimates from studies with sample sizes of more than 50 par-
ticipants. We did not downgrade any of the GRADE judgements
on the basis of publication bias, as there can be no direct evidence
with so few trials for any given intervention. Moreover, it is ac-
cepted that existing approaches to detecting publication bias are
unsatisfactory. To an extent our GRADE judgements reflect this
risk through the assessment of imprecision and the limitations of
included trials. Conversely, the issue of small study size with few
included trials available for any single comparison raises the pos-
sibility of false negatives through lack of statistical power (Button
2013). Many of the comparisons we included in this review did
not demonstrate a statistically significant difference. However, it
is possible that we may have missed real effects on this basis.
The quality of reporting in many included trials was problematic.
There was a lack of detailed descriptions of some interventions and
a number of included trials did not present key numerical outcome
data for all time-points (9/18 trials) or insufficiently reported the
scoring properties of their outcome measures for pain intensity
(7/18 trials). The quality of reporting of pain-related outcomes
measures in clinical trials and observational studies is frequently
insufficient (Smith 2015). In a systematic review of the quality of
pain intensity reporting in three prominent pain journals, Smith
2015 found that nearly one quarter of published studies inade-
quately reported the type of pain intensity measure employed.
Potential biases in the review process
We conducted extensive and sensitive literature searches and in-
cluded trials regardless of the language of publication. As such
this Cochrane review probably represents the totality of currently
available evidence. The choice to use the IMMPACT thresholds
to determine the clinical importance of effect sizes is potentially
controversial. What exactly constitutes an important difference on
any given outcome measure remains contentious as the construct
of a generic importance thresholds for a variety of interventions
fails to reflect that patient satisfaction might differ substantially
between interventions given their risks, costs and inconvenience,
the point in the care pathway at which the participant arrives,
and a range of other possible factors. Moreover, the IMMPACT
thresholds are based on estimates of the degree of within-person
change from baseline that participants might consider to be clin-
ically important, whereas the effect sizes focused on in this re-
view reflect the average change between intervention-groups fol-
lowing the interventions. For some pharmacological interventions
the distribution of participant outcomes is bimodal (Moore 2013;
Moore 2014a; Moore 2014b). That is, some participants experi-
ence a substantial reduction in symptoms, someminimal to no im-
provement and very few experience intermediate (moderate) im-
provements. In this instance, and if the distribution of participant
outcomes reflects the distribution of treatment effects, then the
average effect may be the effect that the fewest participants actu-
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ally demonstrate (Moore 2013). It is therefore possible that a small
average between-group effect size might reflect that a proportion
of participants responded very well to the intervention tested. The
common solution to this problem is to conduct a ‘responder anal-
ysis’, which compares the proportion of participants achieving a
clinically important improvement from baseline in the treatment
and control groups. However responder analysis is very rare in re-
habilitation therapies and there is no evidence to date to establish
whether outcomes are commonly bimodal in rehabilitation trials.
It therefore remains equally possible that a very small average be-
tween-group effect might accurately represent the generally very
small effects of an intervention for most or all individuals.
As such, the between-group change is our sole available estimate
of the specific effectiveness of the interventions in the included
trials. Since the publication of our protocol for this review, Smart
2013, the OMERACT 12 group reported recommendations for
minimally important difference for pain outcomes (Busse 2015).
The group recommends a threshold of 10 mm on a 0 to 100
VAS as the threshold forminimal importance for average between-
group change, though stress that this should be interpreted with
caution as it remains possible that estimates which fall closely be-
low this point may still reflect a treatment that benefits an ap-
preciable number of participants. Using this largely more lenient
threshold would not alter our conclusions regarding clinical im-
portance. The OMERACT thresholds present similar problems
to those associated with all generic thresholds and it seems likely
that the discussion around what constitutes clinical importance
will continue. Arguably, the thresholds used in this Cochrane re-
view of a 15% or 30% improvement in baseline levels of pain that
are specifically attributable to the interventions do not represent
unreasonably high thresholds.
Agreements and disagreements with other
studies or reviews
The results of this systematic review are largely consistent with the
conclusions drawn in our recent overview of systematic reviews of
all interventions for CRPS (O’Connell 2013). In O’Connell 2013
we drew our conclusions mainly based on two non-Cochrane re-
views of physiotherapy interventions for CRPS (Daly 2009; Smith
2005) and we based the analysis of the evidence at the level of
those included reviews. Our current review is more up-to-date,
includes a number of additional studies and our conclusions are
drawn from direct analysis of the original trials. Daly 2009 con-
cluded that there was good to very good quality evidence to sup-
port the use of GMI for CRPS; and a review by Bowering 2013
(of which review author NEO was a co-author) concluded that
there was limited evidence to suggest that GMI may be effective
for CRPS. In O’Connell 2013 we concluded that there was low
quality evidence for the effectiveness of GMI. In this Cochrane
review we downgraded the GRADE rating for the evidence related
to GMI to very low, largely due to the inconsistency introduced
by the inclusion of Schreuders 2014. In Schreuders 2014 the trial
authors adjusted the treatment schedule compared to the sched-
ules delivered by Moseley 2004 and Moseley 2006, though it was
based on the same theoretical model. Smith 2005 concluded that
there was some evidence that exercise, acupuncture, TENS, relax-
ation techniques, mirror therapy, GMI and combined treatment
programmes may be helpful and that it was not possible to deter-
mine the effectiveness of individual treatments for CRPS-I. Ten
years on, that picture has not changed substantially. It is possible
that future systematic reviews may provide further evaluations of
the effectiveness of cortically-directed sensory-motor rehabilita-
tion strategies (Plumbe 2013).
Recent clinical guidelines from the USA (Harden 2013) and the
UK (Goebel 2012) have placed rehabilitation therapies as first-line
treatments for people with CRPS. Both guidelines describe and
recommend an extensive range of possible physiotherapy modal-
ities that might be employed. In making their recommendations,
these guidelines (unlike this Cochrane review) draw on evidence
from non-randomised studies, expert consensus and studies of
neuropathic pain generally. This Cochrane review highlights the
fragility of the evidence underpinning these recommendations.
The optimal approach to physiotherapy for people withCRPS and
the true extent of potential benefits and risks remain uncertain.
Also, there may be substantial redundancy within the broad range
of therapies described or recommended in the guidelines.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
It is likely that, in line with contemporary clinical guidelines, phys-
iotherapy and rehabilitation based interventions will continue to
be first-line treatments for people with complex regional pain syn-
drome (CRPS). In this Cochrane review we have been unable to
find compelling evidence of the effectiveness, or lack thereof, of
physiotherapy interventions, or to inform an optimal approach
to therapy, although very low quality evidence suggests a possi-
ble benefit of multimodal physiotherapy, graded motor imagery
(GMI) and mirror therapy. The available evidence suggests that
applying ultrasound to the stellate ganglion or manual lymphatic
drainage (MLD) to the affected limb are unlikely to offer clinical
benefit to people with CRPS type I.
Implications for research
Overall, given the existing limitations within the current body of
evidence, there is a clear need for further research into physio-
therapy interventions in people with CRPS but many challenges
remain in addressing this problem. Given the relatively low inci-
dence of CRPS, it is likely to be difficult to recruit adequate num-
bers of participants to clinical trials. It seems likely that the best
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chance of addressing this challenge is through multicentre, col-
laborative research projects aimed at recruiting participants from
potentially larger pools of clinical populations. It seems unlikely
that it will be possible to generate sufficient evidence to support
the many individual modalities currently applied to people with
CRPS. In this instance there is a case for taking a pragmatic ap-
proach to developing contemporarymulti-modal, individually tai-
lored “best practice” models of physiotherapy care and prioritising
trials of these programmes against usual or minimal care. Such
trials might provide pragmatic estimates of effectiveness which
best reflect the value of guideline recommended practice. Larger
replication trials of GMI and mirror therapy would also be use-
ful in order to provide more accurate estimates of treatment ef-
fect for these interventions, which current evidence suggests may
offer meaningful clinical benefit. Future trials should use estab-
lished diagnostic criteria, clearly report the type of CRPS under
investigation and their design should consider recent recommen-
dations (Busse 2015; Dworkin 2008; Dworkin 2009; Dworkin
2010; Turk 2008a; Turk 2008b) for the design and reporting of
trials in chronic pain. This will help to ensure that outcomes,
thresholds for clinical importance and study design are optimal
and we also highlight the need to measure patient-focused out-
comes over clinically relevant periods of time. Furthermore, future
trials should adhere to CONSORT guidance, including that re-
lated to the reporting of the development and evaluation of com-
plex interventions (Möhler 2015).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Askin 2014
Methods Design: parallel group, 3-arm, single-blind RCT (Turkey; dates not reported)
Setting: outpatient hospital clinic.
Interventions: conventional care plus low dose high frequency ultrasound therapy (0.
5 watts/cm²) for stellate ganglion blockade or conventional care plus low dose high fre-
quency ultrasound therapy (3.0 watts/cm²) for stellate ganglion blockade or conven-
tional care plus placebo ultrasound therapy
Sample size calculation: not reported.
Participants Number of participants: 45 (15 per group).
Type of noxious initiating event: mixed (fracture of the distal radius (n = 17), tendon
injury (n = 10), hand contusion (n = 5), postsurgery for carpal tunnel syndrome (n = 4)
, fracture of the elbow (n = 2), fracture of the humerus (n = 1), fracture of the finger (n
= 1)) (upper limb)
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. conventional care plus low dose high frequency ultrasound therapy (0.5 watts/
cm²) for stellate ganglion blockade:
i) Mean (range) age = 45 (23 to 69) years; female:male = 7:6;
ii) Mean (range) duration of CRPS I 57 (38 to 156) days;
2. conventional care plus low dose high frequency ultrasound therapy (3.0 watts/
cm²) for stellate ganglion blockade:
i) Mean (range) age = 46 (23 to 69) years; female:male = 7:6;
ii) Mean (range) duration of CRPS I 62 (26 to 161) days;
3. conventional care plus placebo ultrasound therapy
i) Mean (range) age = 44 (22 to 69) years; female:male = 5:9;
ii) Mean (range) duration of CRPS I 70.5 (15 to 162) days.
Inclusion criteria:
1. upper limb CRPS I.
Exclusion criteria:
1. peripheral or central nerve lesions;
2. diabetes mellitus;
3. severe heart failure;
4. severe hypertension;
5. cardiac conduct disorders;
6. chronic obstructive pulmonary disease;
7. chronic alcoholism;
8. rheumatologic disease;
9. malignancy;
10. thyroid disease;
11. participants using anticholinergic or antihypertensive medication.
Interventions Participants in all 3 groups received conventional care including:
1. pharmacotherapy (including 500 mg/day vitamin C, Gabapentin (dose: 1800
mg/day) and Prednisolone (dose: 30 mg/day-2 weeks, stopped within next 2 weeks));
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Askin 2014 (Continued)
2. 20 sessions of transcutaneous electrical nerve stimulation ((Enraf Nonius brand
Endomed 582ID) 100 hertz (Hz) frequency to the painful area of the affected
extremity once a day, 20 minutes);
3. contrast bath applications ((Ewac brand device) by immersing the affected upper
extremity into hot (38°C) water for 4 minutes and then cold water (4°C) for 1 minute
for a total 20 minutes); and
4. exercise (active, active assistive and passive range of motion exercises to the wrist
and fingers, stretching exercises, progressive resistance exercises, performed as 2 sets of
15 repetitions for each exercise, once per day, plus mirror box exercises (details not
reported) for 30 minutes).
Conventional care plus low dose high frequency ultrasound therapy (0.5 watts/cm²)
(N = 15)
Components of intervention: using a Enraf Nonius Sonopuls (590 model) therapeutic
ultrasoundof the stellate ganglionwas applied by placing the 1 cm²ultrasound head at the
level of transverse process of the 7th vertebra and 3 cm to 4 cm above the sternoclavicular
joint, using a 1 MHz frequency and pulsed pattern of 1:4
Dosage: 0.5 watts/cm², for 5 minutes.
Frequency of administration: not reported (5 times per week for 4 weeks (20 sessions))
(Askin, personal communication)
Provider: not reported.
Conventional care plus low dose high frequency ultrasound therapy (3.0 watts/cm²)
(N = 15)
Components of intervention: ultrasound procedure as described above
Dosage: 3.0 watts/cm², for 5 minutes.
Frequency of administration: 5 times per week for 4 weeks (20 sessions)
Provider: not reported.
Conventional care plus placebo ultrasound therapy (N = 15)
Components of intervention: ultrasound procedure as described above, with themachine
turned off
Outcomes Time points at which outcomes were measured were not explicitly specified in the trial
report. Outcomes were assessed at baseline and on completion of the intervention period
(4 weeks post recruitment) (Askin, personal communication). The trial authors did not
state any primary outcome
1. Self-rated pain intensity at rest using a 10 cm VAS (0 = no pain, 10 = severe pain);
2. limitation of total finger flexion was assessed by measuring finger pulp-distal
crease distance using a ruler;
3. grip strength was assessed using a hand dynamometer (average of 3 measurements
in kg);
4. self-reported upper extremity disability was assessed using the Disability of the
Arm, Shoulder and Hand (DASH) questionnaire (Turkish version), with lower scores
indicating better function (score range not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: none declared.
Risk of bias
Bias Authors’ judgement Support for judgement
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Askin 2014 (Continued)
Random sequence generation (selection
bias)
High risk Quote: “Patients were randomly divided
into 3 groups by picking cards in differ-
ent colours. First, three groups of cards
(each group consisted of 15 cards) in 3
different colours (blue for 3 watts/cm2,
pink for 0.5 watts/cm2, yellow for placebo)
were prepared. Participants were asked to
choose a card before starting the treatment.
The US dose was determined according to
the colour of the selected card and it was
recorded. The randomisation process was
performed by another physician”
Comment: the trial authors used a non-
random sequence generation process
Allocation concealment (selection bias) Low risk Quote: “The randomisation process was
performed by another physician”
Comment: the trial authors probably used
an acceptable method to conceal the allo-
cation sequence
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “No information was given to pa-
tients and to the physician who will make
assessments and US application about the
randomisation process until the end of the
study”
Comment: the participants were blinded to
treatment allocation
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Low risk Quote: “No information was given to pa-
tients and to the physician who will make
assessments and US application about the
randomisation process until the end of the
study”
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Quote: “No information was given to pa-
tients and to the physician who will make
assessments and US application about the
randomisation process until the end of the
study”
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Quote: “Thirteen patients from group I, 13
patients from group II and 14 patients from
group III, a total of 40 patients completed
the study”
Comment: an overall drop-out rate of 11%
is unlikely to have biased the results
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Askin 2014 (Continued)
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
High risk Quote: “Two patients from group I, 2 pa-
tients from group II and 1 patient from
group III who did not come to therapy ses-
sions regularly were excluded”
Comment: the trial authors excluded 5 par-
ticipants in violation of the ITT principle
Selective reporting (reporting bias) Low risk Comment: outcome data were fully re-
ported for all outcomes reported in the
methods section of the publication
Sample size High risk Quote: “Fourty-five patients with CRPS
type I were randomly allocated into three
groups”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up High risk Quote: “Before and after the treatment the
severity of the pain experienced at rest was
assessed”
Comment: outcomes were re-measured on
completion of the intervention period only
and were not measured over a clinically rel-
evant length of time
Other bias Low risk Comment: we did not identify any other
sources of bias were identified
Aydemir 2006
Methods Design: parallel group, 3-arm double RCT (Turkey; dates not reported)
Setting: Department of Physical Medicine and Rehabilitation Clinic, Gulhane Military
Medical Academy
Interventions: stellate ganglion block (SGB) with lidocaine and sham SGB with ultra-
sound (US) or SGB with US and sham SGB with lidocaine or sham SGB with lidocaine
and sham SGB with US
Sample size calculation: not reported.
Participants Number of participants: 25 (SGB with lidocaine (N = 9); SGB with US (N = 9); sham
SGB with lidocaine and sham SGB with US (N = 7))
Type of noxious initiating event: mixed (trauma n = 12, fracture n = 11, idiopathic n
= 2) (upper limb)
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. SGB with lidocaine:
i) Mean (±) age = 21.9 (1.05) years; female:male = not reported (assumed to be
all males as setting identical to (Hazneci 2005);
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Aydemir 2006 (Continued)
ii) Mean (SD) duration of CRPS I = not reported;
2. Group receiving SGB with US:
i) Mean (±) age = 21.4 (0.73) years; female:male = not reported (assumed to be
all males);
ii) Mean (SD) duration of CRPS I = not reported;
3. Group receiving sham SGB with lidocaine and US:
i) Mean (±) age = 21.1 (0.38) years; female:male = not reported (assumed to be
all males);
ii) Mean (SD) duration of CRPS I = not reported.
Inclusion criteria:
1. CRPS I.
Exclusion criteria:
1. peripheral or central nervous system lesion affecting the upper limb;
2. participants using anti-hypertensive or anti-cholinergic medications;
3. lidocaine allergy;
4. cardiac arrhthymias;
5. history of stellate ganglion blockade within the last month.
Interventions Participants in all 3 groups received 21 sessions of exercise (active, active assisted, passive
exercises for the wrist and fingers, twice daily supervised by the same physiotherapist),
contrast baths (extremities were put in 38 °C hot water, 4 °C cold water for 4 minutes
hot and 1 minute cold, 4 minutes cold and 1 minute hot and 4 minutes cold (total time
14 minutes)), transcutaneous electrical nerve stimulation (Enraf Nonius Endomed 582
instrument; for a period of 20 minutes with a frequency of 100 Hz), external pneumatic
compression (involved extremity was compressed by a pressure of 50 mmHg for a period
of 60 seconds and then pressure was released for 20 seconds and this compression and
release procedure was repeated for 15 minutes, for participants who could not tolerate
the 50 mmHg pressure a lower level pressure was used) and paracetamol (500 mg orally
every 4 hours, maximum dosage of 3 g/daily was given if it is needed)
Stellate ganglion block with lidocaine (N = 9)
Components of intervention:
1. 10 mL of 1% lidocaine was injected slowly into the stellate ganglion (on the line
of 6th vertebra, 1.5 cm lateral of the median line, 4 cm to 5 cm under the skin);
2. (sham SGB with US) using a Enraf Nonius Sonopuls 590 and with the machine
turned off the instrument was put on the ganglion for 5 minutes.
Dosage: 10 mL of 1% lidocaine.
Frequency of administration: not reported.
Provider: anaesthetist (other providers not reported).
Stellate ganglion block with ultrasound (N = 9)
Components of intervention:
1. (sham SGB with lidocaine) 10 mL saline solution was used as placebo and
injected slowly into the stellate ganglion;
2. SGB with US was applied by using Enraf Nonius Sonopuls 590 (further details
regarding method of application not reported).
Dosage: 3 watt/cm² for 5 minutes.
Frequency of administration: not reported.
Provider: anaesthetist (other providers not reported).
Sham stellate ganglion block with lidocaine and ultrasound (N = 7)
Components of intervention:
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Aydemir 2006 (Continued)
1. (sham SGB with lidocaine) 10 mL saline solution was used as placebo and
injected slowly into the stellate ganglion;
2. (sham SGB with US) using a Enraf Nonius Sonopuls 590 and with the machine
turned off the instrument was put on the ganglion for 5 minutes.
Dosage: n/a.
Frequency of administration: not reported.
Provider: anaesthetist (other providers not reported).
Outcomes Outcomes assessed at baseline, after treatment and 1 month post-treatment:
1. self-reported spontaneous pain measured using a 10 cm VAS (0 to 10) (anchor
points not reported);
2. self-reported provocative pain measured using a Likert-type scale (0 = no pain, 1 =
mild pain with deep palpation, 2 = serious pain with deep palpation, 3 = serious pain
with superficial palpation, 4 = hyperaesthesia) (further details not reported);
3. oedema measured using a standard forearm volumeter (measured in mL, further
details not reported);
4. finger pulp-distal palmer crease distance (measured in cm, further details not
reported);
5. grip strength measured using a Jamar dynamometer, in a sitting position
(measured in kg);
6. functional hand scale (score range 0 to 19 with lower scores indicating better
function);
7. Keitel index score (score range 4 to 42; interpretation of scores not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomised by en-
velope method and 3 groups were estab-
lished”
Comment: “Treatment orders were made
online...”
Comment: it is likely that the trial authors
used an acceptable method to generate the
sequence allocation
Allocation concealment (selection bias) Low risk Quote: “Patients were randomised by en-
velope method and 3 groups were estab-
lished”
Comment: the trial authors probably used
an acceptable method to conceal the allo-
cation sequence
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Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “The study was designed as a dou-
ble blind study. Treatment orders were
made online and except the personnel
who were involved in the therapy nobody
even the doctor was aware of the selected
method”
Comment: participants were likely to have
been adequately blinded
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Low risk Quote: “The study was designed as a dou-
ble blind study. Treatment orders were
made online and except the personnel
who were involved in the therapy nobody
even the doctor was aware of the selected
method”
Comment: participants who
completed self-reported outcome measures
were blinded to treatment allocation
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Quote: “Treatment orders were made on-
line and except the personnel who were in-
volved in the therapy nobody even the doc-
tor was aware of the selected method”
Comment: the outcome assessor was
blinded to the treatment allocation
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Unclear risk Comment: the drop-out rate was not re-
ported.
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Unclear risk Comment: the method of analysis (ITT
versus per protocol) was not reported
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported
outcome data for all outcomes reported in
the methods section of the publication
Sample size High risk Quote: “Twenty-five patients were divided
into three groups”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up Unclear risk Quote: “These evaluations were performed
before and after treatment and one month
later”
Comment: the clinical relevance of a 1
month follow-up of outcomes is uncertain
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Other bias Low risk Comment: we did not identify any other
sources of bias.
Cacchio 2009a
Methods Design: parallel group, 2-arm, single-blind RCT (Italy; October 2000 to December
2006)
Setting: inpatient and outpatient rehabilitation centre.
Interventions: mirror therapy or placebo control (covered mirror).
Sample size calculation: 24 participants per group required to detect a 2 cm reduction
in pain on a 10 cm VAS (SD 1.5) with 0 cm labelled as ”no pain“ and 10 cm as ”worst
pain i have ever had“ at 1 week after treatment at 1% level of statistical significance with
90% power, including a 30% rate of loss at follow-up
Participants Number of participants: 48 (24 per group).
Type of noxious initiating event: stroke (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. conventional stroke rehabilitation plus mirror therapy:
i) mean (SD) age = 57.9 (9.9) years; female:male = 13:11;
ii) mean (SD) duration of CRPS I 2.8 (1.3) months;
2. conventional stroke rehabilitation plus placebo control:
i) mean (SD) age = 58.8 (9.4) years; female:male = 13:11;
ii) mean (SD) duration of CRPS I 2.6 (1.5) months.
Inclusion criteria:
1. first episode of unilateral stroke with hemiparesis during the previous 6 months;
2. VAS, 0 to 10 cm) pain score > 4 cm.
Exclusion criteria:
1. ipsilateral intra-articular shoulder injection within the last 6 months or use of
systemic corticosteroids with the previous 4 months;
2. presence of another obvious explanation for the pain;
3. prior surgery to either shoulder or neck region;
4. serious uncontrolled medical conditions;
5. global aphasia, cognitive or visual impairments interfering with testing or
treatment;
6. visual impairment that might interfere with the trial aims;
7. evidence of recent drug or alcohol abuse or severe depression.
Interventions Participants in both groups received 4 weeks of conventional stroke rehabilitation com-
prising neuro-rehabilitation techniques, occupational therapy (OT) and speech therapy
(if required), consisting of 5 1-hour sessions per week
Conventional stroke rehabilitation plus mirror therapy (N = 24)
Components of intervention: mirror therapy programme: Whilst seated with a mirror
board positioned between the upper limbs, perpendicular to the midline and with the
unaffected limb facing the reflective surface and with their affected upper limb hidden
from view, participants observed the reflection of their unaffected upper limb while
performing flexion and extension at the shoulder, elbow and wrist and pronation and
supination of the forearm
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Dosage: 30 minutes per session (for the first 2 weeks), 1 hour per session (for the second
2 weeks)
Frequency of administration: 5 times per week for 4 weeks (20 sessions)
Provider: physiotherapist.
Conventional stroke rehabilitation plus placebo control (N = 24)
Components of intervention: participants performed the same exercises, according to
the same dosage and frequency, with the reflective mirror surface covered
Outcomes Outcomes assessed at baseline and at 1 week and 6 months post-treatment
Primary outcomes:
1. self-rated pain intensity at rest using a 10 cm horizontal VAS labelled ”no pain“ to
”worst pain I have ever had“ (pain location not reported);
2. self-rated pain intensity on shoulder movement (forward flexion) using a 10 cm
VAS labelled ”no pain“ to ”worst pain I have ever had“;
3. brush evoked tactile allodynia, assessed by means of 3 brush movements within
the area of maximum pain, using a 10 cm VAS labelled ”no pain“ to ”worst pain I have
ever had“.
Secondary outcomes:
1. functional ability value of the Wolf Motor Function Test (WMFT), to assess
upper limb functional limitation (score range 0 to 5, higher scores indicate poorer
performance);
2. performance time value of the WMFT, to assesses upper limb functional
performance speed (measured in seconds, longer times indicate poorer performance);
3. Quality of Movement (QOM) item in the Motor Activity Log (MAL), to assess
how well participants can use their affected upper limb in 30 activities of daily living
(score range 0 to 5, lower scores indicate poorer performance).
Notes Source of funding: not reported
Statement regarding declarations of interest: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: ”...we undertook a randomized
placebo-controlled study in which stroke
patients with CRPSt I were randomly allo-
cated...“
Comment: the trial authors did not report
the method of sequence generation
Allocation concealment (selection bias) Unclear risk Comment: the trial authors did not report
the method of concealment allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Comment: given the nature of the in-
tervention, participants were not blinded
to treatment allocation but the extent to
which the lack of blinding may have intro-
duced bias is uncertain
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Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Comment: unblinded participants self-re-
ported some outcomes (e.g. pain intensity)
but the extent to which the lack of blinding
may have introduced bias is uncertain
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Quote: ”All the patients were examined 3
times by an investigator who was blinded
to the nature of treatment performed“
Comment: the outcome assessor was
blinded to treatment allocation
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Unclear risk Quote: ”Two patients (8%) in the mirror
group and 7 patients (29%) in the control
group dropped out of the study“
Quote: ”One of the 2 patients in the mir-
ror group dropped out because he moved
to another city, while the other decided to
perform corticosteroid injection therapy in
another center. Three of the 7 patients in
the control group refused to complete the
study, while 4 decided to perform corticos-
teroid injection therapy in another center“
Comment: the extent to which an overall
drop-out rate of 19% and an unequal drop-
out rate between groups may have intro-
duced biased estimates of treatment effect
is uncertain
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Quote: ”Both the primary and secondary
outcome analyses were performed accord-
ing to the intention-to-treat (ITT) princi-
ple. In this study, subjects that provided
baseline and at least 1 post-treatment mea-
surement constituted the ITT population,
whereas those who completed all tests from
baseline to the 6-month follow-up consti-
tuted the per protocol population
Comment: the trial authors reported anal-
yses according to the ITT principle
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported
outcome data for all outcomes reported in
the methods section of the publication
Sample size High risk Quote: “48 patients with CRPSt1 of the
affected upper limb were enrolled”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
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Duration of follow-up Low risk Quote: “The decision to set the follow-up
at 6 months is based on the hypothesis that
pain improves spontaneously over a long
period of time”
Comment: the trial authors measured out-
comes over a clinically relevant length of
time
Other bias High risk Quote: “For the ITT population, outcome
measurements were analyzed using the last
observation carried forward method”
Comment: the use of ’last observation car-
ried forward’ when accounting for missing
data may have introduced bias in estimates
of treatment effect
Cacchio 2009b
Methods Design: parallel group, single-blind, 3-arm, sham-controlled RCT (Italy, dates not re-
ported). (Whilst the trial authors reported that a number of participants from the 2
comparator groups crossed over into the experimental group, this was not undertaken in
a randomised way and therefore we deemed that this trial did not employ a true crossover
design. We analysed it as a 3-arm parallel group trial up to the endpoint just prior to
crossover)
Setting: not reported.
Interventions: mirror therapy or placebo control (covered mirror) or mental imagery
Sample size calculation: not reported.
Participants Number of participants: 24 (8 per group).
Type of noxious initiating event: stroke (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics: not adequately reported.
Inclusion criteria: not explicitly reported.
Exclusion criteria: not reported.
Interventions Mirror therapy (N = 8)
Components of intervention: whilst viewing a reflected image of the unaffected arm in
a mirror, participants performed all of the cardinal (proximal to distal) movements of
the affected arm (reported as the ’affected’ arm but assumed to be the ’unaffected’ arm)
Dosage: 30 minutes per session.
Frequency of administration: daily for 4 weeks (28 sessions)
Provider: not reported.
Placebo control (N = 8)
Components of intervention: participants performed the same movements, according
to the same dosage and frequency, with the reflective mirror surface covered
Provider: not reported.
Mental imagery (N = 8)
Components of intervention: not reported.
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Dosage: not reported.
Frequency of administration: not reported.
Provider: not reported.
Outcomes The trial authors assessed outcomes at baseline and on completion of the intervention
period (4 weeks post recruitment)
Primary outcomes:
1. self-rated pain intensity on movement using a 100 mm VAS (anchor point labels
not reported) but with higher scores indicating more severe pain.
Secondary outcomes:
1. motor function as assessed by the Wolf Motor Function Test (WMFT) (scoring
properties not reported);
2. brush-induced allodynia (method of assessment not reported);
3. oedema (method of assessment not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “We conducted a randomised,
sham-controlled study involving 24 pa-
tients with stroke”
Comment: the trial authors did not report
the method of sequence
Allocation concealment (selection bias) Unclear risk Quote: “We randomly assigned the 24 pa-
tients to one of three groups”
Comment: the trial authors did not report
the method of concealment allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Comment: given the nature of the in-
tervention, participants were not blinded
to treatment allocation but the extent to
which the lack of blinding may have intro-
duced bias is uncertain
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Comment: unblinded participants self-re-
ported some outcomes (e.g. pain intensity)
but the extent to which the lack of blinding
may have introduced bias is uncertain
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Quote: “The investigators were unaware of
the study-group assignments”
Comment: outcome assessors were blinded
to participants group allocation
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Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Quote: “In the active-mirror group, seven
of eight patients (88%) reported reduced
pain”
Quote: “In the covered-mirror group, only
one of eight patients (12%) reported re-
duced pain”
Quote: “In the mental-imagery group, two
of eight patients (25%) reported reduced
pain”
Comment: there were no apparent drop-
outs.
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Comment: the trial authors analysed par-
ticipants in the group to which they were
allocated but did not report the method of
analysis (ITT versus per protocol)
Selective reporting (reporting bias) High risk Quote: “After 4 weeks of active mirror ther-
apy, the pain intensity decreased (Fig. 1),
andmotor function, brush-induced allody-
nia, and edema improved (data not shown)
”
Comment: the trial authors presented
mean values for the primary outcome of
pain severity in graphical format only; they
did not report raw data in numerical form
with measures of variation
Comment: the trial authors did not report
any outcome data for the 3 secondary out-
come measures (motor function, brush-in-
duced allodynia, oedema)
Sample size High risk Quote: “We conducted a randomised,
sham-controlled study involving 24 pa-
tients...”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up High risk Quote: “The primary end point was the
score for the severity of pain after 4 weeks
of therapy”
Comment: the trial authors re-measured
outcomes on completion of the interven-
tion period only and did not measure them
over a clinically relevant length of time
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Other bias Unclear risk Comment: the trial was reported and pub-
lished as a ’Letter to the Editor’. Full
trial methodology and results have not
been published elsewhere (Cacchio, per-
sonal communication)
Comment: the trial authors presented lim-
ited group-specific baseline data
Comment: the trial authors did not report
any inclusion/exclusion data
Dimitrijevic 2014
Methods Design: parallel group, 2-arm, single-blind RCT (Serbia; December 2004 to January
2007)
Setting: outpatient clinic.
Interventions: low-level laser therapy and kinesitherapy or interferential current therapy
and kinesitherapy
Sample size calculation: not reported.
Participants Number of participants: 50 (25 per group).
Type of noxious initiating event: trauma (no further details reported) (upper and lower
limb)
Diagnostic criteria: Harden 2005 (CRPS I).
Baseline characteristics:
1. laser therapy and kinesitherapy:
i) Mean (±) age = 53.9 (13.36) years; female:male = 12:8;
ii) Mean (±) duration of CRPS I 33.75 (8.44) days.
2. interferential current therapy and kinesitherapy:
i) Mean (±) age = 57.8 (10.75) years; female:male = 17:8;
ii) Mean (±) duration of CRPS I = 31.64 (7.79) days.
Inclusion criteria:
1. CRPS I.
Exclusion criteria:
1. acute and subacute thrombophlebitis;
2. thrombosis;
3. neoplastic disease;
4. fever;
5. pregnancy.
Interventions Participants were instructed not to take any specific CRPS medication (corticosteroids,
bisphosphonates, calcitonin, nifedipine, antiepileptic drugs, etc.) or analgesic medica-
tion. Participants in both groups received individual kinesitherapy (active and active
assisted exercises, strictly dosed up to pain threshold) for 30 minutes, twice a day
Low-level laser therapy and kinesitherapy (N = 20)
Components of intervention: using a GaAs laser diode, 8 points along the joint line and
painful points in the affected area were treated using the following parameters: a low
power of 70 mW, 810 nm wavelength, and 70 Hz, 640 Hz, and 5000 Hz frequency,
depending on the dominant findings
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Dosage: 1.5 J/cm2.
Frequency of administration: 5 days a week for 2 weeks (10 sessions), and then every
other day (10 sessions) (20 sessions)
Provider: not reported.
Interferential current therapy and kinesitherapy (N = 25)
Components of intervention: bipolar IFC therapy was applied with electrodes positioned
locally on the painful and swollen part using the following parameters: 90 Hz frequency
Dosage: 15 minutes.
Frequency of administration: 5 days a week for 2 weeks (10 sessions), and then every
other day (10 sessions) (20 sessions)
Provider: not reported.
Outcomes The trial authors did not explicitly specify the time points at which outcomes were
measured in the trial report. Outcomes assessed at baseline and on completion of the
intervention period (6 weeks post recruitment) (Dimitrijevic, personal communication)
. The trial authors did not state any primary outcome
1. Self-rated pain intensity at rest using a 100 mm horizontal VAS (0 = no pain, 100
= worst pain possible) with responses based on the average pain intensity over last few
days;
2. self-rated pain intensity during active movements of the wrist/ankle using a 100
mm horizontal VAS (0 = no pain, 100 = worst pain possible) with responses based on
the average pain intensity over last few days;
3. oedema of the hand/foot using a figure-of-8 measurement (measurement tool and
method not reported). Hand/foot oedema was expressed as the difference between
hand/foot circumference of the affected and unaffected sides;
4. total active range of motion of the wrist/ankle joint in the sagittal plane using a
standard full-circle goniometer and recorded in degrees with the final value derived
from mean of 3 measurements.
Notes Source of funding: the trial authors declared that this study received no financial support
Statement regarding declarations of interest: none declared.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...patients were randomly selected
and classified into two groups using se-
quentially numbered, closed, opaque en-
velopes that had been prepared earlier using
a computer-generated list of random num-
bers, and balanced to ensure equal numbers
in each group”
Comment: the trial authors used an accept-
able method to generate the sequence allo-
cation
Allocation concealment (selection bias) Low risk Quote: “...patients were randomly selected
and classified into two groups, using se-
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quentially numbered, closed, opaque en-
velopes that had been prepared earlier”
Comment: the trial authors used an accept-
able method to conceal the allocation se-
quence
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: the participants were not
blinded to treatment allocation but lack of
blinding unlikely to have biased the results
given that participants received interven-
tions judged to have been of relatively equal
credibility
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Low risk Comment: the participants were not
blinded to treatment allocation and self-re-
ported some outcomes but lack of blinding
unlikely to have biased the results given that
participants received interventions judged
to have been of relatively credibility
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Unclear risk Comment: the trial authors did not provide
a statement of procedures regarding blind-
ing of the outcome assessor
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Unclear risk Quote: “During the study, 5 out of 50 pa-
tients dropped out. A total of 45 patients
completed the study”
Comment: all 5 drop-outs came from the
laser therapy group (lost to follow-up, n=2;
discontinued intervention, n = 3). Whilst
the overall drop-out rate was 10%, the ex-
tent to which an unequal drop-out rate be-
tween groups may have biased the results is
uncertain
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
High risk Comment: the trial authors excluded 3 par-
ticipants from the laser therapy group from
the analysis because they discontinued the
intervention, in violation of the ITT prin-
ciple
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported
outcome data for all outcomes reported in
the methods section of the publication
Sample size High risk Quote: “The prospective randomized study
included 50 patients with unilateral post-
traumatic CRPS I”
Comment: the small sample size may have
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introduced bias in estimates of treatment
effect
Duration of follow-up High risk Quote: “All patients underwent evaluation
of each separate parameter before treatment
and after applying 20 therapeutic proce-
dures”
Comment: outcomes were re-measured on
completion of the intervention period only
and were not measured over a clinically rel-
evant length of time
Other bias Low risk Comment: we did not identify any other
sources of bias.
Duman 2009
Methods Design: parallel group, 2-arm RCT (Turkey; dates not reported).
Setting: not reported.
Interventions: conventional care plus manual lymphatic drainage (MLD) or conven-
tional care
Sample size calculation: not reported.
Participants Number of participants: 34 (experimental group N = 18, control group N = 16).
Type of noxious initiating event: mixed (fracture n = 23, soft-tissue trauma n = 7,
incisive injury n = 3, non-traumatic n = 1) (upper limb)
Diagnostic criteria: Bruehl 1999 (RSD i.e. CRPS I).
Baseline characteristics:
Total sample (separate intervention and control group data not reported but no statisti-
cally significant between-group differences)
Mean (±) age = 20.6 (0.8) years; female:male = not reported.
Mean (±) duration of Reflex sympathetic dystrophy (RSD) 5.1 (1.3) months
Inclusion criteria:
1. fulfilled IASP criteria for RSD;
2. minimum 50 cc volumetric difference between 2 upper limbs.
Exclusion criteria:
1. infection;
2. thrombosis;
3. cardiac, pulmonary or renal problems.
Interventions Participants in both groups received conventional care including non-steroidal anti-
inflammatory drugs (NSAIDs) (type, dosage, frequency of administration not reported)
and physical therapy (once per day, 5 days per week for 3 weeks), comprising therapeutic
ultrasoundof the affected limb and stellate ganglions (treatment parameters not reported)
and therapeutic exercises for all joints of the affected limb (10 repetitions, twice per day;
type of exercises performed not reported) followed by a 2-month programme of home
maintenance therapeutic exercises
MLD (N = 18)
Components of intervention: MLD. Light massage for superficial abdominal, axillary
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and upper limb lymphatic stimulation of the affected upper limb followed by light upper
limb massage in a distal to proximal direction up to the axillary region
Dosage: 1 session per day for approximately 45 minutes administered by a therapist plus
1 session per day of participant self-administered MLD (duration not reported)
Frequency of administration: 5 times per week for 3 weeks (15 sessions), followed by a
home maintenance. programme of self-administered MLD for 2 months
Provider: not reported.
Conventional care (N = 16).
Outcomes Outcomes assessed at baseline, at the end of the 3-week treatment period and 2 months
post-treatment. The trial authors did not state any primary outcome
1. Self-rated pain intensity during gentle passive finger flexion using a 10-cm VAS
labelled “no pain” to “worst possible pain”;
2. upper limb oedema using volumetric measurements of water displacement;
3. functional range of motion measuring the third finger pulp-distal palmer crease
distance.
Notes Source of funding: not reported
Statement regarding declarations of interest: not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The patients were allocated ran-
domly into two groups”
Comment: the trial authors did not report
the method of sequence generation
Allocation concealment (selection bias) Unclear risk Comment: the trial authors did not report
the method of concealment allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: given the nature of the inter-
vention, participants were not blinded to
treatment and may have had different ex-
pectations about the benefits of each inter-
vention
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Comment: unblinded participants, who
may have had different expectations about
the benefits of the intervention they re-
ceived, self-reported some outcomes (e.g.
pain intensity)
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Unclear risk Quote: “All of the parameters were ob-
tained before the treatment (baseline), af-
ter treatment and 2 months after treatment
(follow-up) by a different physician”
Comment: the trial authors did not report a
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statement of procedures regarding blinding
of the outcome assessor
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Quote: “After 2 months, all of the patients
were re-evaluated”
Comment: there were no apparent drop-
outs.
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Quote: “After 2 months, all of the patients
were re-evaluated”
Comment: trial authors analysed partic-
ipants analysed in the group to which
they were allocated but did not report the
method of analysis (ITT versus per proto-
col)
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported
outcome data for all outcomes reported in
the methods section of the publication
Sample size High risk Quote: “A total of 34 patients who fulfilled
the modified International Association for
the Study of Pain (IASP) criteria and diag-
nosed as RSD were enrolled”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up Low risk Quote: “After 2 months, all of the patients
were re-evaluated”
Comment: the trial authors measured out-
comes over a clinically relevant length of
time
Other bias Low risk Comment: we did not identify any other
other sources of bias
Durmus 2004
Methods Design: parallel group, 2-arm, double-blind placebo-controlled RCT (Turkey; 1999 to
2001)
Setting: out-patient rehabilitation clinic.
Interventions: usual care plus pulsed electromagnetic field treatment or usual care plus
placebo pulsed electromagnetic field treatment
Sample size calculation: not reported.
Participants Number of participants: 40 (number of participants per group not reported).
Type of noxious initiating event: Colles fracture (upper limb).
Diagnostic criteria: Merskey 1994 (CRPS I).
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Baseline characteristics:
1. pulsed electromagnetic field treatment:
i) mean (SD) age = 37.65 (12.33) years; female:male = 50%:50%;
ii) mean (SD) duration of CRPS I: 48.80 (28.63) days;
2. placebo:
i) mean (SD) age = 40.60 (11.05) years; female:male = 45%:55%;
ii) mean (SD) duration of CRPS I: 54.55 (36.24) days.
Inclusion criteria:
1. aged 18 to 55 years;
2. development of pathology after trauma;
3. presence of phase I CRPS I based on 3 phase bone scintigraphy;
4. absence of any known hypersensitivities to calcitonin.
Exclusion criteria:
1. previous treatment for CRPS I;
2. pacemaker;
3. presence of an infectious or malignant disease;
4. being either pregnant or in a menopausal state.
Interventions Participants in both groups received 100 units of calcitonin via intramuscular injection
for 6 weeks; once per day for the first 3 weeks then once every other day for the second 3
weeks, and performed active and active assisted range of motion exercises and a stretching
programme for 30 minutes, 3 times per day
Electromagnetic field treatment (N = not reported)
Components of intervention: pulsed electric magnetic field treatment. Treatment was
administered using a Magnetic-Therapy Mg Port Cosgamma® device. The trial authors
did not report participant and equipment positioning
Dosage: 100 Gauss intensity and 50 Hz frequency for 60 minutes per session
Frequency of administration: 5 times per week for 6 weeks (30 sessions)
Provider: not reported.
Placebo (N = not reported)
Components of intervention: participants were placed in the same device without it
being switched on
Outcomes The trial authors assessed outcomes at baseline and on completion of the intervention
period (6 weeks post recruitment). The trial authors did not state any primary outcome
1. Self-rated pain at rest using a 10 cm VAS graded between 0 and 10 (anchor point
descriptors not reported);
2. self-rated pain with activity (details not reported) using a 10 cm VAS graded
between 0 and 10 (anchor point descriptors not reported);
3. 4-point verbal pain scale (measurement properties not described);
4. pain on palpation using 5-point grading scale (0 = no pain, 4 = hyperesthesia)
(further measurement properties not reported);
5. ratings of stiffness and change of colour (measurement properties not reported);
6. change in oedema using volumetric displacement;
7. range of motion using a goniometer (joints not specified);
8. 3-phase bone scintigraphy (bone to soft-tissue ratios) (measurement properties
not reported);
9. biochemical markers of bone formation (bone alkaline phosphatase, osteocalcin,
procollagen 1) and bone resorption (pyridinoline, deoxypyridinoline, hydroxyproline)
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(measurement properties not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The patientswere divided into two
groups with the random numbers table”
Comment: the trial authors used an accept-
able method was used to generate the se-
quence allocation
Allocation concealment (selection bias) Unclear risk Comment: the trial authors did not report
the method of concealment allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “In this randomized double-blind,
placebo-controlled study”
Quote: “the second group of patients re-
ceived placebo treatment by being placed in
the same device without it being switched
on”
Comment: participants were likely to have
been adequately blinded but the trial au-
thors did not explicitly report the extent to
which the placebo intervention controls for
the auditory and sensory characteristics of
the intervention
Comment: the trial authors did not report
the procedure for blinding of care providers
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Low risk Quote: “the second group of patients re-
ceived placebo treatment by being placed in
the same device without it being switched
on”
Comment: the participants who com-
pleted self-reported outcome measures
were blinded to treatment allocation
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Quote: “The patients were assessed at the
beginning of a 6 week course of treatment
and on the final week of treatment by a
physician who did not know which group
received the applied magnetic field treat-
ment”
Comment: the outcome assessor was
blinded to treatment allocation
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Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Quote: “There were no refusals or drop-
outs from the study”.
Comment: all randomly assigned partici-
pants completed the study
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Quote: “There were no refusals or drop-
outs from the study”.
Comment: the trial authors did not report
themethod of analysis (ITT versus per pro-
tocol)
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported
outcome data for the 2main pain outcomes
but did not report any outcome data for the
4-point verbal pain scale or any other out-
comes (pain on palpation, ratings of stiff-
ness and change of colour, range of motion
and3-phase bone scintigraphy), as reported
in the methods section of the publication
Sample size High risk Quote: “Forty patients diagnosed as hav-
ing Type I CRPS subsequent to trauma
(Colles Fracture), who consulted the Phys-
ical Medicine and Rehabilitation Depart-
ment of Istanbul University, Istanbul Med-
ical Faculty between 1999 and 2001 were
included in the study”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up High risk Quote: “Patients were assessed at the begin-
ning of a 6 week course of treatment and
on the final week of treatment”
Comment: the trial authors re-evaluated
participants at the end of the treatment pe-
riod only
Other bias Low risk Comment: we did not identify any other
sources of bias.
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Methods Design: parallel group, 2-arm RCT (Turkey; 2001 to 2002).
Setting: Department of Physical Medicine and Rehabilitation Clinic, Gulhane Military
Medical Academy
Interventions: transcutaneous electrical nerve stimulation (TENS) or pulsed ultrasound
of the stellate ganglion
Sample size calculation: not reported
Participants Number of participants: 30 (TENS N = 16; pulsed ultrasound N = 14).
Type of noxious initiating event:mixed (trauma n = 20, sports injury n = 5, post finger
amputation n = 1, post injection n = 1, idiopathic n = 3) (upper limb)
Diagnostic criteria: Kozin 1992 (stage I and II) (Reflex sympathetic dystrophy syn-
drome).
Baseline characteristics
1. TENS:
i) mean (SD) age = 20.75 (0.58) years; female:male = 0:16;
ii) mean (SD) duration of CRPS I 45.31 (26.68) days;
2. pulsed ultrasound of the stellate ganglion:
i) mean (SD) age = 20.6 (0.76) years; female:male = 0:14;
ii) mean (SD) duration of CRPS I 43.21 (17.72) days.
Inclusion criteria: CRPS I.
Exclusion criteria: not reported.
Interventions Participants in both groups received contrast bathing (the upper extremity was put in
hot water for 4 minutes and then in cold water for 1 minute and this procedure was
repeated for 20 minutes) and an exercise programme (undertaken with the assistance of a
physiotherapist and comprising active, assisted active and passive exercise within the pain
limits; including extension, flexion, ulnar and radial deviation for the wrist, abduction
and flexion for the thumb, flexion and extension for the metacarpophalangeal, proximal
and distal interphalangeal joints)
TENS (N = 16)
Components of intervention: TENS was applied, using a Myomed 932 Enraf model, to
the painful area of the involved upper extremity
Dosage: frequency 100 Hz, mono-rec wave module.
Frequency of administration: once per day, for 20 minutes, for 3 weeks (total number
of sessions not reported)
Provider: not reported.
Pulsed ultrasound of the stellate ganglion (N = 14)
Components of intervention: using a BTL 07p model ultrasound device pulsed ultra-
sound was applied with a 1 cm² probe to the stellate ganglion on the involved side of
the upper extremity
Dosage: 3 watt/cm² (pulsed).
Frequency of administration: once per day, for 5 minutes, for 3 weeks (total number of
sessions not reported)
Provider: not reported.
Outcomes The trial authors assessed outcomes at baseline and on completion of the intervention
period (3 weeks post recruitment):
1. self-reported spontaneous pain measured using a VAS (0 = no pain to 10 = worst
pain);
2. self-reported provocative pain (pain on palpation) measured using a Likert-type
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scale (0 = no pain, 1 = mild pain with deep palpation, 2 = severe pain with deep
palpation, 3 = severe pain with superficial palpation, 4 = hyperaesthesia);
3. grip strength measured using a hand dynamometer device with the score (in kg)
determined by the mean of 3 attempts;
4. joint mobility (extension, flexion, ulnar and radial deviation of the wrist; flexion
and extension for the fingers). Active joint movement distance was measured by
standard goniometer. Mobility loss was calculated by the formula: 100 − (measured
value/normal joint movement distance) x 100. The mean value for the joint movement
distance for all directions was calculated and compared with the values of the normal
extremity. The scale was as follows: 0 = total mobility; 1 = 1% to 25% mobility loss; 2
= 26% to 50% mobility loss; 4 = mobility loss of more than 76%;
5. oedema measured using standard volumetric measurements. Firstly the
participant’s uninvolved upper extremity was placed in a container filled with water.
The volume (in mL) of displaced water was measured and compared to the volume
displaced when he involved upper extremity was placed in the same container with the
value taken as the difference between the volumes displaced by the affected and normal
extremities.
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patients were divided into two
groups randomly”.
Comment: the trial authors did not report
the method of sequence generation
Allocation concealment (selection bias) Unclear risk Comment: the trial authors did not report
the method of concealment allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: the participants appear not to
have been blinded to treatment allocation
but lack of blinding is unlikely to have bi-
ased the results given that participants re-
ceived interventions judged to have been of
relatively equal credibility
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Low risk Comment: participants appear not to have
been blinded to treatment allocation and
self-reported some outcomes, but lack of
blinding is unlikely to have biased the re-
sults given that participants received inter-
ventions judged to have been of relatively
equal credibility
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Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Unclear risk Comment: the trial authors did not give a
statement of procedures regarding blinding
of the outcome assessor
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Unclear risk Comment: the trial authors did not report
the drop-out rate.
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Unclear risk Comment: the trial authors did not report
themethod of analysis (ITT versus per pro-
tocol)
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported
outcome data for all outcomes reported in
the methods section of the publication
Sample size High risk Quote: “30 patients diagnosed with Reflex
Sympathetic Dystrophy Syndrome at the
upper extremities were included into the
study”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up High risk Quote: “All patients evaluated before treat-
ment and 3rd week following the treat-
ment”
Comment: the trial authors re-measured
outcomes on completion of the interven-
tion period only and were not measured
over a clinically relevant length of time
Other bias Low risk Comment: we did not identify any other
sources of bias.
Jeon 2014
Methods Design: parallel group, 2-arm, placebo-controlled pilot RCT (South Korea; dates not
reported)
Setting: tertiary university pain centre.
Interventions: virtual body swapping with mental rehearsal or virtual body swapping
alone
Sample size calculation: pilot RCT with bootstrapping method to increase the robust-
ness of small-sample analyses
Participants Number of participants: 10 (number per group not reported).
Type of noxious initiating event: not reported (upper limb only n = 1, lower limb only
n = 1, multiple limbs n = 4, and whole body n = 4)
Diagnostic criteria: Harden 2007 (CRPS I).
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Baseline characteristics:
Total sample (separate intervention and control group data not reported but no statisti-
cally significant between-group differences)
Mean (SD) age: 39.30 (10.99) years; female:male = 0:10.
Median (range) duration of CRPS I: 52 (33 to 120) months.
Inclusion criteria: CRPS I
Exclusion criteria: not reported
Interventions The trial authors did not report any co-interventions.
Virtual body swapping with mental rehearsal (N = not reported)
Components of intervention:
1. whilst lying down and wearing a head mounted display (VR2000; Virtual
Realities, Ltd.) participants watched a virtual body swapping training video in order to
evoke a virtual body swapping illusion. The 3 minute 20 second long video clip was
filmed from the first person perspective and consisted of 4 physical movements
(making fists and opening up the fingers, bending and unbending the elbows, bending
the ankles forward and backward, and bending and unbending the legs). The first
person perspective would help participants to feel as if they observed their body when
they watch the video;
2. participants were additionally asked to assume a posture similar to that of the
body on the screen and rehearse the movements mentally, as if the body presented on
the display was their own body.
Dosage: 1 training session.
Frequency of administration: the experimental video clip was played twice with a 1-
minute break given between viewing’s
Provider: 1 specialist in pain and 2 assistants (trained graduate students); professional
discipline not reported
Virtual body swapping alone (N = not reported)
Components of intervention: participants watched the same video but did not perform
mental rehearsal of the 4 physical movements
Dosage: 1 training session.
Frequency of administration: the experimental video clip was played twice with a 1-
minute break given between viewings
Provider: 1 specialist in pain and 2 assistants (trained graduate students); professional
discipline not reported
Outcomes The trial authors did not explicitly specify the time points at which they measured
outcomes in the trial report. The outcomes were assessed immediately pre-intervention
and postintervention. The trial authors did not state any primary outcome
1. Self-rated pain intensity measured on an 11-point Likert scale ranging from 0 (no
pain) to 10 (severe pain);
2. the modified Body Perception Disturbance Questionnaire (BPDQ) consisting of
9 items with each item rated on an 11-point scale ranging from 0 (not at all) to 10
(very likely). Scores range from 0 to 90 with higher scores indicating greater body
perception disturbance.
Notes Source of funding: Basic Science Research Program through the National Research
Foundation of Korea (NRF) funded by the Ministry of Education, Science and Tech-
nology (2012R1A1A2008624) and the Chung-Ang University Excellent Student Schol-
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arship in 2014
Statement regarding declarations of interest: none declared.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Ten patients who met the diagnostic cri-
terion for CRPS type 1 were randomly as-
signed to either the treatment or control
group”
Comment: the trial authors did not report
the method of sequence generation
Allocation concealment (selection bias) Unclear risk Comment: the trial authors did not report
the method of concealment allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Comment: given the nature of the in-
tervention, participants were not blinded
to treatment allocation but the extent to
which the lack of blinding may have intro-
duced bias is uncertain
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Comment: given the nature of the in-
tervention, participants were not blinded
to treatment allocation but the extent to
which the lack of blinding may have intro-
duced bias is uncertain
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Not applicable.
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Comment: the trial authors did not report
the drop-out rate but, given the methodol-
ogy, it is likely there were no drop-outs
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Comment: the trial authors did not re-
port the method of analysis but, given the
methodology, it is likely that they analysed
all participants in the group to which they
were allocated
Selective reporting (reporting bias) High risk Quote: “Therewas no significant difference
between the groups in pain intensity, F(1,
7) = 0.05, p = 0.81”
Comment: the trial authors did not re-
port any pre-intervention or postinterven-
tion outcome data for self-reported pain in-
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tensity
Sample size High risk “Ten patients with CRPS type 1 were re-
cruited from a tertiary university pain cen-
ter in Seoul, Korea”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up High risk Quote: “The experimental video clip was
played twice with a 1-minute break given
between viewing’s. The participants were
then asked to respond to the pain intensity
question...and to complete the BPDQ”
Comment: the trial authors re-measured
outcomes on immediate completion of the
intervention period only and did not mea-
sure them over a clinically relevant length
of time
Other bias Unclear risk Comment: the trial authors did not report
baseline pain data
Li 2012
Methods Design: parallel group, 2-arm RCT (China; July 2008 to July 2010).
Setting: hospital.
Interventions: acupuncture and massage or rehabilitation therapy.
Sample size calculation: not reported.
Participants Number of participants: 120 (60 per group).
Type of noxious initiating event: stroke (upper limb).
Diagnostic criteria: Steinbrocker 1948 (stage 1).
Baseline characteristics:
1. acupuncture and massage:
i) mean (±) age = 62 (12) years; female:male = 20:40;
ii) mean (±) duration of shoulder-hand syndrome = 28 (6) days.
2. rehabilitation:
i) mean (±) age = 61 (13) years; female:male = 19:41;
ii) mean (±) duration of shoulder-hand syndrome 27 (5) days.
Inclusion criteria:
1. ischemic stroke;
2. age 18 to 75 years;
3. clinical symptoms of shoulder-hand syndrome conforming to stage I of the
Steinbrocker criteria;
4. fixed address and agreement to long-term follow-up visits;
5. sufficient cognitive ability to consent.
Exclusion criteria:
1. shoulder-hand syndrome caused by a second stroke, cerebral haemorrhage,
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cerebral tumour or trauma;
2. shoulder-hand syndrome at stage II or III;
3. pain or restricted shoulder motion secondary to dislocation or subluxation,
fracture or brachial plexus injury;
4. severe heart, liver or kidney disease;
5. severe cognitive dysfunction, mental disorder, malnutrition or poor general
condition;
6. unable to consent.
Interventions Acupuncture and massage (N = 60)
Components of intervention:
1. acupuncture: electric and non-electric acupuncture involving the following
points: Sanjian (LI 3), Houxi (SI 3), Zhongzhu (SJ 3), Jianzhongshu (SI 15), Jianliao
(SJ 14), Shousanli (LI 10), Waiguan (SJ 5) and Tianzong (SI 11);
2. massage: massage of the affected upper limb, passive shoulder movements without
pain.
Dosage: acupuncture = 25 minutes, massage = 25 minutes.
Frequency of administration: once per day for 6 therapeutic courses; each course com-
prised 5 sessions, with a 2-day interval between courses (30 sessions)
Provider: doctors.
Rehabilitation therapy (n = 60)
Components of intervention: active-assisted scapular movements; Bobath exercises to
clench the fist, functional transfers (e.g. changing position from prone to sitting, sitting
to standing); proprioceptive neuromuscular facilitation (PNF)
Dosage: active-assisted scapular movements = 15 minutes, Bobath exercises and func-
tional transfers = 15 minutes, PNF = 10 minutes
Frequency of administration: once per day for 6 therapeutic courses; each course com-
prised 5 sessions, with a 2-day interval between courses (30 sessions)
Provider: doctors.
Outcomes The trial authors assessed outcomes at baseline, at the end of the 6-week treatment period
and at 12 weeks post-treatment
Primary outcomes:
1. self-rated pain on passive shoulder motion [direction of motion not described] to
90° with the participant in a seated position using a numeric pain rating scale (scale
characteristics not reported);
2. number of participants with shoulder-hand syndrome at Steinbrocker stage II or
III after treatment.
Secondary outcomes
1. Fugl-Meyer evaluation of functional movement of the upper limb (33 items,
maximum possible score = 66; higher scores indicating more normal movement);
2. Fugl-Meyer evaluation of functional movement of the hand (7 items, maximum
possible score = 14; higher scores indicating more normal movement);
3. Modified Rankin scale (scale properties and scoring method not reported);
4. adverse events (incidence of shoulder dislocation, fainting during acupuncture,
haematoma, other).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”A random encoding plan was de-
signed using SPSS software“
Comment: the trial authors used an accept-
able method to generate the sequence allo-
cation
Allocation concealment (selection bias) Low risk Quote: ”A random encoding plan was de-
signed using SPSS software and concealed
in an envelope
Comment: the trial authors used an ade-
quate method to conceal the allocation se-
quence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: given the nature of the inter-
vention, participants were not blinded to
treatment and may have had different ex-
pectations about the benefits of each inter-
vention
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Comment: unblinded participants who
may have had different expectations about
the benefits of the intervention they re-
ceived self-reported some outcomes (e.g.
pain intensity)
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Unclear risk Comment: the trial authors did not give a
statement of procedures regarding blinding
of the outcome assessor
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Quote: “All patients finished the treatment
and had a follow-up visit”
Comment: all randomly assigned partici-
pants completed the study
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Quote: “All patients finished the treatment
and had a follow-up visit”
Comment: the trial authors did not report
themethod of analysis (ITT versus per pro-
tocol)
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported
outcome data for all outcomes reported in
the methods section of the publication
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Sample size Unclear risk Quote: “The 120 subjects in this series.
..were selected from 202 stroke patients.
..They were randomly divided into an
acupuncture-massage group and a rehabil-
itation group, with 60 cases in each”
Comment: the extent to which the small to
moderate sample size may have introduced
bias into estimates of treatment effect is un-
certain
Duration of follow-up Low risk Quote: “Each of the above indices was
recorded before treatment, at the end of the
6-week treatment period and at the 12th-
week follow-up visit”
Comment: the trial authors measured out-
comes over a clinically relevant length of
time
Other bias Low risk Comment: we did not identify any other
sources of bias.
Moseley 2004
Methods Design: single-blind, 2-arm RCT (Australia; dates not reported). (The trial author re-
ported that participants in the control group crossed over into the experimental group.
However, we deemed that this trial had not employed a true crossover design and we
analysed it as a 2-arm parallel group trial up to the endpoint just prior to crossover)
Setting: hospital physiotherapy department.
Interventions: graded motor imagery (GMI) or ongoing medical management.
Sample size calculation: not reported.
Participants Number of participants: 13 (experimental group n = 7; control group n = 6).
Type of noxious initiating event: wrist fracture (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. GMI:
i) Mean (SD) age = 35 (15) years; female:male = 5:2;
ii) Mean (SD) duration of CRPS I: 51 (18) weeks;
2. ongoing medical management:
i) Mean (SD) age = 38 (14) years; female:male = 4:2;
ii) Mean (SD) duration of CRPS I : 65 (19) weeks.
Inclusion criteria: > 6 months post non-complicated wrist fracture.
Exclusion criteria:
1. previously benefited from an intravenous regional sympathetic blockade;
2. any other upper limb pathology or pain;
3. any neurological or motor disorder including dyslexia or difficulty performing a
rapid naming task;
4. visually impaired;
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5. a diagnosed psychopathology;
6. any invasive analgesic strategy (e.g. spinal cord stimulator);
7. lived beyond the immediate metropolitan area of the host department.
Interventions GMI (N = 7)
Components of intervention:
1. recognition of hand laterality stage (2 weeks): whilst seated at a computer
monitor, participants viewed a random sequence of 56 photographic images of either a
right or left hand in a variety of postures. Participants were instructed to identify
whether the displayed image was of a right or left hand by pressing an appropriate
button on the computer keyboard. participants borrowed a notebook computer to
repeat the task at home;
2. imagined hand movements stage (2 weeks): whilst viewing a random sequence of
28 images of the affected hand participants were advised to deliberately imagine
moving their hand to adopt the posture shown in the picture, 3 times
3. Mirror therapy stage (2 weeks): using a mirror box which concealed the affected
limb from view but allowed participants to view a mirror image of their unaffected
limb, participants viewed a sequence of 20 pictures of the unaffected hand and were
instructed to slowly and smoothly adopt the posture shown in each picture with both
hands. Emphasis was placed on watching the reflection of their unaffected hand in the
mirror.
Dosage: hand laterality and imagined movements tasks - 3 times; mirror therapy task -
10 times
Frequency of administration: each waking hour, daily for 2 weeks (6 weeks in total)
Provider: not reported.
Ongoing medical management (N = 6)
Components of intervention:
1. no limitations placed on treatment;
2. participants were requested not to change medication type or dosage and to
record any new treatments received;
3. predominantly physical therapy (2 to 3 sessions per week) comprising active and
passive limb mobilisation, systemic desensitisation and hydrotherapy;
4. chiropractic manipulation and acupuncture (1 participant); psychological
counselling (1 participant).
Outcomes Trial authors assessed outcomes at baseline, at 2 and 4 weeks after commencement of
treatment, at the end of the 6-week treatment period (week 6) and 6weeks post-treatment
(week 12). The trial authors did not state a primary outcome
1. Neuropathic pain scale (NPS), with responses regarding the 2 previous days
(scoring properties not reported);
2. swelling, using the average of measure of the circumference of the base of the 2nd
and 3rd digits, as measured with a hand measuring tape.
Notes Source of funding:Clinical Research Fellowship from the National Health andMedical
Research Council of Australia ID 210348
Statement regarding declarations of interest: not reported.
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomised by an
independent investigator to the 6-week
MIP treatment group or to ongoing medi-
cal management (control) using a random
number table”
Comment: the trial authors used an accept-
able method to generate the sequence allo-
cation
Allocation concealment (selection bias) Low risk Quote: “Patients were randomised by an
independent investigator...”
Comment: the trial authors used an accept-
able method to conceal the allocation se-
quence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: given the nature of the inter-
vention, participants were not blinded to
treatment and may have had different ex-
pectations about the benefits of each inter-
vention
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Comment: unblinded participants, who
may have had different expectations about
the benefits of the intervention they re-
ceived, self-reported some outcomes (e.g.
NPS)
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Quote: “All assessments were made by a
separate investigator who was blind to ex-
perimental group and measurement occa-
sion”
Comment: the outcome assessor of objec-
tive outcomes was blinded to treatment al-
location
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Comment: all randomly assigned partici-
pants completed the study (as displayed in
the published report’s ’Experimental plan’)
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Comment: the trial authors analysed par-
ticipants in the group to which they were
allocated
Selective reporting (reporting bias) High risk Comment: the trial authors fully reported
outcome data graphically for all outcomes;
but did not report raw data in numerical
form with measures of variation
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Sample size High risk Quote: “Written informed consent was ob-
tained from the remaining 13 subjects”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up Unclear risk Quote: “Post hoc analyses showed...a sig-
nificant reduction in all three variables dur-
ing the MIP with the effect maintained for
at least 6 weeks after the completion of
treatment”
Comment: the clinical relevance of a 6-
week follow-up of outcomes is uncertain
Other bias Unclear risk Comment: we did not identify any other
sources of bias.
Moseley 2005
Methods Design: parallel group, 3-arm, single-blind RCT (Australia; dates not reported)
Setting: not reported.
Interventions: hand laterality recognition followed by imagined movements followed
by mirror movements (RecImMir, MIP) or imagined movements followed by laterality
recognition followed by imagined movements (ImRecIm) or laterality recognition fol-
lowed by mirror movements followed by recognition (RecMirRec)
Sample size calculation: not reported.
Participants Number of participants: 20 (RecImMir, MIP group (1) N = 7; ImRecIm group (2) N
= 6; RecMirRec group (3) N = 7)
Type of noxious initiating event: wrist fracture (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I)
Baseline characteristics:
1. RecImMir, MIP:
i) mean (SD) age = 36 (8) years; female:male = 5:2;
ii) mean (SD) duration of CRPS I: 12 (6) months;
2. ImRecIm:
i) mean (SD) age = 27 (7) years; female:male = 4:2;
ii) mean (SD) duration of CRPS I : 16 (5) months;
3. RecMirRec:
i) mean (SD) age = 39 (8) years; female:male = 5:2;
ii) mean (SD) duration of CRPS I : 14 (5) months.
Inclusion criteria: onset of CRPS I post non-complicated wrist fracture > 6 months
prior to enrolment
Exclusion criteria:
1. previously obtained relief from an intravenous regional sympathetic blockade;
2. any invasive analgesic strategy (e.g. spinal cord stimulator, sympathectomy);
3. any other neurological, psychopathology or motor disorder or dyslexia;
4. difficulty performing a rapid naming task;
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5. visually impaired;
6. any other upper limb pathology or pain;
7. lived outside the immediate metropolitan area of the host department.
Interventions Participants were advised to avoid changing medication or seeking alternative treatment
during the course of the trial up to and including the 12-week follow-up. Participants
were permitted to attend physiotherapy during the 12-week follow-up, but no criteria
about physiotherapy were set
RecImMir, group 1 (N = 7)
Components of intervention:
1. hand laterality recognition (2 weeks): whilst seated at a computer monitor,
participants viewed a random sequence of 56 photographic images of either a right or
left hand in a variety of postures. Participants were instructed to identify whether the
displayed image was of a right or left hand by pressing an appropriate button on the
computer keyboard. Participants borrowed a notebook computer to repeat the task at
home;
2. imagined hand movements (2 weeks): whilst viewing a random sequence of 28
images of the affected hand participants were advised to imagine moving their own
hand to adopt the posture shown in the picture then returning it to its resting position,
and to repeat the process twice for each picture;
3. mirror therapy (2 weeks): using a mirror box which concealed the affected limb
from view but allowed participants to view a mirror image of their unaffected limb,
participants viewed a sequence of 20 pictures of the unaffected hand and were
instructed to slowly and smoothly adopt the posture shown in each picture with both
hands. Emphasis was placed on watching the reflection of their unaffected hand in the
mirror.
Dosage: hand laterality task - 3 times, imagined movements task - twice; mirror therapy
task - 5 times
Frequency of administration: each waking hour, daily for 2 weeks (6 weeks in total)
Provider: not reported.
ImRecIm, group 2 (N = 6)
Components of intervention: 2 weeks imagined movements, 2 weeks hand laterality
recognition, 2 weeks imagined movements (components described above)
Dosage and frequency of administration: as described above.
RecMirRec, group 3 (N = 7)
Components of intervention: 2weeks hand laterality recognition, 2weeksmirror therapy,
2 weeks hand laterality recognition (components described above)
Dosage and frequency of administration: as described above.
Outcomes The trial authors assessed outcomes at baseline, at 2 and 4 weeks after commencement
of treatment, at the end of the 6-week treatment period (week 6) and 12 weeks post-
treatment (week 18). The trial authors did not state a primary outcome
1. NPS, with responses regarding the 2 previous days (possible range 0 to 100);
2. self-rated function with respect to 5 self-selected activities or tasks using an 11-
point numerical rating scale (NRS) anchored with “0, completely unable to perform”
and “10, able to perform normally” (final score average of 5 tasks, possible range 0 to
10 higher number indicates less severe limitation).
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Notes Source of funding: Australian Clinical Research Fellowship from the National Health
and Medical Research Council of Australia ID 210348
Statement regarding declarations of interest: not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Using a random numbers table,
an independent investigator allocated con-
senting patients into one of three treatment
groups”
Comment: the trial authors used an accept-
able method to generate the sequence allo-
cation
Allocation concealment (selection bias) Low risk Quote: “Using a random numbers table,
an independent investigator allocated con-
senting patients...”
Comment: the trial authors used an accept-
able method to conceal the allocation se-
quence
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Comment: participants were not blinded
to treatment allocation but a lack of blind-
ing is unlikely to have biased the results
given that participants received interven-
tions judged to have been of relatively equal
credibility
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Low risk Comment: participantswere not blinded to
treatment allocation and self-reported their
outcomes but lack of blinding unlikely to
have biased the results given that partici-
pants received interventions judged to have
been of relatively equal credibility
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Unclear risk Not applicable.
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Comment: all but 1 randomly assignedpar-
ticipant completed the study, and the 1 par-
ticipant appeared to have dropped out from
group 3 (as displayed in the published re-
port’s ’Treatment plan’)
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Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
High risk Comment: the trial author did not report
themethod of analysis (ITT versus per pro-
tocol). The trial authors appear to have ex-
cluded 1 participant from group 3 from
the analysis in an apparent violation of the
principle of ITT
Selective reporting (reporting bias) High risk Comment: the trial authors fully reported
outcome data graphically for all outcomes;
but did not report raw data in numerical
form with measures of variation
Sample size High risk Quote: “Twenty subjects with chronic
CRPS1 initiated by wrist fracture and who
satisfied stringent inclusion criteria, were
randomly allocated to one of three groups”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up Low risk Quote: “Single blind randomised trial with
12-week follow-up”
Comment: the trial authors measured out-
comes over a clinically relevant length of
time
Other bias Unclear risk Comment: we did not identify any other
sources of bias.
Moseley 2006
Methods Design: parallel group, 2-arm, single-blind RCT (Australia; dates not reported). NB:
this trial recruited participants with CRPS I and phantom limb pain. However we only
included information and data from participants with CRPS for the purpose of this
systematic review
Setting: not reported.
Interventions: GMI or physiotherapy and ongoing medical care.
Sample size calculation: a total sample size of 51 participants would detect an effect
size of 0.80 (equivalent to a reduction in pain of 29 mm on a 100 mm VAS), with a
probability of 80%, assuming an alpha level of 0.05
Participants Number of participants: 37 (experimental group N = 17; control group N = 20).
Type of noxious initiating event: mixed (fractures n = 14, soft-tissue injury n = 15,
post carpal tunnel release n = 2, venepuncture site n = 2, post finger/toe amputation n
= 2, carpal tunnel syndrome n = 1, nail infection n = 1) (upper and lower limb)
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. GMI:
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i) mean (SD) age = 45 (14) years; female:male = 11:6;
ii) mean (SD) duration of CRPS I: 14 (10) months;
2. physical therapy and ongoing medical care:
i) mean (SD) age = 41 (14) years; female:male = 15:5;
ii) mean (SD) duration of CRPS I: 12 (8) months.
Inclusion criteria: CRPS I of an upper or lower limb.
Exclusion criteria:
1. any other neurologic, psychopathology or motor disorder;
2. dyslexia;
3. difficulty performing a rapid naming task;
4. visually impaired;
5. any other limb pathology or pain;
6. lived outside the immediate metropolitan area of the host department.
Interventions GMI (N = 17)
Components of intervention
1. limb laterality recognition phase (2 weeks): whilst seated at a computer,
participants viewed a random sequence of photographic images (matched to gender) of
either a right or left hand (participants with an affected upper limb) or foot
(participants with an affected lower limb) in a variety of positions and alignments.
Participants indicated whether the displayed image was of a right or left limb by
pressing an appropriate key on the computer keyboard;
2. imagined movements phase (2 weeks): whilst viewing a random sequence of
images of both limbs participants were required to imagine twice adopting the posture
shown with a smooth and pain-free movement;
3. mirror movements phase (2 weeks): using a mirror box which concealed the
affected limb from view but allowed participants to view a mirror image of their
unaffected limb, participants viewed a sequence of images and were instructed to twice
adopt the posture shown with both limbs, using smooth and pain-free movements.
Dosage: participants were prescribed a training protocol of gradually increased training
load according to task difficulty during each of the 3 GMI phases, as detailed by the trial
authors
Frequency of administration: hourly training (further details not reported)
Provider: physiotherapist.
Physiotherapy and ongoing medical care (N = 20)
Components of intervention: not reported.
Dosage: not reported.
Frequency of administration: minimum of once per week together with a hourly home
programme
Provider: physiotherapists.
Outcomes Outcomes assessed at baseline, at the end of the 6-week treatment period and 6 months
post-treatment
Primary outcomes:
1. self-rated function with respect to 5 self-selected activities or tasks using an 11-
point NRS anchored with “0, completely unable to perform” and “10, able to perform
normally”;
2. self-rated pain severity using a 0 to 100mm VAS (anchor points not described) to
rate average level of pain over the last 2 days;
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3. McGill Pain Questionnaire (MPQ).
Notes Original trial publication reported data for participants with CRPS I and phantom limb
pain (N = 51). Details reported above refer to only those participants with CRPS I (N
= 37)
Source of funding: not reported
Statement regarding declarations of interest: the authors declared no conflicts of in-
terest.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomized via ran-
dom number generation by an indepen-
dent investigator...using a random num-
bers table”
Comment: the trial authors used an accept-
able method to generate the sequence allo-
cation
Allocation concealment (selection bias) Low risk Quote: “Patients were randomized via ran-
dom number generation by an indepen-
dent investigator...”
Comment: the trial authors used an accept-
able method to conceal the allocation se-
quence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: given the nature of the inter-
vention, participants were not blinded to
treatment and may have had different ex-
pectations about the benefits of each inter-
vention
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Comment: unblinded participants, who
may have had different expectations about
the benefits of the intervention they re-
ceived, self-reported some outcomes (e.g.
pain intensity)
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Not applicable.
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Quote: “One female subject in the control
group withdrew from the study because she
sustained an unrelated injury. There were
no other dropouts or withdrawals”
Comment: the minimal drop-out rate (5%
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from 1 trial arm) is unlikely to have biased
the results
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Comment: the trial authors performed an
available case analysis
Selective reporting (reporting bias) Low risk Comment: the trial authors fully reported
outcome data for self-reported function
and pain severity outcomes for participants
with CRPS and phantom limb pain com-
bined as conceived in the original trial de-
sign. They presented outcome data for par-
ticipants with CRPS graphically only
Sample size High risk Quote: “Fifty-one patients [37with CRPS]
with phantom limb pain or CRPS1 were
randomly allocated”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect. (We acknowledge that our judge-
ment regarding the risk of bias linked to
sample size for this study is based on the
purposeful exclusion of a number of par-
ticipants with phantom limb pain (N = 14)
that the original design did not intend)
Duration of follow-up Low risk Quote: “All assessments were undertaken
at prerandomization and at 6 weeks (com-
pletion of the treatment period). Pain VAS
and function NRS were also undertaken at
6 months follow-up”
Comment: the trial authors measured out-
comes over a clinically relevant length of
time
Other bias Unclear risk Comment: we did not identify any other
sources of bias.
Moseley 2009
Methods Design: within-subject randomised crossover design (Australia; dates not reported)
Setting: not reported.
Interventions: tactile discrimination training (TDT) under 4 separate conditions
Sample size calculation: not reported.
Participants Number of participants: 10.
Type of noxious initiating event: mixed (fractures of the hand or wrist n = 4, sprains
n = 2, carpal tunnel syndrome n = 2, post hand cannulation n = 1, thumb dislocation n
70Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Moseley 2009 (Continued)
= 1) (upper limb)
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. mean (SD) age = 43 (11) years; female:male = 6:4;
2. mean (SD) duration of CRPS I: 20 (5) months.
Inclusion criteria: CRPS of 1 wrist of hand.
Exclusion criteria: not reported.
Interventions TDT (N = 10)
Components of intervention:
1. two probes (2 mm and 12 mm in diameter) were applied to 1 of 5 stimulation sites
on the affected limb in a random order, with an interstimulus interval of 15 seconds;
2. TDT was performed under 4 different conditions:
i) facing + skin: involved participants watching the reflected image of their
unaffected, non-stimulated arm in a mirror placed between the upper limbs while
facing the stimulated arm;
ii) skin only: involved participants watching their unaffected, non-stimulated
arm directly
iii) facing only: involved participants looking in the direction of their affected,
stimulated arm but with no mirror and the unaffected limb hidden;
iv) control condition: involved participants looking away from their stimulated
limb with the unaffected limb hidden.
Dosage: three 6-minute blocks of 24 stimuli were undertakenwith a 3-minute rest period
between blocks. Each treatment session involved 72 stimuli and lasted for 24 minutes
Frequency of administration: each participant received 4 sessions of each experimental
condition in varying order (total of 16 sessions), with 3 to 4 days between sessions
Provider: not reported.
Outcomes The trial authors assessed outcomes at baseline, immediately and 2 days post-treatment
Primary outcomes: 2-point discrimination threshold, measured in mm, using a me-
chanical calliper
Secondary outcomes: self-rated current pain (at rest) severity using a 100 mm VAS
anchored with “no pain” and “worst possible pain”
Notes Source of funding: Nuffield Oxford Medical Fellowship, NHMRC Senior Research
Fellowship, Templeton Foundation
Statement regarding declarations of interest: the authors declared no conflicts of in-
terest.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The conditions were randomised
and counterbalanced so that each partici-
pant had four sessions of each condition,
but in varying order”
Comment: the trial authors did not report
the method of sequence generation
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Allocation concealment (selection bias) Low risk Comment: this was not applicable (when
crossover design employed)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Comment: given the nature of the in-
tervention, participants were not blinded
to treatment allocation but the extent to
which the lack of blinding may have intro-
duced bias is uncertain
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Comment: unblinded participants self-re-
ported some outcomes (e.g. pain intensity)
but the extent to which the lack of blinding
may have introduced bias is uncertain
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Unclear risk Comment: we do not known whether or
not the outcome assessors were blinded to
the treatment condition
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Comment: the trial authors did not report
any drop-outs; they presented results based
on the total number of included partici-
pants
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Comment: not applicable (when crossover
design employed).
Selective reporting (reporting bias) High risk Comment: the trial authors fully reported
outcome data graphically for all outcomes;
they did not report raw data in numerical
form with measures of variation
Sample size High risk Quote: “Ten patients with chronic CRPS
of one hand or wrist (diagnosed according
to Bruehl et al.) were recruited”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up High risk Quote: “The TPD for the three sites was
averaged to provide a measure at pre-train-
ing, post-training and 2 days later”
Comment: the trial authors did not mea-
sure outcomes over a clinically relevant
length of time
Other bias Unclear risk Quote: “...there were 1-2 days between the
follow-up assessment and the next train-
ing session. Participants were advised not
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to undertake tactile training in between ses-
sions”
Comment: the extent to which an interval
of 1 to 2 days between outcome assessment
and training sessions represented an ade-
quate wash-out period, and therefore the
extent towhich a carry-over effectmay have
introduced bias in estimates of treatment
effect, is not known
Mucha 1992
Methods Design: parallel group, 2-arm RCT (Germany; dates not reported). (The trial authors
reported that participants in the control group crossed over into the experimental group.
However, we deemed that this trial did not employ a true crossover design and we
analysed it as a 2-arm parallel group trial up to the endpoint just prior to crossover)
Setting: not reported.
Interventions: CO2 baths plus exercise therapy or exercise therapy alone.
Sample size calculation: not reported.
Participants Number of participants: 40 (20 per group).
Type of noxious initiating event: post-trauma (no further details reported) (upper limb)
.
Diagnostic criteria: acute algodystrophy of the hand (diagnostic criteria not reported)
Baseline characteristics:
Total sample (separate intervention and control group data not reported)
Age range 47 to 56 years (group data not reported).
Duration of CRPS (range) 2 to 6 weeks (group data not reported)
1. CO2 baths plus exercise therapy
i) Female:male = 13:7
2. exercise alone
i) Female:male = 11:9
Inclusion criteria:
1. CRPS I of the hand;
2. post-traumatic onset;
3. ’high active stage of condition’;
4. minimum of 2 weeks duration of symptoms.
Exclusion criteria: more than 6 weeks duration of symptoms.
Interventions Those participants on medication prior to the trial were instructed to cease their medi-
cation at the start of the trial
CO2 baths plus exercise (N = 20)
Components of intervention
1. CO2 bath;
2. after the bath, 30 to 45 minutes rest in an anti-swelling functional position;
3. exercise therapy (as below).
Dosage: 12 minute CO2 bath with water temperature of 32 to 33 °C and a CO2
concentration of 800 to 1000 mg/L.
Frequency of administration: 5 times a week for 4 weeks (20 sessions)
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Provider: not reported.
Exercise (N = 20)
Components of intervention: progressive exercise therapy. The intensity was dependent
on pain level and symptom behaviour
Dosage: not reported.
Frequency of administration: 5 times a week for 4 weeks (20 sessions)
Provider: not reported.
Outcomes The trial authors assessed outcomes at baseline and twice weekly until completion of
the intervention period (4 weeks post recruitment). The trial authors did not state any
primary outcomes
1. self-rated pain intensity at rest; measured using a graphic analogue scale (no scale
reported);
2. self-rated pain intensity at night; measured using a graphic analogue scale (no
scale reported);
3. self-rated pain intensity with movement; measured using a graphic analogue scale
(no scale points reported);
4. hand circumference: measured over the wrist, MCPs and DIPs, recorded in cm.
Probably difference between sides. Only MCP data provided;
5. range of motion: neutral 0 method of forearm, hand and fingers, recorded in
degrees, only wrist data reported;
6. grip strength: hand held dynamometer, relative to other side;
7. temperature: difference between sides; more than 0.8 degrees difference was
recorded as positive.
Notes Source of funding: not reported
Statement regarding declarations of interest: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “ Patients were randomised into
two groups”.
Comment: the trial authors did not report
the method of sequence generation
Allocation concealment (selection bias) Unclear risk Comment: the trial authors did not report
the method of concealment allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: given the nature of the inter-
vention, participants were not blinded to
treatment and may have had different ex-
pectations about the benefits of each inter-
vention
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Comment: unblinded participants, who
may have had different expectations about
the benefits of the intervention they re-
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ceived, self-reported some outcomes (e.g.
pain intensity)
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Unclear risk Comment: the trial authors did not re-
port the statement of procedures regarding
blinding of the outcome assessor
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Comment: there were no apparent drop-
outs.
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Comment: the trial authors analysed par-
ticipants in the group to which they were
allocated but did not report the method of
analysis (ITT versus per protocol)
Selective reporting (reporting bias) High risk Comment: the trial authors fully reported
outcome data graphically for all outcomes;
but did not report raw data in numerical
form with measures of variation
Sample size High risk Quote: “20 participants per group”.
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up High risk Comment: comparison was only possible
immediately at the end of the 4-week ther-
apy session as the control group crossed
over to the treatment arm at this point
Other bias Low risk Quote: “Statistical testing showed homo-
geneity across both groups”
Comment: there were no apparent baseline
differences between groups
Comment: we did not identify any other
sources of bias.
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Methods Design: parallel group, 3-arm, single-blind RCT (The Netherlands; June 1994 to Febru-
ary 1998)
Setting: outpatient clinics of 2 university hospitals.
Interventions: physical therapy (PT) plus medical treatment or occupational therapy
(OT) plus medical treatment or social work (SW) plus medical treatment (control)
Sample size calculation: the study planned to recruit 150 participants (50 per group) in
order to be able to detect between-group differences of 6 to 7 points in the impairment
level sumscore (ISS) with 80% power
Participants Number of participants: 135 (physical therapy group N = 44; OT group N = 44; SW
(control) group N = 47)
Type of noxious initiating event: mixed (fracture (53%), spontaneous onset (13%)
, contusion (11%), mallet finger, carpal tunnel syndrome, postoperative interventions,
sprains (proportions not reported) (upper limb)
Diagnostic criteria: Veldman 1993 (CRPS I).
Baseline characteristics:
1. PT:
i) mean (SD) age = 50.4 (15.6) years; female:male = 29:15;
ii) mean (SD) duration of CRPS I: 3.1 (3.4) months;
2. OT:
i) mean (SD) age = 56.3 (17) years; female:male = 31:13;
ii) mean (SD) duration of CRPS I: 2.9 (2.5) months;
3. SW:
i) mean (SD) age = 51.5 (16.9) years; female:male = 35:12;
ii) mean (SD) duration of CRPS I: 2.9 (3.1) months.
Inclusion criteria:
1. CRPS I of 1 upper limb of less than 1 year duration;
2. participants could complete treatment at 1 of 2 study sites;
3. aged 18 years or older.
Exclusion criteria:
1. impairment of contralateral extremity;
2. relapse of CRPS I;
3. pregnancy or lactation;
4. prior sympathectomy of the affected extremity.
Interventions All participants received medical treatment according to a fixed pre-established protocol,
consisting of free-radical scavengers (dimethylsulfoxide (DMSO) 50% applied locally 5
times a day at the affected location or if DMSO-intolerant, N-acetylcysteine (600 mg
3 times a day), peripheral vasodilators in the case of primarily cold CRPS I (calcium
entry blocker verapamil, sustained-release 240 mg once per day or ketanserine 20 mg
twice per day eventually increased to 40 mg or pentoxifylline 400 mg twice per day)
and treatment of trigger points. Participants also received general information regarding
CRPS I; including advice to rest the extremity and not provoke pain
PT (N = 44)
Components of intervention:
1. intensity and form of treatment adjusted to the needs of each individual
participant;
2. pain management advice/counselling directed towards helping participants gain
control of the pain and optimise coping by offering insight, practical advice, and
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support and/or by relaxation exercises;
3. connective tissue massage, transcutaneous electric nerve stimulation (TENS),
exercises for reducing the pain (details not reported);
4. instruction, training and practicing of skills by addressing compensatory activities
and body positioning (details not reported).
Dosage: 30 minutes per session (details for individual components not reported)
Frequency of administration: adjusted to the needs of each individual participant (details
not reported)
Provider: physical therapists.
OT (N = 44)
Components of intervention:
1. intensity and form of treatment adjusted to the needs of each individual
participant;
2. splinting;
3. desensitisation (tactile and proprioceptive) programme (details not reported);
4. improving functional abilities of the arm/hand by executing various activities,
while moving as normally as possible;
5. training to improve performance of activities of daily living (e.g. learning how to
perform activities differently, advice regarding assistive devices).
Dosage: 30 minutes per session (details for individual components not reported)
Frequency of administration: adjusted to the needs of each individual participant (details
not reported)
Provider: occupational therapists.
SW (N = 47)
Components of intervention:
1. participants were given attention in the form of listening and insight into the
social problems accompanying CRPS I;
2. advice regarding how not to evoke pain, rest and asking for help with performing
activities perceived as excessively demanding.
Dosage: 45 minutes per session.
Frequency of administration: adjusted to needs of each individual participant (details
not reported)
Provider: social workers.
Outcomes Outcomes, as reported across trial reports, variously assessed at baseline and at 6 weeks,
3 months, 6 months and 12 months post recruitment. The primary endpoint was the
difference in impairment level sum score between baseline and 12 months post recruit-
ment
1. Self-rated pain intensity (present) using a VAS (0 to 100 scale, anchor points not
reported);
2. self-rated pain intensity (resulting from effort with the affected extremity) using a
VAS (0 to 100 scale, anchor points not reported);
3. self-rated pain intensity (least pain experienced in the preceding week) using a
VAS (0 to 100 scale, anchor points not reported);
4. self-rated pain intensity (worst pain experienced in the preceding week) using a
VAS (0 to 100 scale, anchor points not reported);
5. McGill Pain Questionnaire (Dutch language version), including the: a. total pain
rating index (PRI-T), b. total number of words chosen (NWC-T), c. number of
’sensory’ words chosen (NWT-S), d. number of ’affective’ words chosen (NWT-A), e.
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number of ’evaluative’ words chosen (NWT-E);
6. percentage of reduced normal mobility, measured by dividing the difference in
active range of motion, as measured with a plastic transparent goniometer, between the
joints (shoulder, elbow, wrist, digits) of the affected and unaffected upper limbs;
7. impairment rating (according to the Guides to the Evaluation of Permanent
Impairment (GEPI): a composite score derived from a. measures of loss of active range
of motion assessed using goniometry, b. sensory loss in the fingers and thumb assessed
via 2-point discrimination testing and c. grip strength assessed by a dynamometer; with
a maximum possible score of 60%, with higher scores indicating greater impairment
(only measured at 12 months post-treatment; not measured at baseline);
8. impairment level sumscore (ISS): constructed to map alterations in impairment in
RSD participants; formed by outcomes obtained with 4 measurement parameters and
5 instruments. The outcomes for each instrument are converted into a score, from
which the compounded ISS is derived, including a. VAS pain/effort; b. McGill Pain Qr
(NWC-T); c. active ROM (from 5 joints (wrist/fingers); d. temperature difference
between hands; e. volume difference between hands. Score range was from 5 to50, with
higher scores indicating more severe impairment;
9. the Radboud Skills Questionnaire; used to determine the perceived degree of
deviation from normal use of both hands in activities of daily living (details regarding
scoring and interpretation not reported);
10. the modified Greentest; used to measure differences in the degree to which both
hands could move light objects (e.g. small pins, discs) within 15 seconds using different
grips (details regarding scoring and interpretation not reported);
11. the Radboud Dexterity Test; used to make qualitative assessments of 7 skills
associated with daily activities (e.g. closing a zip fastener, washing hands) (details
regarding scoring and interpretation not reported);
12. Sickness Impact Profile (SIP) 36. The total score was computed (score range of 0
to 100) as well as the sub-scores for the degree of physical dysfunction and the degree
of psychosocial dysfunction (details regarding scoring and interpretation not reported).
Notes Source of funding: research grant from the National Health Insurance Board (Zieken-
fondsraad), The Netherlands
Statement regarding declarations of interest: not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomly assigned
to one of three groups”
Quote: “Randomisation was restricted to
blocks of six”.
Quote: “Assigmnent to groups was per-
formed according to allocation lists estab-
lished by theDepartment ofMedical Statis-
tics of the University of Nijmegen”
Comment: the trial authors used an accept-
able method to generate the sequence allo-
cation
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Allocation concealment (selection bias) Unclear risk Quote: “Assigmnent to groups was per-
formed according to allocation lists estab-
lished by theDepartment ofMedical Statis-
tics of the University of Nijmegen”
Comment: the trial authors did not ade-
quately report the method of concealment
allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: given the nature of the inter-
vention, participants were not blinded to
treatment and may have had different ex-
pectations about the benefits of each inter-
vention
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Comment: unblinded participants, who
may have had different expectations about
the benefits of the intervention they re-
ceived, self-reported some outcomes (e.g.
pain intensity)
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Unclear risk Comment: we do not know if outcome as-
sessors were blinded to treatment allocation
when measuring percentage loss of joint
mobility, impairment ratings, impairment
level sumscore and disability-based mea-
sures
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Unclear risk Quote: “After inclusion in the study, 44 pa-
tients were assigned to PT, 44 patients to
OT and 47 patients to CT. In the course
of the 1-year study period, seven, four and
four patients abandoned the trial, respec-
tively”
Comment: whilst the overall drop-out rate
was acceptable (11%), therewas anunequal
drop-out rate between groups (PT: 16%,
OT: 9%, CT: 9%) and the trial authors did
not report the reasons for dropping out
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
Low risk Quote: “Two analyses were done: an in-
tention-to-treat analysis (ITT) and a per-
protocol analysis (PP). In the ITT analysis,
outcomes of all the participants were used
for the group they were originally assigned
to. In the PP analysis, outcomes of protocol
violators were ignored”
Quote: “Three patients from the PT group
could not complete the treatment proto-
col (so were protocol violators) but had test
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continuity”
Comment: the trial authors presented lim-
ited data from both ITT and per protocol
analyses for selected outcomes
Selective reporting (reporting bias) High risk Comment: the trial authors reported lim-
ited and incomplete outcome data across 4
separate trial reports for self-reported pain
and disability outcomes and for investiga-
tor-administered outcomes
Comment: no numerical data presented for
3 out of the 4 measures of self-rated pain
intensity or percentage of reduced normal
mobility outcomes
Comment: no numerical data reported for
impairment rating.
Comment: limited numerical data pre-
sented for ISS.
Comment: no numerical data presented for
the Radboud Skills Questionnaire, modi-
fied Greentest or Radboud Dexterity Test
Sample size High risk Quote: “After inclusion in the study, 44
patients were assigned to PT, 44 patients to
OT and 47 patients to CT”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up Low risk Quote: “Re-assessment was performed 6
weeks (t1), 3 months (t2), 6 months (t3)
and 12 months (t4) after inclusion in the
study”
Comment: the trial authors measured out-
comes over a clinically relevant length of
time
Other bias High risk Quote: “If, during the period of the trial,
the patient explicitly indicated that he or
she wanted to switch to another adjuvant
therapy, this was allowed. Using a coin,
with heads or tails it was decided which ad-
juvant therapy was next”
Quote: “Fourteen patients switched thera-
pies: 12 from CT to PT (nine patients) or
OT (three patients) and two from OT to
PT”
Comment: violations of the random se-
quence generation were permitted
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Quote: “Thus, with the inclusion of 135
patients, the power to recognize signifi-
cant differences was somewhat smaller: the
power to detect a significant treatment ef-
fect within each group was 72%, whereas
differences between the 3 groups could be
established with a power of 79%”
Comment: the trial was slightly underpow-
ered, which may have introduced bias in
estimates of treatment effect and/or con-
tributed to a lack of precision regarding es-
timates of treatment effect
Schreuders 2014
Methods Design: parallel group, 2-arm, single-blind RCT (The Netherlands; dates not reported)
Setting: not reported.
Interventions:GMI programme plus conventional treatment or conventional treatment
alone
Sample size calculation: not reported.
Participants Number of participants: 18 (experimental group N = 11, control group N = 7).
Type of noxious initiating event: not reported (upper limb).
Diagnostic criteria: Bruehl 1999 (CRPS I).
Baseline characteristics:
1. GMI programme (and included in the analysis N = 10):
i) mean (SD) age = 42.4 (16.8) years; female:male = 8:2;
ii) mean (SD) duration of CRPS I: 50.3 (53.7) months;
2. standard care (and included in the analysis N = 5):
i) mean (SD) age = 52.8 (12.7) years; female:male = 4:1;
ii) mean (SD) duration of CRPS I: 127.4 (87.5) months.
Inclusion criteria:
1. aged between 18 and 75 years;
2. symptoms > 6 months.
Exclusion criteria: not reported
Interventions All participants received conventional treatment including a 6-weekOT and physiother-
apy programme, including training of grip function, muscle strengthening and joint mo-
bility interventions, writing exercises and advice to reduce the use of splints. Participants
were asked not to participate in other treatment programmes during the 12-week period
and not to change the type or dosage medication of their medication unless instructed
to do so by their physician
GMI programme (N = 11)
Components of intervention:
1. adapted from Moseley 2004;
2. hand laterality recognition (1 week);
3. visual movement imagery exercises (1 week);
4. mirror therapy (4 weeks).
Dosage: 10 minutes.
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Frequency of administration: every hour (3 times per day minimum) for a total of 6
weeks
Provider: therapists (distinction between physio- and occupational therapist not re-
ported)
Standard care (N = 7)
Components of intervention:
1. supervised exercise (first 3 weeks);
2. feedback regarding home exercises (second 3 weeks);
3. training of grip functions (details not reported);
4. muscle strengthening exercises (details not reported);
5. joint mobility (details not reported);
6. housekeeping and other daily activities (details not reported);
7. writing exercises;
8. coaching to reduce the use of splints.
Dosage: 60 minutes per week (over 1 or 2 sessions).
Frequency of administration: 1 or 2 sessions per week, for 6 weeks
Provider: physical therapists and occupational therapists.
Outcomes Outcomes were assessed at baseline and after 3, 6 (immediately post-treatment) and 12
weeks (6 weeks post-treatment) post enrolment
Primary outcomes:
1. self-rated current pain intensity using a VAS ranging from 0 (no pain) to 100
(unbearable pain);
2. self-rated minimum pain intensity (last 3 days) using a VAS ranging from 0 (no
pain) to 100 (unbearable pain);
3. self-rated maximum pain intensity (last 3 days) using a VAS ranging from 0 (no
pain) to 100 (unbearable pain);
4. activities of daily living using the Radboud Skills Questionnaire (RASQ) total
score and 3 sub-scales:
i) clothing, washing, eating;
ii) household activities;
iii) recreation, social activities.
Secondary outcomes: fine hand coordination of both hands by using the Nine Hole
Peg Test (recorded in seconds)
Notes Source of funding: ErasmusMCMrace Project Zorg 2004-20, grant number 2004-20.
Statement regarding declarations of interest: the trial authors declared no conflicts of
interest.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Based on a computerized random
schedule...”
Comment: the trial authors used an accept-
able method to generate the sequence allo-
cation
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Allocation concealment (selection bias) Low risk Quote: “Based on a computerized random
schedule, a researcher not involved in the
execution of the trial, made a sequence
of numbered opaque envelopes. These en-
velopes were prepared with equality being
achieved after every ten subjects (block size
10)”
Quote: “Envelopes were given in sequence
of entry to the patient and were opened by
the patient”
Comment: the trial authors used an accept-
able method to conceal the allocation se-
quence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “Patients were not blinded to the
treatment as they were aware of the treat-
ment content”
Comment: given the nature of the inter-
vention, participants were not blinded to
treatment and may have had different ex-
pectations about the benefits of each inter-
vention
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Comment: unblinded participants, who
may have had different expectations about
the benefits of the intervention they re-
ceived, self-reported some outcomes (e.g.
pain intensity)
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Quote: “The assessor was blinded for the
allocation to the experimental or control
group”
Quote: “The measurements were per-
formed by trained blinded assessors”
Comment: the trial authors blinded out-
come assessors to participant group alloca-
tion
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
High risk Comment: the trial authors did not ade-
quately report drop-out rate in the ’Results’
section of the manuscript
Comment: according to ’Figure 2’ of the
manuscript, 1 participant was lost to fol-
low-up and 2 discontinued the interven-
tion from the experimental group, 1 partic-
ipant withdrew after randomisation, 1 par-
ticipant was lost to follow-up and 3 dis-
continued the intervention from the con-
ventional treatment group, giving drop-out
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rates of 27% and 71% respectively, and an
overall drop-out rate of 44%
Comment: the high drop-out ratemay have
introduced bias in estimates of treatment
effect
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
High risk Comment: the trial authors reported anal-
ysis as ITT in Figure 2 of the unpublished
manuscript
Quote: “Three patients (one in the exper-
imental group, two in the control group)
could not be included in the analysis due
to insufficient compliance in filling out the
VAS and RASQ questionnaires or because
of immediate withdrawal from the con-
trol therapy because the participants only
wanted the graded MIP”
Comment: violation of the principle of
ITT analysis may have introduced bias in
estimates of treatment effect
Quote: “From seven of the remaining fif-
teen patients (five in the experimental
group and two in the control group) there
were missing end-tests” (i.e. at 12 weeks
post enrolment/6 weeks postintervention)
Quote: “Differences in changes in both
groups over times were tested using a gen-
eralized estimating equations (GEE) ap-
proach.Under the assumption thatmissing
data were random and not due to group al-
location or treatment effect, this model es-
timates missing data values, thereby allow-
ing the use of data from all participants, ir-
respective of whether they were measured
at all time points”
Comment: use of GEE may have intro-
duced bias in estimates of treatment effect
Selective reporting (reporting bias) High risk Comment: the trial authors reported out-
come data graphically for all self-reported
pain outcomes; and did not report raw data
in numerical form with measures of varia-
tion. The trial authors presented effect sizes
with measures of variation for the Rad-
boud Skills Questionnaire and Nine Hole
Peg Test; and did not report numerical data
with measures of variation
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Sample size High risk Quote: “For this trial eighteenpatientswere
included”.
Quote: “For this study only 18 patients
were assessed for eligibility and only 15 of
them could be included in the analysis. The
number of patients in the study was there-
fore too small to detect possible effects with
the intended power for which 52 patients
were needed”
Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up Unclear risk Quote: “Outcome was assessed at baseline,
after 3, 6 and 12 [i.e. 6 weeks post-treat-
ment] weeks”
Comment: the clinical relevance of a 6-
week follow-up of outcomes is uncertain
Other bias High risk Comment: baseline data for 3 participants
excluded from the analysis not reported
Comment: likely highly significant base-
line imbalance in durationof symptomsbe-
tween groups
Uher 2000
Methods Design: parallel group, 2-arm, RCT (Germany, dates not reported).
Setting: not reported.
Interventions: manual lymph drainage (MLD) plus exercise or exercise alone
Sample size calculation: not reported.
Participants Number of participants: 40 (15 in themanual lymph drainage group, 25 in the exercise
alone group)
Type of noxious initiating event: mixed (postfracture n = 27, post dislocation n = 9,
postsurgery n = 4) (lower limb)
Diagnostic criteria: CRPS I (diagnostic criteria not reported).
Baseline characteristics:
Total sample: female:male 31:4.
1. Group receiving manual lymph drainage plus exercise:
i) mean (SD) age = not reported; female:male = not reported;
ii) mean (SD) duration of CRPS I = not reported.
2. Group receiving exercise:
i) mean (SD) age = not reported; female:male = not reported;
ii) mean (SD) duration of CRPS I = not reported.
Inclusion criteria:
1. clinical, radiographic and scintigraphic signs of CRPS 1;
2. < 6 months post-trauma/surgery.
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Exclusion criteria:
1. venous insufficiency;
2. recurrent thrombophlebitis;
3. peripheral vascular disease;
4. blood disorders;
5. currently receiving physical treatment.
Interventions Participants were given a brochure providing general advice (details not reported), no
analgesic or anti-inflammatory medication prescribed, participants were asked to inform
the clinician if they took analgesia or anti-inflammatory medication for more than 3
days
Manual lymph drainage plus exercise (N = 15)
Components of intervention:
1. manual lymph drainage (further details not reported);
2. exercise (as below).
Dosage: 30 minutes
Frequency of administration: 3 times per week for 6 weeks (18 sessions)
Provider: physiotherapists
Exercise (N = 25)
Components of intervention:
1. goal to improve range of motion and reduce pain;
2. rhythmic stabilisation techniques of Klein Vogelbach and passive movements as
tolerated of the affected ankle.
Dosage: 30 minutes.
Frequency of administration: 3 times per week for 6 weeks (18 sessions)
Provider: physiotherapists.
Outcomes Outcomes assessed at baseline and immediately on completion of the intervention period
(6 weeks post recruitment). The trial authors did not state any primary outcome
1. Self-rated pain intensity measured using a 6-point verbal rating scale (0 = no pain,
5 = maximum pain);
2. range of motion (dorsiflexion and plantarflexion) at the talocrural joint measured
using a goniometer;
3. temperature measured using a surface thermometer, between the malleoli, with
the value recorded as the difference between 2 sides;
4. swelling measured as the difference in ankle circumference (in cm), at level of
malleoli, between 2 sides;
5. radiological assessment (details not reported);
6. scintigraphic assessment (details not reported).
Notes Source of funding: not reported.
Statement regarding declarations of interest: not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: the trial authors did not report
the method of sequence generation
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Allocation concealment (selection bias) Low risk Quote: “Randomisation was done using
the sealed envelope method, by a doctor
not involved in the study”
Comment: the trial authors used an accept-
able method to conceal the allocation se-
quence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: given the nature of the inter-
vention, participants were not blinded to
treatment and may have had different ex-
pectations about the benefits of each inter-
vention
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Comment: unblinded participants, who
may have had different expectations about
the benefits of the intervention they re-
ceived, self-reported some outcomes (e.g.
pain intensity)
Blinding of outcome assessment (detection
bias)
Investigator-administered outcomes
Low risk Quote: “Tested by a doctor who did not
know group assignment”
Comment: the outcome assessor was
blinded to treatment allocation
Incomplete outcome data (attrition bias)
Drop-out rate described and acceptable
Low risk Comment: an overall, and balanced, drop-
out rate of 12% is unlikely to have biased
the results
Incomplete outcome data (attrition bias)
Participants analysed in the group to which
they were allocated
High risk Comment: the trial authors excluded 3
participants (2 from the MLD group and
1 from the exercise group) were excluded
from the analysis because they did not reg-
ularly attend for therapy, in violation of
the ITT principle. Two participants from
the exercise group were excluded after ran-
domisation secondary to wrongful inclu-
sion despite fulfilment of exclusion criteria
Selective reporting (reporting bias) High risk Comment: the trial authors did not report
outcome data for pain intensity
Sample size High risk Comment: the small sample size may have
introduced bias in estimates of treatment
effect
Duration of follow-up High risk Quote: “Assessment after six weeks of ther-
apy”.
Comment: outcomes were re-measured on
immediate completion of the intervention
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period only and were not measured over a
clinically relevant length of time
Other bias Low risk Comment: we did not identify any other
sources of bias.
Abbreviations: CRPS I: complex regional pain syndrome type 1; CT: control therapy; GMI: graded motor imagery; IFC: interferential
current; ITT: intention to treat; MIP: motor imagery programme; MLD: manual lymphatic drainage; NRS: numerical rating
scale; OT: occupational therapy; PT: physiotherapy/physical therapy; RCT: randomised controlled trial; RSD: reflex sympathetic
dystrophy; SD: standard deviation; SGB: stellate ganglion block; SPSS: Statistical Package for the Social Sciences; SW: social work;
TDT: tactile discrimination training; TENS: transcutaneous electrical nerve stimulation; TPD: two-point discrimination; US:
ultrasound; VAS: visual analogue scale.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bolel 2006 This study only evaluated the outcome measure of ’sympathetic skin response’ and fell outside the inclusion
criteria of this review
Fialka 1992 Not a RCT.
Fialka 1996 Autogenic training does not fall within the scope of practice of physiotherapy
Field 1993 Not a RCT.
Gromo 1974 Not a RCT.
Jasmina 2012 Not a RCT.
Karabegovi 2009 Not a RCT.
Koci 2010 The study authors only evaluated ’infrared thermovision’ as the only outcome measure and fell outside the
inclusion criteria of this review
Perrigot 1982 Not a RCT.
Toth 2014 The trial included participants (N = 54) with mixed aetiologies but only 2 participants with complex regional
pain syndrome (CRPS) with 1 randomised to each trial arm. We could not make any meaningful comparison
Tulgar 1991 Not a RCT.
Wu 1999 Qigong does not fall within the scope of practice of physiotherapy
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Zyluk 1994 Not a RCT.
Abbreviations: RCT: randomised controlled trial.
Characteristics of studies awaiting assessment [ordered by study ID]
ISRCTN39729827
Methods Unavailable.
Participants Unavailable.
Interventions Unavailable.
Outcomes Unavailable.
Notes We are awaiting submission for publication.
Mete-Topcuoglu 2010
Methods Not yet assessed.
Participants Not yet assessed.
Interventions Not yet assessed.
Outcomes Not yet assessed.
Notes This is currently only available as a conference abstract.
NCT00625976
Methods Unavailable.
Participants Unavailable.
Interventions Unavailable.
Outcomes Unavailable.
Notes We were unable to contact the study authors.
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Barnhoorn 2012
Trial name or title The effectiveness and cost evaluation of pain exposure physical therapy and conventional therapy in patients
with complex regional pain syndrome type 1. Rationale and design of randomized controlled trial
Methods Parallel-group, 2-arm randomised controlled trial (RCT) (The Netherlands)
Participants Inclusion criteria:
1. diagnosis of CRPS I; of upper or lower extremity; and of between 3 and 24 months duration;
2. age 18 to 80 years.
Exclusion criteria:
1. alternative diagnoses that may explain the pain syndrome;
2. impairments of the contra-lateral extremity;
3. relapse of CRPS I;
4. prior sympathectomy of the affected extremity;
5. pregnancy; lactation.
Interventions Experimental group: ’pain exposure physical therapy’, consisting of a progressive-loading exercise pro-
gramme, de-sensitising massage and management of pain-avoidance behaviour
Conventional group: conventional treatment according to Dutch guidelines; comprising pharmacological
and physical therapy exercise interventions
Outcomes Primary outcome measures:
1. impairment level SumScore (ISS) (restricted version).
Secondary outcome measures:
1. Disability of Arm, Shoulder and Hand questionnaire;
2. Lower Limb Tasks Questionnaire;
3. Fear-Avoidance Beliefs Questionnaire;
4. SF-36;
5. muscle force measurements, as measured by a hand-held dynamometer;
6. 10 metre walking test;
7. Timed Up and Go test;
8. compliance and adherence, as measured by interview, questionnaires (the Seven Days Physical Activity
Recall, International Physical Activity Questionnaire, Pain Catastrophising Scale, Pain Disability Index) and
accelerometry.
Starting date January 2009
Contact information Jan Paul Frölke MD, PhD; J.Frolke@chir.umcn.nl
Notes http://clinicaltrials.gov/show/NCT00817128
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ISRCTN48768534
Trial name or title Transcutaneous electrical nerve stimulation (TENS) for patients with upper limb complex regional pain
syndrome: a feasibility study
Methods Parallel-group, 2-arm RCT (UK)
Participants Inclusion criteria:
1. 18 years of age or older;
2. have had CRPS for ≥ 6 months;
3. can speak English to a good standard;
4. no neurological conditions;
5. capable of making an informed decision to take part or not.
Exclusion criteria:
1. individuals with a pacemaker, heart disease or epilepsy;
2. individuals who are pregnant;
3. abnormal skin sensation in the area below the electrodes.
Interventions Intervention group: transcutaneous electrical nerve stimulation
Placebo group: sham transcutaneous electrical nerve stimulation
Outcomes Primary outcome measures:
1. pain intensity using a VAS;
2. medication use;
3. Disability of Arm, Shoulder and Hand questionnaire;
4. Hand Laterality Recognition Task;
5. Bath CRPS Body Perception Disturbances questionnaire.
Secondary outcome measures:
1. placebo blinding credibility;
2. adverse reactions;
3. qualitative interviews.
Starting date November 2013
Contact information Dr Cormac Ryan PhD, c.ryan@tees.ac.uk
Notes http://controlled-trials.com/ISRCTN48768534
NCT01915329
Trial name or title Effects of repetitive electrical sensory stimulation (RSS) as intervention in complex regional pain syndrome
type I (CRPS)
Methods Parallel-group, 2-arm RCT (Germany)
Participants Inclusion criteria:
1. age 18 to 75 years;
2. diagnosed with CRPS.
Exclusion criteria:
1. intolerable hyperalgesia;
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2. lesions at the finger tips;
3. high grade digit contracture;
4. central neurological disorders;
5. psychiatric disorders;
Interventions Experimental group: repetitive electrical sensory stimulation
Sham comparator: sham repetitive electrical sensory stimulation
Outcomes Primary outcome measures:
1. static tactile 2-point discrimination threshold.
Secondary outcome measures:
1. pain intensity using an 11-point NRS;
2. somatosensory evoked potentials.
Starting date February 2012
Contact information Christoph Maier MD, PhD; christopp.maier@rub.de
Notes http://clinicaltrials.gov/show/NCT01915329
NCT01944150
Trial name or title Association of transcutaneous electrical nerve stimulation and hypnosis (HYPTENS)
Methods Parallel-group, 2-arm RCT (France)
Participants Inclusion criteria:
1. age 18 to 80 years suffering from chronic non-cancer pain of mixed aetiologies (either nociceptive or
neuropathic) including osteoarthritic limb arthralgia, chronic lumbo radiculalgia, chronic back pain,
cervical radiculopathy, postherpetic neuralgia, postsurgical peripheral neuropathic pain, post-trauma
neuropathic pain, CRPS I or II, tendinopathy;
2. uninjured skin;
3. ability to comply with requirements of the trial.
Exclusion criteria:
1. participants with fibromyalgia;
2. participants receiving relaxation therapy, acupuncture or cognitive/behavioural therapies;
3. participants with cognitive disorders, unaided hearing loss, a major hearing impairment, a pace maker,
allodynia or complete anaesthesia of the painful territory or already been treated by TENS or hypnosis, or
both;
4. pregnancy.
Interventions Experimental group: transcutaneous electrical nerve stimulation and hypnosis.
Active comparator group: transcutaneous electrical nerve stimulation.
Outcomes Primary outcome measures:
1. pain intensity using a VAS (0 to 100 mm).
Secondary outcome measures:
1. analgesic consumption;
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2. SF36;
3. patient global impression of change (PGIC).
Starting date September 2013
Contact information Louise Geoffroy, ide.emdsp@sat.aphp.fr
Notes http://clinicaltrials.gov/show/NCT01944150
UKCRN ID 12602
Trial name or title Development of an Electrical Sensory Discrimination Therapies device (ESDT) for the relief of chronic pain
in Complex Regional Pain Syndrome. A proof of concept study
Methods Parallel-group, 2-arm RCT (UK)
Participants Inclusion criteria:
1. diagnosed with CRPS type I.
Exclusion criteria:
1. diagnosed with any other neurological, psychopathologic, motor disorder or major nerve damage
(CRPS II);
2. the presence of any other limb pathology or pain on the affected CRPS limb;
3. cutaneous damage on the area to be stimulated;
4. receiving intensive CRPS-specific MDT rehabilitation in an inpatient setting during the time course of
the study or within the previous month;
5. unable to understand written or verbal English and give informed consent.
Interventions Intervention group: ESDT and de-sensitisation tasks.
Control group: routine care, including de-sensitisation tasks.
Outcomes 1. Short form McGill Pain Questionnaire;
2. Brief Pain Inventory questionnaire;
3. Disability of Arm, Shoulder and Hand questionnaire (upper limb CRPS);
4. Lower Extremity Functional Scale questionnaire (lower limb CRPS);
5. Hospital Anxiety and Depression Scale;
6. adverse events.
Starting date 2012
Contact information Prof CS McCabe PhD, Candy; Mccabe@uwe.ac.uk
Notes
Abbreviations: ESDT: electrical sensory discrimination therapies; PGIC: patient global impression of change; RCT: randomised con-
trolled trial; RSS: repetitive electrical sensory discrimination; TENS: transcutaneous electrical nerve stimulation; UK: United King-
dom; VAS: visual analogue scale.
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D A T A A N D A N A L Y S E S
Comparison 1. Graded motor imagery versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain intensity (post-treatment) 2 49 Mean Difference (IV, Random, 95% CI) -14.45 [-23.02, -5.
87]
2 Function (0 to 11 patient
specific functional scale)
(post-treatment)
2 49 Mean Difference (IV, Random, 95% CI) 1.87 [1.03, 2.71]
Analysis 1.1. Comparison 1 Graded motor imagery versus usual care, Outcome 1 Pain intensity (post-
treatment).
Review: Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II
Comparison: 1 Graded motor imagery versus usual care
Outcome: 1 Pain intensity (post-treatment)
Study or subgroup GMI Usual care
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Moseley 2004 7 38 (10) 6 58 (12) 38.3 % -20.00 [ -32.13, -7.87 ]
Moseley 2006 19 36 (16) 17 47 (10) 61.7 % -11.00 [ -19.62, -2.38 ]
Total (95% CI) 26 23 100.0 % -14.45 [ -23.02, -5.87 ]
Heterogeneity: Tau2 = 11.68; Chi2 = 1.41, df = 1 (P = 0.24); I2 =29%
Test for overall effect: Z = 3.30 (P = 0.00096)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours GMI Favours usual care
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Analysis 1.2. Comparison 1 Graded motor imagery versus usual care, Outcome 2 Function (0 to 11 patient
specific functional scale) (post-treatment).
Review: Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II
Comparison: 1 Graded motor imagery versus usual care
Outcome: 2 Function (0 to 11 patient specific functional scale) (post-treatment)
Study or subgroup GMI Usual care
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Moseley 2004 7 4.42 (0.786) 6 2.16 (0.752) 54.7 % 2.26 [ 1.42, 3.10 ]
Moseley 2006 19 3.3 (1.7) 17 1.9 (1.3) 45.3 % 1.40 [ 0.42, 2.38 ]
Total (95% CI) 26 23 100.0 % 1.87 [ 1.03, 2.71 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 1.70, df = 1 (P = 0.19); I2 =41%
Test for overall effect: Z = 4.37 (P = 0.000013)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours usual care Favours GMI
A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL, DARE and HTA search strategies
#1 MeSH descriptor: [Complex Regional Pain Syndromes] explode all trees
#2 “complex regional pain syndrome*”:ti,ab,kw (Word variations have been searched)
#3 crps:ti,ab,kw (Word variations have been searched)
#4 (Post traumatic near/1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome)):ti,ab,kw (Word variations
have been searched)
#5 “Minor causalgia”:ti,ab,kw (Word variations have been searched)
#6 “Transient migratory osteoporosis”:ti,ab,kw (Word variations have been searched)
#7 “Peripheral trophneurosis”:ti,ab,kw (Word variations have been searched)
#8 ((Major or mitchell*) near/1 causalgia):ti,ab,kw (Word variations have been searched)
#9 “Neurovascular dystrophy”:ti,ab,kw (Word variations have been searched)
#10 “Sudecks Osteodystrophy”:ti,ab,kw (Word variations have been searched)
#11 Sympathalgia:ti,ab,kw (Word variations have been searched)
#12 Chronic traumatic oedema:ti,ab,kw (Word variations have been searched)
#13 Sympathetic dystrophy syndrome:ti,ab,kw (Word variations have been searched)
#14 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13
#15 MeSH descriptor: [Physical Therapy Modalities] explode all trees
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#16 physiotherap*:ti,ab,kw (Word variations have been searched)
#17 “physical therap*”:ti,ab,kw (Word variations have been searched)
#18 manual therapy:ti,ab,kw (Word variations have been searched)
#19 manipulative therapy:ti,ab,kw (Word variations have been searched)
#20 ((therapeutic or therapy) near/2 exercise):ti,ab,kw (Word variations have been searched)
#21 MeSH descriptor: [Electric Stimulation Therapy] explode all trees
#22 (electrotherapy or TENS or “transcutaneous electrical nerve stimulation” or “therapeutic ultrasound” or interferential or “shortwave
diathermy” or “laser therapy ” or “heat therapy” or cryotherapy):ti,ab,kw (Word variations have been searched)
#23 graded motor imagery:ti,ab,kw (Word variations have been searched)
#24 mirror therapy:ti,ab,kw (Word variations have been searched)
#25 MeSH descriptor: [Musculoskeletal Manipulations] explode all trees
#26 tactile sensory discriminatory training:ti,ab,kw (Word variations have been searched)
#27 sensory-motor integration:ti,ab,kw (Word variations have been searched)
#28 sensory-motor re-tuning:ti,ab,kw (Word variations have been searched)
#29 hydrotherapy:ti,ab,kw (Word variations have been searched)
#30 (pain near/3 (advice or education)):ti,ab,kw (Word variations have been searched)
#31 (manipulation or massage or de-sensiti?ation or mobili?ation):ti,ab,kw (Word variations have been searched)
#32 #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31
#33 #14 and #32
MEDLINE search strategy
1. exp Complex Regional Pain Syndromes/
2. “complex regional pain syndrome*”.tw.
3. crps.tw.
4. (Post traumatic adj1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome)).tw.
5. “Minor causalgia”.tw.
6. “Transient migratory osteoporosis”.tw.
7. “Peripheral trophneurosis”.tw.
8. “Sudeck’s Osteodystrophy”.tw.
9. “Neurovascular dystrophy”.tw.
10. ((Major or mitchell*) adj1 causalgia).tw.
11. Sympathalgia.tw.
12. Chronic traumatic oedema.tw.
13. Sympathetic dystrophy syndrome.tw.
14. or/1-13
15. exp Physical Therapy Modalities/
16. physiotherap*.tw.
17. “physical therap*”.tw.
18. manual therapy.tw.
19. manipulative therapy.tw.
20. ((therapeutic or therapy) adj2 exercise).tw.
21. exp Electric Stimulation Therapy/
22. (electrotherapy or TENS or “transcutaneous electrical nerve stimulation” or “therapeutic ultrasound” or interferential or “shortwave
diathermy” or “laser therapy ” or “heat therapy” or cryotherapy).tw.
23. graded motor imagery.tw.
24. mirror therapy.tw.
25. exp Musculoskeletal Manipulations/
26. tactile sensory discriminatory training.tw.
27. sensory-motor integration.tw.
28. sensory-motor re-tuning.tw.
29. hydrotherapy.tw.
30. (pain adj3 (advice or education)).tw.
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31. (manipulation or massage or de-sensiti#ation or mobili#ation).tw.
32. or/15-31
33. 14 and 32
34. randomized controlled trial.pt.
35. controlled clinical trial.pt.
36. randomized.ab.
37. placebo.ab.
38. drug therapy.fs.
39. randomly.ab.
40. trial.ab.
41. or/34-40
42. exp animals/ not humans.sh.
43. 41 not 42
44. 33 and 43
EMBASE search strategy
1. exp Complex Regional Pain Syndromes/
2. “complex regional pain syndrome*”.tw.
3. crps.tw.
4. (Post traumatic adj1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome)).tw.
5. “Minor causalgia”.tw.
6. “Transient migratory osteoporosis”.tw.
7. “Peripheral trophneurosis”.tw.
8. “Sudeck’s Osteodystrophy”.tw.
9. “Neurovascular dystrophy”.tw.
10. ((Major or mitchell*) adj1 causalgia).tw.
11. Sympathalgia.tw.
12. Chronic traumatic oedema.tw.
13. Sympathetic dystrophy syndrome.tw.
14. or/1-13
15. exp Physical Therapy Modalities/
16. physiotherap*.tw.
17. “physical therap*”.tw.
18. manual therapy.tw.
19. manipulative therapy.tw.
20. ((therapeutic or therapy) adj2 exercise).tw.
21. exp Electric Stimulation Therapy/
22. (electrotherapy or TENS or “transcutaneous electrical nerve stimulation” or “therapeutic ultrasound” or interferential or “shortwave
diathermy” or “laser therapy ” or “heat therapy” or cryotherapy).tw.
23. graded motor imagery.tw.
24. mirror therapy.tw.
25. exp Musculoskeletal Manipulations/
26. tactile sensory discriminatory training.tw.
27. sensory-motor integration.tw.
28. sensory-motor re-tuning.tw.
29. hydrotherapy.tw.
30. (pain adj3 (advice or education)).tw.
31. (manipulation or massage or de-sensiti#ation or mobili#ation).tw.
32. or/15-31
33. 14 and 32
34 random$.tw.
35 factorial$.tw.
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36 crossover$.tw.
37 cross over$.tw.
38 cross-over$.tw.
39 placebo$.tw.
40 (doubl$ adj blind$).tw.
41 (singl$ adj blind$).tw.
42 assign$.tw.
43 allocat$.tw.
44 volunteer$.tw.
45 Crossover Procedure/
46 double-blind procedure.tw.
47 Randomized Controlled Trial/
48 Single Blind Procedure/
49 or/34-48 (1433702)
50 (animal/ or nonhuman/) not human/
51 49 not 50
52 33 and 51
PsycINFO search strategy
1. exp “Complex Regional Pain Syndrome (Type I)”/
2. “complex regional pain syndrome*”.tw.
3. crps.tw.
4. (Post traumatic adj1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome)).tw.
5. “Minor causalgia”.tw.
6. “Transient migratory osteoporosis”.tw.
7. “Peripheral trophneurosis”.tw.
8. “Sudeck’s Osteodystrophy”.tw.
9. “Neurovascular dystrophy”.tw.
10. ((Major or mitchell*) adj1 causalgia).tw.
11. Sympathalgia.tw.
12. Chronic traumatic oedema.tw.
13. Sympathetic dystrophy syndrome.tw.
14. or/1-13
15. exp Physical Therapy/
16. physiotherap*.tw.
17. “physical therap*”.tw.
18. manual therapy.tw.
19. manipulative therapy.tw.
20. ((therapeutic or therapy) adj2 exercise).tw.
21. exp Electrical Stimulation/
22. (electrotherapy or TENS or “transcutaneous electrical nerve stimulation” or “therapeutic ultrasound” or interferential or “shortwave
diathermy” or “laser therapy ” or “heat therapy” or cryotherapy).tw.
23. graded motor imagery.tw.
24. mirror therapy.tw.
25. tactile sensory discriminatory training.tw.
26. sensory-motor integration.tw.
27. sensory-motor re-tuning.tw.
28. hydrotherapy.tw.
29. (pain adj3 (advice or education)).tw.
30. (manipulation or massage or de-sensiti#ation or mobili#ation).tw.
31. or/15-30
32. 14 and 31
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33. clinical trials/
34. (randomis* or randomiz*).tw.
35. (random$ adj3 (allocat$ or assign$)).tw.
36. ((clinic$ or control$) adj trial$).tw.
37. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
38. (crossover$ or “cross over$”).tw.
39. random sampling/
40. Experiment Controls/
41. Placebo/
42. placebo$.tw.
43. exp program evaluation/
44. treatment effectiveness evaluation/
45. ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw.
46. or/33-45
47. 32 and 46
CINAHL search strategy
S43 S33 AND S42
S42 S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41
S41 (allocat* random*)
S40 (MH “Quantitative Studies”)
S39 (MH “Placebos”)
S38 placebo*
S37 (random* allocat*)
S36 (MH “Random Assignment”)
S35 (Randomi?ed control* trial*)
S34 (singl* blind* ) or (doubl* blind* ) or (tripl* blind* ) or (trebl* blind* ) or (trebl* mask* ) or (tripl* mask* ) or
(doubl* mask* ) or (singl* mask* )
S33 S14 AND S32
S32 S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29
OR S30 OR S31
S31 (manipulation or massage or de-sensiti?ation or mobili?ation)
S30 (pain N3 (advice or education))
S29 hydrotherapy
S28 sensory-motor re-tuning
S27 sensory-motor integration
S26 tactile sensory discriminatory training
S25 (MH “Manual Therapy+”)
S24 mirror therapy
S23 graded motor imagery
S22 (electrotherapy or TENS or “transcutaneous electrical nerve stimulation” or “therapeutic ultrasound” or interferential or “shortwave
diathermy” or “laser therapy ” or “heat therapy” or cryotherapy)
S21 (MH “Transcutaneous Electrical Nerve Stimulation (Iowa NIC)”)
S20 ((therapeutic or therapy) N2 exercise)
S19 manipulative therapy
S18 manual therapy
S17 “physical therap*”
S16 physiotherap*
S15 (MH “Physical Therapy+”)
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
S13 Sympathetic dystrophy syndrome
S12 Chronic traumatic oedema
99Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S11 Sympathalgia
S10 ((Major or mitchell*) N1 causalgia)
S9 “Neurovascular dystrophy”
S8 “Sudeck’s Osteodystrophy”
S7 “Peripheral trophneurosis”
S6 “Transient migratory osteoporosis”
S5 “Minor causalgia”
S4 (Post traumatic N1 (algodystrophy or dystrophy or neurodystrophy or osteoporosis or pain syndrome))
S3 crps
S2 “complex regional pain syndrome*”
S1 (MH “Complex Regional Pain Syndromes+”)
LILACS search strategy
1. “crps”
2. “physiotherapy”
3. “clinical trial”
PEDro search strategy
1. “complex regional pain syndrome”
2. “reflex sympathetic dystrophy”
3. “causalgia”
4. “sudeks”’
5. “sympathetic pain”
6. “clinical trial”
Web of Science search strategy
1. “crps”
2. “physiotherapy”
3. “orthopaedic rehabilitation”
4. “articles”
C O N T R I B U T I O N S O F A U T H O R S
KMS conceived and designed the protocol, implemented the search strategy, applied eligibility criteria, assessed studies, extracted and
analysed data, and led the write-up of the review. BMW informed the protocol design, applied eligibility criteria, assessed studies,
extracted and analysed data, and assisted with the write-up of the review. NEO informed the protocol design, acted as the third review
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
With respect to Types of interventions, after the publication of Smart 2013 we decided to exclude studies that evaluated non-
physiotherapy based interventions (e.g. pharmacological) inwhich all study arms received the same physiotherapy intervention (differing
only in the application of the non-physiotherapy component) as they are unlikely to offer any insight into the value of physiotherapy
management. In Smart 2013 we stated our intention to search the SciVerse SCOPUS electronic database. However we did not search
this database as the primary review author (KMS) did not have institutional access. The Trials Search Co-ordinator of the Cochrane
PaPaS group advised that its omission was unlikely to adversely influence our search results. We have described, in additional detail,
our operational definitions upon which we based our ’Risk of bias’ judgements (see the ’Assessment of risk of bias in included studies’
section). In this Cochrane review we have specified the criteria upon which we based our GRADE judgements for rating the quality of
evidence (see the ’Data synthesis’ section).
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